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Initiating Complement-dependent Synaptic Refinement: Mechanisms of Neuronal C1q 
Regulation 
 
Immune molecules, including complement proteins, C1q and C3, have emerged as critical 
mediators of synaptic refinement and plasticity.  Complement proteins localize to synapses and refine 
the developing retinogeniculate system via C3-dependent microglial phagocytosis of synapses.  
Retinal ganglion cells (RGCs) express C1q, the initiating protein of the classical complement cascade, 
during retinogeniculate refinement; however, the signals controlling C1q expression and function 
remain elusive.  RGCs grown in the presence of astrocytes significantly upregulated C1q compared to 
controls, implicating an astrocyte-derived factor in neuronal C1q expression.  A major goal of my 
dissertation research was to identify the signals that regulate C1q expression and function in the 
developing visual system.  In this study, I have identified transforming growth factor beta (TGF-β), 
an astrocyte-secreted cytokine, as both necessary and sufficient for C1q expression in RGCs through 
an activity-dependent mechanism.  Specific disruption of retinal TGF-β signaling resulted in a 
significant reduction in the deposition of C1q and downstream C3 at retinogeniculate synapses and 
significant synaptic refinement defects in the retinogeniculate system.   Microglia engulfment of RGC 
inputs in the lateral geniculate nucleus (LGN) was also significantly reduced in retinal TGFβRII KOs, 
phenocopying the engulfment defects observed in C1q KOs, C3 KOs, and CR3 KOs.  Interestingly, in 
C1q KOs and retinal TGFβRII KOs, microglia also failed to preferentially engulf less active inputs 
when retinal activity was manipulated, suggesting that retinal activity and TGF-β signaling 
cooperatively regulate complement mediated synaptic refinement.  In support of this hypothesis, 
blocking spontaneous activity in RGC cultures significantly reduced C1q upregulation by TGF-β.  
Moreover, manipulating spontaneous retinal activity in vivo modulated C1q expression levels in RGCs 
and C1q deposition in the LGN.  Together these findings support a model in which retinal activity and iv 
 
TGF-β signaling control expression and local release of C1q in the LGN to regulate microglia-
mediated, complement-dependent synaptic pruning. These results provide mechanistic insight into 
synaptic refinement and, potentially, pathological synapse loss which occurs in the early stages of 
neurodegenerative diseases concurrently with aberrant complement expression and reactive gliosis. 
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Immune molecules have emerged as critical mediators of CNS development; however, 
the mechanisms regulating the expression and function of immune molecules in the CNS 
remain a mystery.  As a site of immune privilege, the developing CNS is an unexpected place to 
encounter the expression and function of many immune system genes.  Previous reports had 
characterized upregulation of immune system components primarily during injury and disease.  
More recent studies have revealed that immune molecules are not only present in the normal 
CNS, but also, they are functionally relevant for brain development (Bjartmar et al., 2006; Huh et 
al., 2000; Stevens et al., 2007).  Processes ranging from programmed cell death, neurite 
outgrowth, and polarization to synapse development, function, and plasticity can be modulated 
at some level by proteins traditionally associated with the immune system.  In most of these 
processes, immune molecules execute functions in the CNS that are very different from their 
conventional immune system roles.  One intriguing exception is the classical complement 
cascade.  Proteins from this innate immune system pathway are traditionally responsible for 
tagging and eliminating pathogens and apoptotic debris in the immune system.  Surprisingly, the 
nervous system has adopted this pathway to tag and eliminate inappropriate synapses in the 
developing CNS.  Recent work has shown that complement proteins localize to synapses during 
development and promote their elimination by the resident immune cells and phagocytes of the 
brain, microglia (Schafer et al., 2012a; Stevens et al., 2007).   
Thus, the CNS and the immune system use similar mechanisms to eliminate unwanted 
and potentially harmful material.  In the immune system, failure to clear pathogens can result in 
cell death and widespread infection.  In the CNS, failure to prune inappropriate connections 
results in dysfunctional circuitry and potentially hyperexcitability and seizures.  Indeed, several 
immune system components that have been implicated in normal brain development, including 
complement proteins, have been linked to neurodevelopmental disorders such as Autism 
Spectrum Disorders (ASD) and epilepsy (Aronica et al., 2007; Vargas et al., 2005; Voineagu et 
al., 2011).  Despite the importance of these molecules for CNS function, very little is known 3 
 
about the molecular mechanisms regulating the expression and function of immune system 
molecules in the CNS.  For my dissertation research, I have investigated the cellular and 
molecular components required for the developmental process of complement-dependent 
synapse elimination.  This work provides insight into the normal molecular mechanisms driving 
this process in development and suggests how these mechanisms may go awry in 
neurodevelopmental disorders, such as ASD and epilepsy.   
 
Mechanisms Driving Synaptic Refinement in the CNS  
One of the developmental processes utilizing immune system molecules is synaptic 
refinement, which is the process by which circuits become mature and precise.  Synaptic 
refinement is an activity-dependent process encompassing the strengthening and maturation of 
some synapses and the weakening and elimination of others.  This process has been 
extensively studied in the peripheral nervous system at the neuromuscular junction where 
motorneurons compete for synaptic territory on muscle fibers.  Activity-dependent synaptic 
competition has also been studied in the brain, most notably in the dorsal lateral geniculate 
nucleus in the developing visual system (Boulanger and Shatz, 2004; Hua and Smith, 2004; 
Huberman, 2007; Katz and Shatz, 1996; Sanes and Lichtman, 1999).  The maturation of 
nervous system circuitry is driven in part by Hebb‘s rule, which states that synapses which 
successfully and reproducibly evoke responses in the postsynaptic cell are maintained and 
mature (Butts et al., 2007; Hebb, 1949).  CNS circuits initially are connected in an imprecise 
manner, however, and contain many inappropriate connections that must be removed for proper 
brain function.  It is unclear why this ―overwiring‖ occurs in the vertebrate nervous system, but 
one idea is that this process is a product of evolution (Lichtman and Coleman, 2000).  In simpler 
invertebrate nervous systems, such as C. Elegans, neurons are unique and simple circuits of 
only one or two neurons regulate most functions.  In more complex nervous systems, however, 
a function such as photosensitivity requires an entire visual system comprised of thousands of  4 
 
 
 
 
 
 
 
 
 
 
Figure 1.1. The Punishment Model for Synapse Elimination.   (A) In the immature 
CNS, strong inputs are hypothesized to secrete an activity-dependent punishment signal 
(blue) that targets inappropriate synapses and promotes their elimination.  Strong inputs 
also produce a protective cue (orange) that blocks their own elimination.  (B) After 
synapse elimination, strong inputs are maintained and strengthened.  
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neurons and synapses, while a single neuron is charged with this function in the worm.  Thus, 
the vertebrate nervous system can be thought of as having a large degree of redundancy 
compared to the invertebrate.  This redundancy occurs both pre- and post-synaptically, 
therefore if we think of the mouse retinogeniculate system as evolving from a simpler visual 
system in which each neuron only has one postsynaptic target, we can imagine that each 
presynaptic neuron, or for example a retinal ganglion cell (RGC), is equally capable of 
innervating all postsynaptic cells, for example lateral geniculate nucleus (LGN) relay neurons.  
As a result, many RGCs project to the same LGN relay neurons and overlapping circuits are 
established.  Of course, the generation of many identical circuits confers no advantage to the 
mouse over the worm, but refinement of these circuits to generate thousands of unique 
connections results in the ability to discern objects and colors in space, which can help 
vertebrates to find food and avoid predators.  This overwiring allows for the animal to test out 
multiple circuits to determine which are the most appropriate based on its environment and 
sensory experience.  Given the importance of synaptic refinement in generating the complex 
circuitry in the vertebrate nervous system, a longstanding question in neurobiology is what 
determines which synapses will be eliminated versus maintained in the developing brain? 
One model for synapse elimination, based on the pioneering work of Lichtman et al. at 
the NMJ, is the punishment model (Jennings, 1994; Lichtman and Colman, 2000) (Figure 1.1).   
This model proposes that this developmental synaptic competition is mediated by the production 
of two activity-dependent signals: a punishment signal and a protective signal (Jennings, 1994; 
Lichtman and Colman, 2000).  Strong connections that successfully fire the postsynaptic cell are 
proposed to secrete an activity-dependent punishment signal that eliminates nearby 
inappropriate connections, while concurrently expressing a protective signal that prevents 
elimination of these strong inputs (Figure 1.1A).  It is not known whether this model is correct or 
relevant to the developing CNS and the identity of the potential punishment and protective 
signals have not been identified.   6 
 
   The mouse visual system has served as an excellent model for addressing questions 
related to how specific synapses are eliminated in the postnatal brain. A classic example of 
synaptic pruning in the CNS occurs in the postnatal visual system at the retinogeniculate 
synapse between retinal ganglion cells (RGCs) and the thalamic relay neurons of the dorsal 
lateral geniculate nucleus (dLGN) (Hooks and Chen, 2006; Jaubert-Miazza et al., 2005; Kano 
and Hashimoto, 2009) (Figure 1.2A). In adult mammals, after retinogeniculate refinement, RGC 
axons terminate in distinct, non-overlapping eye-specific domains in the dLGN (Figure 1.2A).  In 
the neonatal retinogeniculate system (P0-P10), however, each dLGN relay neuron initially 
receives many weak, immature RGC inputs (Figure 1.2B) from both contralateral and ipsilateral 
eyes.  RGC inputs in the dLGN segregate into eye specific territories by P10 such that each 
dLGN relay neuron is only innervated by immature inputs from a single eye.  Within eye specific 
territories, synaptic refinement or remodeling continues to occur during a period spanning eye 
opening (P10-P30 in mouse).  During this period, certain inputs strengthen and mature while 
others that fail to strengthen are eliminated such that by P30 each dLGN neuron receives stable 
inputs from an average of 1-2 RGC axons (Chen and Regehr, 2000; Hooks and Chen, 2006; 
Jaubert-Miazza et al., 2005) (Figure 1.2C).   
This later stage of synapse elimination is driven initially by spontaneous retinal wave 
activity that persists until P15 (Demas et al., 2003), and after by visual experience (Figure 1.2C) 
(Hooks and Chen, 2006; Huberman, 2007).  Interestingly, later phases of synaptic remodeling 
after eye opening are significantly disrupted if mice are placed in the dark, deprived of visual 
experience, after one week of vision (after P20).  This late dark rearing can actually revert the 
dLGN to a less refined state: synapses that have strengthened on relay neurons weaken and 
additional immature RGC inputs can again be detected innervating relay neurons after 7-12 
days of visual deprivation (Hooks and Chen, 2006).  Visual experience also regulates the 
maturation of the visual cortex which acquires exquisite organization as it matures.  The period  7 
 
 
 
Figure 1.2. Synaptic Remodeling in the Mammalian Visual System.  (A) RGCs in the 
eye project to LGN neurons of the thalamus that then project to primary visual cortex.  At 
both of these levels, a refinement process in which imprecise connections are weakened 
and eliminated and correctly targeted connections are strengthened and maintained to 
develop eye-specific layers in the LGN and ocular dominance columns in primary visual 
cortex (V1). (B) Eye specific segregation in the dLGN. Yellow represents overlapping 
inputs from both eyes.  By P30, there is no overlap and LGN neurons are innervated by 
single RGCs that have strengthened and elaborated their axonal arbors. (C)Time course 
for synaptic remodeling in the dLGN. Initially, synaptic remodeling is driven by 
spontaneous activity (blue) and leads to the formation of eye specific territories by P10.  
Around eye opening, spontaneous retinal wave activity stops and visual experience 
begins to drive later phases of remodeling (red) in which weak inputs are eliminated while 
remaining inputs strengthen and elaborate their arbors. Experience-dependent 
remodeling in the dLGN partially overlaps the cortical critical period (pink), suggesting a 
link between cortical and subcortical plasticity.      
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of sensory experience dependent remodeling in the dLGN closely matches the timing of the 
critical period for plasticity in visual cortex, suggesting that these processes may be linked 
(Hooks and Chen, 2006, 2007).  Complex cortical characteristics develop during the critical 
period including visual receptive fields, as well as ocular dominance and orientation selectivity 
columns (Hensch, 2004; Sur & Rubenstein, 2005).  Disruption of neuronal firing at any of these 
stages of visual development has profound effects on synaptic connectivity, yet surprisingly little 
is known about the molecular mechanisms that drive the elimination of some synapses and the 
maintenance and strengthening of others at each of these phases.     
 
Retinal Wave Activity and Synaptic Refinement 
Pioneering studies have revealed that synaptic refinement is driven by correlated bursts 
of action potentials in RGCs that initiate in random RGCs and then stream across the retina.  
These spontaneous ―waves‖ of activity start around birth in the rodent and continue until eye 
opening.  Waves occur in stages and each stage has different properties thought to drive 
different aspects of visual development.  In the rodent, stage I waves begin before birth and can 
be partially blocked by nicotinic acetylcholine receptor (nAChR) inhibitors (Bansal et al. 2000).  
Stage II waves begin around birth and continue for the first two postnatal weeks during the 
retinogeniculate refinement period (Bansal et al. 2000, Syed et al. 2004).  These waves are 
driven by acetylcholine released from starburst amacrine cells (Feller et al. 1996, Zheng et al. 
2004).  Desensitizing nAChRs with intraocular injection of the cholinergic agonist epibatidine 
disrupts eye stage II waves (Penn et al., 1998), and mice lacking β2-subunits of neuronal 
nAChRs (β2nAChR−/−) lack stage II retinal waves and exhibit uncorrelated retinal spiking 
(Bansal et al., 2000; Muir-Robinson et al., 2002).   Conversely, intraocular injections of 
pharmacological agents that elevate intracellular levels of cAMP, such as forskolin or dbcAMP, 
increase wave activity within the retina (Stellwagen et al., 1999).   Blocking nAChRs 
pharmacologically or genetically results in a failure to segregate into eye specific territories 9 
 
(Grubb et al., 2003; Huberman, 2007).  Intriguingly, increasing wave activity by raising cAMP 
levels also disrupts eye specific territories such that the more active eye occupies more dLGN 
territory than the less active eyes (Huberman, 2007; Stellwagen and Shatz, 2002).  Stage III 
waves occur later and last until eye opening.  These waves are thought to drive the specification 
of retinal circuits into ON-OFF and direction selective classes as well as the later stages of 
synaptic remodeling in the dLGN during which innervations of dLGN relay neurons is reduced 1-
2 strong RGC inputs (Hooks and Chen, 2006; Huberman, 2007) (Figure 1.2).   
Although manipulating retinal wave activity has clear effects on eye specific segregation 
and synaptic refinement, uncertainty remains over whether activity plays an instructive or 
permissive role in refinement and what aspects of activity are most important for driving 
refinement (Blankenship and Feller, 2010; Feller, 2009).  Early studies showed that spiking in 
dLGN neurons is required for eye-specific segregation by blocking dLGN activity with 
intracranial infusions of TTX and disrupting eye specific segregation (Sretavan et al., 1988).  
The first evidence that activity might be instructive came from studies in which one eye was 
removed before eye specific segregation and RGC axons from the intact eye continued to 
innervate the entire dLGN (Morgan and Thompson, 1993; Sretavan and Shatz, 1986).  The 
effects of increasing retinal wave activity with cAMP on eye specific segregation further support 
an instructive role for activity in the retina (Stellwagen and Shatz, 2002).  The relative levels of 
spontaneous activity in the two retinas, rather than a required threshold level of retinal activity, 
dictate how much LGN territory axons from a given RGC will occupy.  Results from 
β2nAChR−/− mice also support an instructive role for the patterns of activity in the retina since 
RGCs in these mice still exhibit firing but not in a correlated fashion (Bansal et al., 2000).  Thus, 
the importance of neuronal activity in retinogeniculate refinement is clear; however, the 
molecules required for the pruning of retinogeniculate synapses and the mechanism linking 
differences in neural activity with the removal of a synapse remain elusive.   
 10 
 
The Role of Activity-dependent Gene Transcription in Synapse Development  
How can neuronal activity be translated to the physical removal of inappropriate 
synapses?  One possible mechanism is that activity drives the expression of genes encoding 
proteins that execute synapse elimination.  Activity-dependent gene transcription is initiated 
when neurons fire action potentials, resulting in calcium influx through voltage gated calcium 
channels or glutamate receptors (Greer and Greenberg, 2008; Sheng et al., 1990).  Rises in 
intracellular calcium can activate pathways such as the Ras/MAPK pathway, the 
calcium/calmodulin-dependent protein kinases, the phosphatase calcineurin, and Rac GTPases 
(Greer and Greenberg, 2008).  Differences in patterns of activity preferentially drive certain 
pathways and consequently activate the transcription of a specific subset of activity-dependent 
genes.  Several hundred genes have been identified as calcium- and activity-dependent and 
have been implicated in many stages of nervous system development.  Surprisingly, however, 
only a handful of activity-dependent genes have been implicated in synapse elimination.   
Interestingly, two of these genes encode components of the innate immune system, 
MHC class I and neural pentraxins.  MHC class I molecules are expressed on the surface of 
every cell in the body and present peptides from within the cell to T cells.  Healthy cells are 
ignored while infected cells can be identified and targeted for removal.  In the immune system, 
pentraxins are acute phase proteins which can recognize pathogens and help to activate 
complement and phagocytic cells to clear these pathogens.  Both MHC I and neural pentraxins  
are expressed in an activity-dependent manner in the retinogeniculate system and mice 
deficient in MHC I signaling or neural pentraxins exhibit defects in eye specific segregation in 
the dLGN (Bjartmar et al., 2006; Corriveau et al., 1998b; Huh et al., 2000).  However, it remains 
unclear how these molecules lead to the specific targeting and removal of inappropriate 
synapses.       
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The Classical Complement Cascade Expression and Function in CNS 
The classical complement cascade is a branch of the innate immune system that traditionally 
is responsible for tagging or opsonizing apoptotic debris or pathogens to promote rapid elimination 
of this material from the body.  Although most complement components are synthesized by 
hepatocytes, many other cells in the body locally produce complement components at low levels 
and can be induced to express higher levels of complement during inflammation.  Additional 
functions for complement components have also been identified in the immune system during 
B-cell proliferation (Ambrus et al., 1990; Peters et al., 1988), in liver regeneration (Strey et al., 
2003), during neurogenesis (Rahpeymai et al., 2006), and recently in synaptic refinement in the 
CNS (Stevens et al., 2007).  In the CNS, some of the over forty complement proteins are 
synthesized by neurons, microglia, astrocytes, and oligodendrocytes (Alexander et al., 2008b; 
Barnum, 1995; Gasque et al., 2000).   
The complement cascade includes three branches: the classical pathway, the alternative 
pathway, and the lectin pathway (Degn et al., 2007; Fujita, 2002; T.J. Kindt, 2006).  The proteins 
that have been implicated in synaptic refinement are components of the classical pathway.  In 
this classical branch, C1, composed of the proteins C1q, C1r, and C1s, initiates the classical 
complement cascade when it binds to immune complexes and coats (opsonizes) dead cells, 
pathogens, or debris.  The C1 complex is secreted by circulating macrophages in the 
bloodstream and is only activated when C1q binds to the surface of a target.  C1q is the 
recognition and binding domain of C1 and is a large hexameric protein composed of 3 peptide 
chains, C1qA, B, and C (Kishore and Reid, 2000).  C1q structurally consists of a collagen-like 
domain and six globular head domains which can recognize and bind immune complexes, 
apoptotic debris, or pathogens (Eggleton et al., 1998; Kishore and Reid, 2000).  Binding of C1q 
causes activation of the two associated enzymes, C1r and C1s, that cleave downstream  12 
 
  
 
 
 
 
 
 
Figure 1.3. The Classical Complement Cascade.   (A) The classical complement 
cascade is activated by the binding of C1q, the initiating protein, to the surface of a 
pathogen such as a bacterium.  C1 then cleaves C2 and C4 to form C3 convertase, which 
can cleave C3 to produce a strong opsonin, C3b. The pathogen is then removed by 
phagocytosis or lysis by deposition of the membrane attack complex.  (B) Complement 
regulatory proteins (shown in red) can inhibit complement cascade activation at many 
levels. (C) C1q, the initiating protein of the classical complement cascade, is a large 
hexameric secreted protein composed of C1qA,C1qB, and C1qC peptide chains.  The 6 
domains come together to form a collagen-like tail and 6 globular head domains which 
bind to immune complexes, apoptotic debris, and pathogens to activate complement. 
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components C2 and C4, leading to formation of C3 convertase.  This enzyme cleaves inert C3   
protein into activated C3a (an anaphylatoxin) and C3b (a potent opsonin) fragments, which 
recruit phagocytic cells and tag material for phagocytosis, respectively (Klos et al., 2009; Zhou, 
2011).  Macrophages and other phagocytic cells express receptors for C3b, including 
complement receptor 3 (CR3), allowing these cells to engulf any particles or cells coated with 
this protein.  Also, C3b initiates formation of the membrane attack complex (MAC).  This 
complex of proteins can lyses cells when it is deposited in the cell membrane (T.J. Kindt, 2006).   
While these complement proteins are responsible for eliminating pathogens and 
apoptotic debris from the body, another class of complement proteins, known as complement 
regulatory proteins, is responsible for protecting healthy cells from damage during complement 
activation.  These regulatory proteins can be membrane bound or secreted and prevent 
cascade activation at several different levels of the cascade (Figure 1.3)  (Kraus et al., 2006; 
Sahu and Lambris, 2000).  C1-inhibitor irreversibly binds C1r and C1s to inhibit spontaneous 
activation of the complement cascade (Gasque et al., 2000).  Downstream, secreted inhibitors 
C4 binding protein (C4-BP) and Factor H interfere with C3 convertase formation and function.  
Inhibitors of C3 and C5 formation can also be membrane bound (Elward and Gasque, 2003; 
Gasque et al., 2000).  These inhibitors including Crry and CSMD1, which prevents C3 and C4 
deposition, DAF and CR1, which inhibit C3 and C5 convertases (Iida and Nussenzweig, 1981), 
and a co-factor for C3 and C4 inactivation known as MCP (Elward and Gasque, 2003).  The 
expression and function of complement regulatory proteins in the brain are not well understood; 
however, in the immune system these regulatory proteins are critical for homeostatic regulation 
of complement cascade function and protection against aberrant complement mediated 
elimination in health and disease.  
The Classical Complement Cascade Mediates Retinogeniculate Refinement 
Recent work has implicated this classical complement cascade in synaptic refinement in the 
retinogeniculate system.  This result was surprising since previously reports of classical complement 14 
 
cascade proteins in the CNS were associated with injury and disease.  Perhaps even more surprising 
was the finding that C1q expression was detected in developing neurons of the retina (Stevens et al., 
2007).  Microglia, the resident phagocytic immune cell of the brain, are the main source of C1q in the 
CNS; however in the postnatal retina, C1q is enriched in developing RGCs during the peak of 
synaptic refinement, suggesting C1q as a candidate activity-dependent gene regulating the 
development and refinement of retinogeniculate synapses.  Indeed, complement deficient mice (C1q 
or C3 KO) exhibit sustained defects in CNS synapse elimination, as shown by the failure to 
segregate into eye-specific territories and the retention of multi-innervated LGN neurons (Stevens et 
al., 2007); however, many mechanistic questions remain:  1) How do secreted complement 
proteins regulate the elimination of specific synapses at the right time and place?  2) What are 
the contribution and function of neuronal C1q in retinogeniculate synapse elimination?  3) What 
are the signal(s) that regulate and restrict neuronal C1q expression in the postnatal retina?  These 
questions have been the focus of my dissertation research. 
The immune system continues to provide important mechanistic insight into these 
questions.  Based on published and ongoing studies in the lab, the overarching hypothesis is 
that the classical complement cascade regulates the selective elimination of specific synapses 
using similar activation and regulatory pathways as seen in the immune system (Figure 1.3).  In 
the innate immune system, C1q and C3 opsonize unwanted cells and debris for rapid removal 
by macrophages.  If the complement cascade were working in its traditional manner, in the 
developing brain, I hypothesize that activity-dependent release of soluble C1q from active 
synapses would lead to local C3 cleavage to opsonize neighboring ‗weaker‘ synapses by C1q 
and/or C3 (iC3b).  In response, phagocytic cells would be recruited to the area to engulf the 
tagged material.  In the CNS, microglia express many of the same phagocytic receptors as 
macrophages, including complement receptor 3, CR3, suggesting that these cells could work to 
clear inappropriate synapses by complement-dependent engulfment.  Recent work has shown 15 
 
that, indeed, C1q and C3 localize to retinogeniculate synapses (Stevens et al., 2007) and 
microglia engulf retinogeniculate projections during the refinement period in a complement-
dependent manner (Schafer et al., 2012a). However, the mechanisms regulating this process 
are unknown.  Given that C1q is the initiating protein of the classical complement cascade and 
that C1q is developmentally expressed in RGCs during the retinogeniculate refinement period, I 
hypothesize that C1q also initiates complement-dependent synapse elimination.  Thus, 
understanding how C1q is regulated and functions at CNS synapses is critical and the focus of 
my thesis. 
 
Microglia: Novel Mediators of Synapse Development  
In the immune system, macrophages express phagocytic receptors including C3 
receptors (CR3/CD11b), which promote engulfment of complement-tagged material (Carroll, 
2004; Gasque, 2004; van Lookeren Campagne et al., 2007).  In the healthy postnatal CNS, 
microglia are the primary immune and phagocytic cells and the only cells to express CR3 
(Bobak et al., 1987; Graeber, 2010; Guillemin and Brew, 2004; Ransohoff and Perry, 2009; 
Schafer et al., 2012a). Microglia are myeloid-derived cells and, until recently, they were thought 
to develop from peripheral macrophages that entered and colonized the brain throughout 
development and into adulthood. We now know that most microglia arise from a unique pool of 
yolk-sac derived myeloid progenitors and migrate into the CNS by embryonic day E10.5 
(Ginhoux et al., 2010). Following migration into the CNS, microglia undergo a slow maturation 
and differentiation process that persists through late postnatal development (Ransohoff and 
Perry, 2009). Microglia start as highly phagocytic, amoeboid cells and maintain this morphology 
through the period of programmed cell death when they actively remove debris and dead cells 
(Ferrer et al., 1990). By the first postnatal week in mouse, these cells develop branches which 
are used to continually survey the environment and downregulate their phagocytic receptors 
(Ling and Wong, 1993).  In the event of injury or infection, microglia quickly adopt a more 16 
 
classically ―reactive‖ state and migrate to the site of injury where they shield the injury site, 
engulf pathogenic material or debris, and release many cytokines and chemokines (Davalos et 
al., 2005; Nimmerjahn et al., 2005).  While past work had focused on the role of microglia during 
disease, recent studies have revealed dynamic interactions between microglia and synapses in 
the healthy brain, particularly during developmental synaptic pruning (Schafer et al., 2012c; 
Tremblay et al., 2011).   
The process of synaptic refinement occurs corresponding to a specific time in microglial 
development when these cells have acquired processes but remain phagocytic (Schafer et al., 
2012a).  These special process-bearing phagocytic microglia have been observed in the dLGN 
and several other postnatal brain regions including hippocampus, cerebellum, and olfactory bulb 
(Dalmau et al., 1998; Perry et al., 1985), suggesting a role in synaptic remodeling, but until 
recently, the function of microglia in normal brain had remained a mystery.     
 
Microglia Sculpt Postnatal Neural Circuits in an Activity- and Complement-dependent Manner 
Since Microglia express an array of phagocytic receptors, including complement 
receptor 3 (CR3/CD11b/CD18) that could mediate the engulfment of complement-tagged 
material, these cells were a prime candidate to execute complement-dependent synapse 
elimination.  Using the mouse retinogeniculate system as a model, microglia were found to 
engulf RGC presynaptic inputs during the peak of retinogeniculate refinement in the developing 
dLGN (Schafer et al., 2012a). Moreover, genetic or pharmacological disruptions in microglia-
mediated engulfment during the postnatal period resulted in sustained functional deficits in eye-
specific segregation.  Furthermore, microglia-mediated engulfment of synaptic inputs was 
dependent upon signaling between CR3, expressed specifically by microglia, and complement 
component C3, which is present at high levels and localizes to synapses in the postnatal dLGN 
(Schafer et al., 2012a).  17 
 
Interestingly, microglia-mediated engulfment was found to be regulated by neuronal 
activity.  When competition between RGC inputs originating from the two eyes was enhanced by 
monocular injection of TTX or forskolin, microglia preferentially engulfed inputs from the eye 
with reduced neuronal activity relative to the other eye (Schafer et al., 2012a).  These data are 
consistent with previous work demonstrating a decreased synaptic territory of the ―weaker‖ 
inputs and increased territory of ―stronger‖ inputs within the dLGN (Cook et al., 1999; Del Rio 
and Feller, 2006; Hooks and Chen, 2006; Huberman et al., 2008a; Penn et al., 1998; 
Stellwagen and Shatz, 2002).  Although it is not yet known how microglia target specific 
“weaker” synapses, complement is partially required for microglial engulfment, suggesting a link 
between neuronal activity and complement. 
Recent studies also suggest that microglia associate with postsynaptic elements during 
synaptic remodeling in the hippocampus and juvenile visual cortex, raising the question of 
whether microglia-dependent pruning is a global mechanism of synaptic remodeling in the CNS 
(Paolicelli et al., 2011b; Tremblay et al., 2010).  Paolicelli et al. demonstrated a role for the 
fractalkine receptor (CX3CR1), expressed on the surface of microglia, in hippocampal synapse 
development and maturation. Cx3cr1
KO mice have a transient reduction in the number of 
microglia in the postnatal brain; thus, fractalkine signaling could interact with complement and 
other signals to regulate microglia-mediated developmental pruning by influencing microglia 
number or, possibly, recruitment to synaptic sites in the postnatal brain (Ransohoff and Stevens, 
2011).  In addition, recent electron microscopy studies in visual cortex have revealed 
significance changes in microglia dynamics in response to sensory experience (Tremblay et al., 
2010), providing further evidence that microglia can sense changes in neuronal activity. 
Together these new findings raise several fundamental questions related to the underlying 
mechanisms of microglia- and complement-mediated pruning including how neural activity, 
complement, and microglia may interact to sculpt developing visual circuits       
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Other Roles for Microglia in the CNS  
Microglia are well positioned to influence many nervous system functions in addition to 
synaptic remodeling.  Fine microglial processes are dynamic surveyors of the extracellular 
milieu and contact neuronal cell bodies, synapses, and astrocytes (Nimmerjahn et al., 2005).  
Recent work has demonstrated repeatedly, however, that these glial cells are particularly 
important at synapses (Ransohoff and Stevens, 2011; Schafer et al., 2012c; Tremblay et al., 
2011).  Microglia have been implicated in synapse maturation (Roumier et al., 2004), synaptic 
remodeling (Paolicelli et al., 2011b; Schafer et al., 2012a), synaptic transmission (Coull et al., 
2005; Pascual et al., 2012), and synaptic plasticity, including long-term potentiation (LTP) 
(Roumier et al., 2004) and synaptic scaling (Stellwagen and Malenka, 2006). 
At developing synapses, in addition to helping to prune inappropriate connections, 
microglia also influence synaptic plasticity and maturation.  Mice deficient in the microglia-
expressed protein KARAP/DAP12, a 12 kDa transmembrane polypeptide associate with a 
variety of cell-surface receptors including MHC-I receptors (Lanier, 2001;Olcese et al., 1997; 
Lanier et al., 1998), show enhanced LTP as well as changes in glutamate receptor content, by 
physiology and biochemical methods. Specifically, expression of the AMPA receptor GluR2 
subunit was decreased in the postsynaptic densities versus cell membrane fractions, 
demonstrating specific impairment of synaptic receptor accumulation (Roumier et al., 2004; 
Roumier et al., 2008). Additional studies have also supported a role for microglia in synapse 
maturation.  Mice deficient in fractalkine signaling, Cx3cr1
KO mice, showed increased spine 
density, enhanced hippocampal long-term depression (LTD), and increased pentylenetetrazol 
(PTZ)-induced seizure susceptibility, consistent with immature circuitry (Paolicelli et al., 2011b). 
These mice have a transient decrease in microglial density in the hippocampus; however, 
abnormalities in microglia number and synapse density in postnatal Cx3cr1
KO mice returned to 
normal levels by adulthood, suggesting that the observed effects are likely a more general effect 
caused by reduced microglial density rather than a specific Cx3cr1-dependent effect.    19 
 
Microglia also participate in the regulation of glutamatergic and GABAergic synaptic 
transmission, particularly after injury or inflammation (Coull et al., 2005; Pascual et al., 2012; 
Tsuda et al., 2003).  Triggering microglia activation with Lipopolysaccharide (LPS), a bacteria-
derived endotoxin, elevated AMPA receptor-mediated spontaneous EPSC frequency in 
organotypic hippocampal slices (Pascual et al., 2012).  Microglia were required for this effect in 
that slices prepared from PU.1 null mice, which lack lymphoid and myeloid lineage cells, 
showed no LPS-induced changes (McKercher et al., 1996; Pascual et al., 2012). Interestingly, 
this microglia-specific effect on EPSCs is thought to be indirect.  Microglia release ATP in 
response to LPS, which is thought to bind P2Y1 receptors on astrocytes and mediate an 
increase in excitatory transmission via a previously described metabotropic glutamate receptor 
5 (mGluR5)-dependent mechanism (Pascual et al., 2012).  Activated microglia have also been 
linked to the development of allodynia after peripheral nerve injury.  One mechanism for 
allodynia after injury or inflammation is the conversion of GABAergic synaptic transmission from 
hyperpolarizing (inhibitory) to depolarizing (excitatory) (Coull et al., 2003).  Recent work has 
shown that microglia, activated in response to ATP released during nerve injury, contribute to 
this effect by releasing brain-derived neurotrophic factor (BDNF) (Coull et al., 2005).  
Consequently, BDNF downregulates the K
+–Cl
--cotransporter KCC2 via TrkB signaling on 
dorsal horn neurons and impairs neuronal Cl
- extrusion.  Blocking microglial production of BNDF 
by RNAi can prevent this shift in GABA transmission and prevents allodynia (Coull et al., 2005).  
While both of these studies revealed a role for microglia in synaptic transmission in response to 
injury, it remains unclear if similar microglia-mediated mechanisms may modulate 
neurotransmission in the healthy brain. 
Microglia continue to modulate synaptic plasticity and function in the mature CNS.  In 
vitro studies have demonstrated that when either cultured microglia or conditioned media from 
cultured microglia was added to cortical or hippocampal slice cultures, NMDA-receptor 
mediated excitatory postsynaptic currents (EPSCs) were larger in amplitude and longer in 20 
 
duration (Hayashi et al., 2006; Moriguchi et al., 2003). Microglia-secreted glycine and l-serine 
were required for this effect (Hayashi et al., 2006). Further supporting a role for microglia in 
adult plasticity, organotypic hippocampal slices prepared from adult (3 month) Cx3cr1
KO mice 
showed reduced LTP induction compared with WT littermates (Rogers et al., 2011). These mice 
also exhibited learning and memory defects in the Morris water maze and in contextual and 
cued fear conditioning (Rogers et al., 2011). Defects in adult neurogenesis have also been 
reported in these mice, suggesting that these observed phenotypes may be indirect effects of 
microglial deficits.  Taken together, these studies support an integral role for microglia in 
synapse development and function in the normal and diseased brain; however, the molecular 
mechanisms regulating microglia function and microglia-synapse interactions, in most cases, 
remain a mystery.        
 
What Are the Mechanisms Regulating Complement Expression and Function? 
Proteins of the complement cascade represent a class of proteins that could regulate 
microglia function and synapse development.  Could regulatory pathways controlling 
complement expression during synaptic refinement modulate downstream microglial functions 
such as engulfment during retinogeniculate refinement?  Expression of C1q in RGCs is  
developmentally restricted in the postnatal retina to the period of acetylcholine-dependent retinal 
wave activity that drives retinogeniculate refinement (Stevens et al., 2007).  C1q, as the initiating 
protein of the classical cascade, controls the cleavage of downstream C3 to generate C3b, a 
phagocytosis cue to cells expressing CR3, including macrophages in the periphery or microglia, the 
only cells to express CR3 in the CNS (Figure 1.3A) (Graeber et al., 1988; T.J. Kindt, 2006).  Thus, 
the mechanisms that control C1q expression in the brain ultimately control complement function.  I 
hypothesize that C1q expression in developing RGCs is a critical mediator of microglia pruning of 
synapses and complement-mediated synapse elimination. Thus, a major goal of my dissertation 21 
 
research is to understand the signals that control C1q expression in the postnatal retina and its 
function at retinogeniculate synapses in the dLGN.  
What Are the Mechanisms Regulating C1q Expression? 
What are the signals that regulate C1q transcription in developing retinal ganglion cells?  
Most components of the complement cascade are known to be synthesized in hepatocytes of 
the liver; however, C1q is unique in that it is produced locally by circulating macrophages in the 
bloodstream (Lu et al., 2008).  Pathways have been identified regulating transcription of other 
complement components, but little progress has been made in characterizing the regulation of 
C1q transcription in any cell type, including peripheral macrophages.  C1q levels in the blood 
are known to rise with inflammation and many pro-inflammatory cytokines have been known to 
induce C1q transcription.  In the CNS, however, C1q does not enter the brain from the 
bloodstream and is instead produced primarily by microglia, the primary phagocytic cells of the 
brain.  During retinogeniculate refinement, RGCs express C1q, but these neurons downregulate 
C1q expression around eye opening (Stevens et al., 2007).  This developmental expression of 
C1q in RGCs suggests that neuron-derived C1q may be regulated differently and may have 
unique functions, including synaptic refinement. 
The expression of C1q in RGCs corresponds with the onset of spontaneous retinal 
activity, suggesting that neuronal activity could modulate C1q expression in RGCs.  
Furthermore, Havik et al. recently showed genes involved with innate immunity, including 
several complement genes (c2, c3, c4a/b, seizure-related gene 6 (sez6), cfb, crry/cr1 and 
itgb2/cd18), were upregulated in non-anesthetized adult animals in response to in vivo high 
frequency stimulation, demonstrating that complement can be upregulated by activity (Håvik et 
al., 2007).  Interestingly, blocking electrical activity in vivo results in incomplete synaptic pruning, 
giving a phenotype similar to what is seen in C1q and C3 KO mice (Huberman et al., 2008b).  
These data suggest a link between activity and complement; however, neurons fire action 
potential throughout life, while C1q expression in RGCs is confined to a tight developmental 22 
 
window.  Interestingly, at the same time that C1q is expressed in RGCs and retinal wave activity 
is driving refinement, immature astrocytes also arrive in the retina, suggesting that these 
developmental processes may be linked. 
 
Additional Functions for C1q in the Healthy and Diseased CNS 
  In addition to the role of C1q in synapse elimination, other functions have been 
discovered for C1q in the healthy brain, during neurodegeneration, and after spinal cord injury 
and stroke.  C1q expression in response to injury and neurodegeneration suggested that C1q 
may have a neuroprotective role in these contexts.  A recent study addressed this question in 
vitro and found that adding exogenous C1q, in the absence of other complement proteins, 
improved neuronal viability and neurite outgrowth and prevented β-amyloid-induced neuronal 
death (Benoit and Tenner, 2011). C1q effects on neurite outgrowth were blocked with siRNAs 
targeting C/EBP-ʴ, NGF, or NT-3.  In addition, exogenous C1q significantly upregulated 
expression of genes associated with cholesterol metabolism and transiently decreased 
cholesterol levels in neurons, known to facilitate neurite outgrowth.  C1q also increased the 
nuclear translocation of cAMP response element-binding (CREB) protein and CCAAT/enhancer-
binding protein-ʴ (C/EBP-ʴ), two transcription factors involved in nerve growth factor (NGF) 
expression. These data directly show that, in addition to clearing apoptotic debris during injury 
by activating the classical complement cascade, C1q can also directly effect changes in 
neuronal gene expression to promote survival and outgrowth (Benoit and Tenner, 2011).  In 
addition, in vivo studies using laser-capture microdissection and microarray analysis after stroke 
show that inosine treatment, known to potently improve recovery after stroke,  upregulated the 
expression of genes associated with axon growth and the complement cascade (Zai et al., 
2009), suggesting that complement proteins contribute to inosine‘s effects.  Conversely, many 
studies have also suggested that C1q can have a harmful role in injury and disease (Alexander 
et al., 2008a).  Most recently, C1q was implicated in the development of inflammation-induced 23 
 
persistent pain (Simonetti et al., 2013). In this scenario, C1q was downregulated in response to 
increased nuclear calcium signaling in spinal neurons, which contributed to activity-dependent 
spine remodeling on spinal neurons after inflammation and the development of allodynia 
(Simonetti et al., 2013).  In addition to identifying a role for C1q in the development of pain 
hypersensitivity, this work also suggests that activity is an important regulator of C1q expression 
and function in neurons.     
  Intriguingly, proteins with structural similarity to C1q, known as C1q-like molecules, are 
highly expressed in cells of the CNS, including neurons, and have also been implicated in 
synapse development (Bolliger et al., 2011; Yuzaki, 2010).  The C1ql subfamily of the C1q 
family includes small, secreted proteins that are expressed in differential patterns in the brain 
(Iijima et al., 2010).  These proteins have similar globular head domains resembling C1q but 
lack the N-terminal collagen domain found in C1q (Bolliger et al., 2011; Ghai et al., 2007).  
Adding any of the four C1ql molecules to cortical neuron cultures reduced synapse density, 
suggesting that these molecules regulate synapse number.  Recent work has shown that these 
proteins are ligands for BAI3 protein, a member of the cell-adhesion class of G protein-coupled 
receptors that has recently been linked to schizophrenia in human genome wide association 
studies (DeRosse et al., 2008).  The globular domains of all four C1ql proteins bind to the 
extracellular thrombospondin-repeat domain of BAI3, and adding the thrombospondin-repeat 
fragment of BAI3 to neuronal cultures blocked the effects of C1ql proteins on synapse density, 
demonstrating that the effect was specific for C1ql proteins (Bolliger et al., 2011).  It is not clear 
how C1ql proteins function to limit synapse density, or if BAI3 is required for this effect, but it is 
intriguing to speculate whether C1q can also bind BAI3 and has similar functions.   
Another member of the C1q family that is highly expressed in the CNS is Cbln1, which 
functions as a synaptic organizer at the parallel fiber-purkinje cell synapse in the cerebellum 
(Matsuda et al., 2010).  Cbln1 is a small, secreted protein similar to the C1q-like proteins and 
lacking the collagen domain found in C1q.  The globular domains of Cbln1 closely resemble 24 
 
those found in C1q; however, while C1q is a hexameric protein composed of six trimers (C1q A, 
B, C) (Figure 1.3), Cbln1 functions as a dimer composed of two trimers.  The genes encoding 
Cbln1 are expressed by granule cells in the cerebellum and secreted Cbln1 rapidly induces 
parallel fiber synapse formation.  Cbln1 signaling also is required to maintain mature synapse 
function as well.  The binding partner for Cbln1 was recently identified as glutamate receptor ʴ2 
(GluD2) (Matsuda et al., 2010; Yuzaki, 2009).   Secreted Cbln1 released from parallel fibers 
binds to neurexin presynaptically and GluD2 postsynaptically to coordinate synaptogenesis 
(Yuzaki, 2010).  In evaluating the functions for the known C1q family members in the CNS, it 
becomes clear that this family of molecules is an important regulator of synapse development 
and suggests that C1q itself may have other roles in synapse development aside from activating 
the complement cascade which may involve interactions with some of these receptors for C1q-
like molecules.   
 
Astrocytes Regulate Synapse Development and Function 
Recent work has shown that astrocytes have an active role in many nervous system 
processes, including synapse development; however, their role in synapse elimination is not 
well understood.  The arrival of immature astrocytes in the CNS is highly correlated with the 
formation of synapses.  In the rodent visual system, RGC axons innervate the superior colliculus 
by birth.  However, there is a 1-week delay before the majority of synapses are formed (Lund, 
1969). This delay coincides with the birth and proliferation of astrocytes.  The establishment of 
methods to purify and culture rodent RGCs allowed Pfrieger and Barres to ask whether 
synapses could form in the absence of astrocytes (Pfrieger and Barres, 1997). Purified RGCs 
were healthy, elaborated dendrites and axons but formed few synapses when cultured without 
astrocytes. In contrast, addition of a feeding layer of astrocytes or astrocyte-conditioned medium 
significantly increased RGC synaptic activity and the number of structural synapses that formed 
(Pfrieger and Barres, 1997; Ullian et al., 2001).  25 
 
These and other findings indicated that secreted factors from astrocytes strongly 
enhance pre- and postsynaptic function in developing RGCs and prompted further exploration 
into the specific molecules that control this process.  One class of astrocyte-secreted molecules 
that was recently identified is a family of extracellular matrix proteins, thrombospondins (TSPs) 
(Christopherson et al., 2005).  TSPs were found to be required for synaptogenesis in vitro and in 
vivo (Christopherson et al., 2005), and recent work identified the calcium channel subunit, 
alpha2delta-1, as the receptor for TSP required for synaptogenesis (Eroglu et al., 2009). Recent 
work has identified additional astrocyte-secreted proteins, hevin and SPARC, that regulate 
synaptogenesis (Kucukdereli et al., 2011). Hevin, like TSP, promotes the formation of 
ultrastructurally normal synapses that are postsynaptically silent. Conversely, SPARC inhibits 
synaptogenesis by specifically antagonizing hevin (Kucukdereli et al., 2011).  Furthermore, 
Glypican-4 and -6  recently were identified as molecules sufficient to induce fully functional 
synapses in RGC cultures and in vivo (Allen et al., 2012). Understanding how these astrocyte-
derived factors cooperate to regulate synapse formation is an area of active investigation.  The 
discovery of these molecules demonstrates that astrocytes can both positively and negatively 
regulate synaptogenesis to influence synapse number. 
In addition to the function for astrocytes in synapse formation and function, a question that 
remains is whether and how astrocytes affect synapse elimination.  Astrocytes show evidence of 
phagocytic capabilities, like microglia (Al-Ali and Al-Hussain, 1996; Bechmann and Nitsch, 1997; 
Cahoy et al., 2008), suggesting they may also function to prune synapses during development.  
Previous studies also suggested a role for microglia and astrocytes in engulfing axonal debris 
during large-scale cortical pruning (Berbel and Innocenti, 1988).  Although it is not yet clear 
whether astrocytes can refine circuitry on a fine scale like microglia, a specialized class of 
astrocytes in the optic nerve head myelin transition zone (MTZ) has been shown to normally 
express a common phagocytic marker, the galactose-specific lectin Mac-2 (also known as 
Lgals3 or galectin-3) (Nguyen et al., 2011; Sun et al., 2009).  In normal, healthy mice, large 26 
 
inclusions of axonal material have been observed in these astrocytes, suggesting that MTZ 
astrocytes may phagocytose axonal components as a form of axonal maintenance in the normal 
animal (Nguyen et al., 2011). 
 
Immature Astrocytes Upregulate C1q in Developing Retinal Ganglion Cells 
The role of astrocytes in directly engulfing synapses remains unclear; however, recent 
work has implicated astrocytes in regulating complement-dependent synapse elimination.  Neuronal 
C1q expression in RGCs was initially discovered in an unbiased in vitro screen for neuronal genes 
that are upregulated upon exposure to immature astrocytes (Stevens et al., 2007).  Purified rodent 
RGCs have proven a useful model system with which to investigate the role of astrocytes in synapse 
development, as RGCs can be immunopurified and cultured for weeks in the complete absence of 
glia and other cell types (Barres et al., 1988a; Meyer-Franke et al., 1995). As discussed earlier, 
neurons form few synapses unless they are cultured with a feeding layer of astrocytes, or astrocyte-
conditioned medium (ACM) (Ullian et al., 2001).  These findings led to the question of whether 
astrocyte-derived signals regulate neuronal genes involved in synapse development.  Surprisingly, 
gene chip studies revealed that one of the most highly upregulated genes in purified RGCs exposed 
to astrocytes was the complement component C1q (Stevens et al., 2007).  Given the correlation 
between the arrival of astrocytes in the retina and C1q expression, I hypothesize that this astrocyte-
derived factor is an important molecular switch to initiate C1q expression and downstream 
complement activation. 
 
What Is the Astrocyte-derived Factor Regulating C1q Expression?  
Astrocytes secrete a number of neuroactive substances shown to regulate neuronal 
gene expression, synapse development, and plasticity.  These glial cells are also a major 
source of cytokines in the brain, which are known to modulate immune system function.  IFN-γ, 
IL-6, IL-10, IL-1, TGF-β1, 2, 3, and TNF-ʱ are all known to be produced by astrocytes under 27 
 
some conditions; however, it is not known what of these cytokines are present in the brain 
during retinogeniculate refinement.   
There are two basic requirements for the candidate astrocyte-derived signal that 
regulates C1q expression in RGCs.  First, the molecule must be secreted by astrocytes during 
development.  Second, there must be a corresponding receptor for this molecule on RGCS.  
Any connection with C1q regulation in the periphery could suggest a role for this molecule in the 
CNS as well.  IFN-γ is a well-known pro-inflammatory cytokine in the immune system shown to 
increase C1q expression in macrophages (Lu et al., 2008).  Rat astrocytes secrete it, 
particularly in response to TNF-ʱ (Xiao and Link, 1998).  Neurons are also known to express 
type II interferon receptors, which bind IFN- γ (Neumann et al., 1997).  IL-6 is known to increase 
C1q expression in peritoneal macrophages and is secreted by astrocytes especially in the 
diseased brain (Dong and Benveniste, 2001; Lu et al., 2008).  Neurons of the CNS do express 
the IL-6 receptor, but specific expression by developing RGCs has not been shown (Qiu et al., 
1998; Schobitz et al., 1993).  IL-10 is an anti-inflammatory cytokine shown to cause C1q 
upregulation and expressed by astrocytes (Dong and Benveniste, 2001; Moosig et al., 2006).  In 
neurons, IL-10 receptor expression has been shown to provide an anti-apoptotic signal (Watkins 
and Maier, 2003).  IL-1 and TNF-ʱ are also both expressed by astrocytes and can influence C1q 
expression in other systems (Dong and Benveniste, 2001; Lu et al., 2008).  They have been 
shown to influence neuronal plasticity and outgrowth (Stellwagen and Malenka, 2006; Temporin 
et al., 2008).  
The isoforms of TGF-β represent strong candidates for C1q regulation.  The 
characteristics of the TGFβ signaling pathway make it well-suited to the task of regulating C1q 
in neurons.  First, TGFβ interacts with TGFβ receptors expressed in neurons and throughout the 
body (Lacmann et al., 2007; Massague, 2000).  Second, published reports indicate that TGFβ2 
and TGFβ3 are enriched in astrocytes, which trigger neuronal C1q upregulation in vitro (Cahoy 
et al., 2008; Unsicker et al., 1991).  Third, TGFβ has been shown to influence C1q expression in 28 
 
other cell types (Morgan et al., 2000).  TGFβ signaling is also connected with synapse 
development.  The three mammalian isoforms of TGFβ (β1, β2, and β3) have each been 
connected with synapse formation, function, or maintenance in recent studies (Chin et al., 
2002b; Heupel et al., 2008b).  TGFβ1 plays a role in synaptogenesis at the frog neuromuscular 
junction.  Interestingly, Schwann cells, the ―astrocyte-like‖ glial cells of the peripheral nervous 
system, are the source of TGFβ1 in this system (Feng and Ko, 2008a).  It is not known if TGFβ1 
similarly affects CNS synapses.  TGFβ2 and β3 have been linked to synapse function and 
dysfunction.  Loss of TGFβ2 causes central synapse impairment and TGFβ3 becomes highly 
upregulated in astrocytes during seizure (Heupel et al., 2008b; Kim et al., 2002).  In addition, 
TGFβ signaling has been implicated in neurodegenerative diseases, which exhibit synapse loss 
in the early stages of the disease (Flanders et al., 1995).    
Another class of candidates I considered as potential regulators of C1q were toll-like 
receptor (TLR) ligands.  Signaling through toll-like receptors (TLRs) has been shown to 
upregulate C1q (Lu et al., 2008).  One TLR2 ligand, CD14, is known to be expressed by 
astrocytes, and neurons have been shown to express TLR2 especially in response to ischemia 
(Bsibsi et al., 2007; Tang et al., 2007).  Other astrocyte-derived secreted molecules have been 
shown to upregulate C1q as well.  Prostaglandin E2 increases C1q expression in macrophages 
and has been shown to influence plasticity in visual cortex (Akaneya and Tsumoto, 2006; 
Trinder et al., 1995).   Thrombospondins, a known activator of latent TGF-β (Schultz-Cherry et 
al., 1994), are secreted by astrocytes and are known to influence the formation of structural 
synapses in RGC cultures (Ullian et al., 2004).  Astrocytes also produce amyloid precursor 
protein (APP) as well, and β-amyloid, a cleavage product of APP has been shown to upregulate 
C1q (Li et al., 2008).     
A number of these cytokines and other neuroinflammatory factors have been shown to 
affect plasticity in the adult brain (Stellwagen and Malenka, 2006; Temporin et al., 2008; Vikman 
et al., 2001). Because of their ability to influence neuronal activity in the adult, their secretion 29 
 
from astrocytes, and their ability to upregulate C1q, neuroinflammatory signals are potential 
candidates for the C1q-upregulating factor during synapse elimination.   
In this dissertation, I have focused on the following questions with particular focus on 
C1q, the initiating protein of the classical complement cascade: 1) How do secreted 
complement proteins regulate the elimination of specific synapses at the right time and place?  
2) What are the contribution and function of neuronal C1q in retinogeniculate synapse 
elimination?  3) Does neuronal activity regulate and restrict neuronal C1q expression in the postnatal 
retina?  Chapter 2 details the methods used to address these questions. Chapter 3 will present 
my experimental approach to determine the role of neuronal C1q in complement-dependent 
synapse elimination identify TGF-β as a key signal neuronal C1q expression in the postnatal 
retina. In chapter 4, I focus on how activity may guide complement-dependent synapse 
elimination to elimination specific synapses at the right time and place.  Chapter 5 discusses the 
implications of my findings for the field of synaptic refinement and suggests future directions for 
this study. 
 
Significance 
This purpose of the work presented here is to advance our understanding of the 
molecular mechanisms that regulate CNS synapse elimination.  Identifying the signals and 
molecular pathways that regulate C1q in neurons may allow one to target neuronal complement 
upregulation to manipulate synapse elimination in vivo.  Given the importance of astrocytic 
signaling in the CNS, disrupting astrocyte signaling globally is not an option; therefore, 
identifying the factor and the neuronal receptor it binds is crucial for in vivo manipulation of this 
neuron-glia signaling pathway.  The molecular mechanisms of synapse elimination have yet to 
be characterized; thus, understanding whether and how C1q regulates complement cascade 
activation and function in the developing retinogeniculate system could have broad implications 30 
 
in understanding the role of complement in establishing precise synaptic connectivity in other 
sensory systems.  
In addition to providing insight into normal CNS development, these experiments have 
implications for neurodevelopmental disorders such as Autism Spectrum Disorders (ASD) that 
are thought to involve aberrant synapse development and synaptic connectivity.  Recent work 
has shown elevated cytokine levels and other signs of neuroinflammation in the brains of 
autistic individuals (Li et al.; Vargas et al., 2005).  Particularly of interest are increases in 
specific cytokines with the potential ability to upregulate C1q:  IL-6, TNF-ʱ, IFN-γ, and TGFβ 
isoforms.  Inappropriate regulation of C1q and the complement cascade during brain 
development could negatively influence synaptic refinement and brain wiring.  A synapse 
elimination defect could cause an imbalance in excitation and inhibition in the brain, which is 
one theory about the etiology of ASD (Chao et al., 2010; LeBlanc and Fagiolini, 2011; 
Rubenstein and Merzenich, 2003).  Unraveling the mechanistic details of complement-
dependent synapse elimination may also provide insight into the mechanisms underlying the 
synaptic dysfunction reported in Autism Spectrum Disorders (Careaga et al., 2010; Enstrom et 
al., 2009; Garay and McAllister, 2010).     
Complement proteins are also highly upregulated in the early stages of many CNS 
neurodegenerative diseases, such as Alzheimer‘s disease, in which early synapse loss is a 
hallmark.  In CNS injury or disease, C1q is rapidly upregulated in microglia and neurons, 
concurrently with the appearance of reactive astrocytes (Cowell et al., 2003; Shen et al., 1997). 
As reactive astrocytes antigenically resemble immature astrocytes (Cahoy et al., 2008), I 
hypothesize that reactive astrocytes re-express immature signals, including the signal 
responsible for C1q expression in neurons.  Thus, astrocytes and complement could have an 
early role in the pathophysiology ultimately leading to synapse loss and neuronal death.  
Consistent with this hypothesis, in the DBA/2J glaucoma mouse model, C1q expression and 
localization to synapses corresponded with the appearance of reactive astrocytes early in the 31 
 
disease prior to substantial synapse loss and neuronal degeneration (Howell et al., 2011; Rosen 
and Stevens, 2010; Stevens et al., 2007). The parallels between disease and development 
suggest that the signals regulating synapse elimination in the immature brain may be part of the 
pathway leading to synapse loss in diseased states.  Identification of the signals associated with 
C1q upregulation could lead to several potential therapeutic targets in the treatment of 
neurodegenerative diseases such as glaucoma and Alzheimer‘s disease.   
Growing evidence also supports a link between complement-dependent synapse 
elimination and epilepsy (Aronica et al., 2007; Vargas et al., 2005; Vezzani, 2008).  Studies 
have shown that defects in synapse elimination can promote seizure activity.  Importantly, a 
recent study has reported seizure activity in C1q KO mice (Chu et al., 2010).  This phenotype is 
consistent with the model that synaptic refinement helps to set the balance between excitation 
and inhibition in the brain.  A nervous system that fails to prune away inappropriate connections 
can become hyperexcitable with a lowered threshold for seizure activity and epileptogenesis.  In 
this context, understanding the mechanisms regulating complement-dependent synapse 
elimination may be important for identifying therapeutic targets that can be anti-epileptogenic, 
correcting the potential hyperinnervation underlying seizures instead of simply suppressing 
seizures.     
In addition, complement has been shown to become chronically upregulated and 
activated during epileptogenesis in both animal models of epilepsy and in human temporal lobe 
epilepsy (TLE) (Aronica et al., 2007).  This upregulation and activation of complement could 
play an early role in destabilizing neural networks and promoting the development of more 
severe and frequent seizures.  Understanding the role of activity in complement regulation could 
provide insight into its upregulation during seizure activity as well.  Taken together, the results 
presented in this dissertation will advance our understanding of the mechanisms of synaptic 
refinement and may ultimately help to determine the mechanisms of synapse loss and 
dysfunction in several disorders and diseases of the nervous system. 32 
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Mice 
Floxed TGF-βr2 mice (B6.129S6-TGF-βr2
tm1Hlm) were obtained from the NCI Mouse Repository 
and crossed to the CHX10-Cre line, Tg(Chx10-EGFP/cre,-ALPP)2Clc/J (Jackson Lab), to 
generate retina-specific TGF-βr2KO mice.  C1qA KO   mice   (C57BL6   background)   were   
generously   provided   by M. Botto (Botto et al., 1998).  Experiments were approved by the 
institutional animal use and care committee in accordance with NIH guidelines for the humane 
treatment of animals.  
Neuron and Astrocyte Cultures 
Retinal ganglion cells were cultured from P8 Sprague-Dawley rats after serial immunopanning 
steps to yield >99.5% purity as described in (Barres et al., 1988c).  Cells were maintained in 
serum-free media as described (Meyer-Franke et al., 1995).  Cortical   astrocytes   were   
prepared   from P1-P2 rat cortices as previously described (Ullian et al., 2001).  Retinal 
astrocytes were prepared from P8 Sprague Dawley rat or mouse retinas by adapting described 
methods for purification of cortical astrocytes (Foo et al., 2011).  After first immunopanning away 
microglia and RGCs, an anti-ITGB5-coated petri plate was used to isolate astrocytes from 
remaining cells in suspension.  Purified cortical astrocytes were prepared as described in (Foo 
et al., 2011).  Purified retinal and cortical astrocytes were maintained in a defined serum-free 
medium supplemented with hbEGF as described (Foo et al., 2011).  Astrocyte conditioned 
medium (ACM) was prepared as previously described [Ullian et al., 2001].  Astrocytes were 
switched to minimal media (Neurobasal + glutamine, Pen/Strep, Sodium Pyruvate) once 
confluent and media was collected after 5 days and concentrated to 10X using Vivaspin 
columns (Sartorius).     
qPCR 
RGCs, microglia, and astrocytes were acutely isolated using immunopanning as described 
above from either mice or rats at indicated ages.  For acute isolation experiments, RNA was 45 
 
collected directly from the immunopanning plate without culturing the cells.  For cultured RGC 
experiments, total RNA was prepared, cDNA was synthesized, and qPCR performed using the 
Applied Biosystems Cells to Ct Power SYBR green kit as described by the manufacturer.  
Briefly, cell lysates were collected from 80,000 RGCs in provided lysis buffer and cDNA was 
synthesized directly from this lysate.  QPCR reactions were assembled for the genes of interest 
(c1qa, c1qb, tieg, gapdh) using 4ul of cDNA per reaction and samples were run on the 
Rotogene qPCR machine (QIAGEN).  Expression levels were compared using the ddCT method 
normalized to GAPDH.     
Immunohistochemistry 
Brains and eyes were harvested from mice after transcardial perfusion with 4% 
paraformaldehyde (PFA).  Tissue was then immersed in 4% PFA for 2 hours following 
perfusion, cryoprotected in 30% sucrose, and embedded in a 2:1 mixture of OCT:20% sucrose 
PBS.  Tissue was cryosectioned (12-14 microns), sections were dried, washed three times in 
PBS, and blocked with 2% BSA+ 0.2% Triton X in PBS for 1 hr. Primary antibodies were diluted 
in antibody buffer (+ 0.05% triton + 0.5% BSA) as follows: C1q (undiluted culture supernatant), 
C3 (Cappel,1:300), vglut2 (Millipore,1:2000), TGFβRII (R&D Systems goat anti-human,1:200), 
psmad (Millipore,1:200), Calretinin (Millipore,1:1000), arc (Synaptic Systems, 1:300), PSD95 
(Zymed, 1:500), Iba1 (Wako, 1:500), Neurofilament (Sigma,1:1000), and MAP2 
(Chemicon,1:500)  and incubated overnight at 4°C. Secondary Alexa-conjugated antibodies 
(Invitrogen) were added at 1:200 in antibody buffer for 2 hr at room temperature. Slides were 
mounted in Vectashield (+DAPI) and imaged using the Zeiss Axiocam, Zeiss LSM700, or Perkin 
Elmer Ultraview Vox Spinning Disk Confocal. 
ELISA 
The 7-plex Mouse Inflammatory Cytokine kit (MSD) was used to profile cytokines in ACM.  
Freshly prepared ACM was profiled according to manufacturer‘s provided protocol.  Standards 46 
 
were diluted in minimal media used to make ACM for greater accuracy.  Plates were read and 
data were acquired and analyzed using the MSD Sector Imager 2400.  ELISA kits were 
obtained for TGF-β1, 2, and 3 separately (R&D systems, MSD) and were performed according 
to manufacturer‘s instructions.     
Western Blot 
RGC and whole retina lysates were collected and homogenized in RIPA buffer with complete 
protease inhibitors (Roche).  Samples were boiled for 5 min in SDS sample buffer, resolved by 
SDS PAGE, transferred to PVDF membranes, and immunoblotted.  Antibodies were diluted in 
5% milk in PBS + 0.1% Tween. Antibodies: Rabbit anti-C1qA polyclonal (Epitomics, 1:5000); 
Goat anti-TGFβRII (R&D Systems, 1:1000).      
In situ hybridization 
In situ hybridization for C1qb was performed on 12 um retinal   sections   as previously   
described in (Stevens et al., 2007).  Probes targeting the entire C1qb coding sequence (Open 
Biosystems clone: 5715633) were generated by digesting the plasmid with EcoRI, and 
performing in vitro transcription with T7 polymerase using the DIG RNA labeling kit (Roche 
Applied Science) as per the manufacturer‘s instructions.  1.8kb probes were then cleaved to 
form 300 bp probes by alkaline hydrolysis before use.  
 
LGN analysis 
Mice received intraocular injection of cholera toxin-b subunit (CTB) and were sacrificed the 
following day. Tissue was processed and analyzed as previously described (Jaubert-Miazza et 
al., 2005; Stevens et al., 2007). Mouse pups were anesthetized   with inhalant isofluorane. Mice 
received intravitreal injections of cholera toxin-b subunit (CTb) conjugated to Alexa 488 (green 
label) in the left eye and CTb conjugated Intraocular injection to Alexa 594 (red label) into the 
right eye as described in(Bjartmar et al., 2006).  Images were digitally acquired using the Zeiss 47 
 
Axiocam.  All images were collected and quantified ‗‗blind,‘‘ and compared to age-matched 
littermate controls. Gains and exposures were established for each label. Raw images of the 
dLGN were imported to Photoshop (Adobe), and the degree of left and right eye axon overlap in 
dLGN was quantified using the multithreshold protocol as previously described (Bjartmar et al., 
2006) and using threshold independent R value analysis as described by (Torborg and Feller, 
2004).  For threshold independent analysis, we performed background subtraction using a 200 
pixel rolling ball raidus filter and normalized the images.  We then calculated the R value 
(log(FI/FC)) for each pixel and determined the variance of the R value distribution for each image 
(4 images/animal).  Pseudocolored images representing the R value distribution were generated 
in ImageJ.     
Retinal cell counts 
Retinal flat mounts were prepared by dissecting out retinas whole from the eyecup and placing 
four relieving cuts along the major axis, radial to the optic nerve. Each retina was stained with 
DAPI (Vector Laboratories, Burlingame, CA) to reveal cell nuclei. Measurements of total cell 
density in the ganglion cell layer (which includes both ganglion cells and displaced amacrine 
cells) were carried out blind to genotype from matched locations in the central and peripheral 
retina for all four retinal quadrants of each retina. Quantification was limited to P30 retinas, 
which is an age subsequent to ganglion cell genesis and apoptosis in the mouse. For each 
retina (1 retina per animal; n=3 mice per treatment condition or genotype), 12 images of 
peripheral retina and 8 images of central retina were collected. For each field of view collected 
(20 per retina), Macbiophotonics ImageJ software (NIH) was used to quantify the total number 
of DAPI using the nuclei counter plugin and TUJ1-positive cells were counted using the cell 
counter plugin. All analyses were performed blind to genotype or drug treatment. 
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Zstack Image and Microglial Engulfment Analysis 
Mice received intraocular injections of anterograde tracers at P4. All mice were sacrificed at P5 
and brains were 4% PFA fixed overnight (4°C). Only those brains with sufficient dye fills were 
analyzed.  For each animal, two sections of medial dLGN were chosen for imaging for 
reconstruction of RGC inputs and C1q staining as well as for microglia engulfment analysis. 
Images were acquired on a spinning disc confocal at 60X using 0.2 μm z-steps. For each dLGN, 
4-8 fields were imaged in the ipsilateral territory and 4-8 fields were imaged in the contralateral 
territory (minimum of 8 fields per dLGN, 16 fields per animal). Subsequent images were 
processed and quantified using ImageJ (NIH) and Imaris software (Bitplane). For subsequent 
acquired z-stacks, ImageJ (NIH) was used to subtract background from all fluorescent channels 
(rolling ball radius=10) and a mean filter was used for the EGFP channel (stained for Iba1) of 
1.5. Subsequently, Imaris software (Bitplane) was used to create 3D volume surface renderings 
of each z-stack. Surface rendered images were used to determine the volume of the microglia, 
all RGC inputs, and the volume of C1q staining. To visualize and measure the volume of 
engulfed inputs, any fluorescence that was not within the microglia volume was subtracted from 
the image using the mask function. The remaining engulfed/internal fluorescence was surface 
rendered using parameters previously determined for all RGC inputs/C1q and total volume of 
engulfed/internal inputs was calculated. To determine % engulfment (or %C1q-positive 
terminal), the following calculation was used: Volume of internalized RGC input (or volume of 
C1q) (μm3)/Volume microglial cell (or RGC inputs) (μm3). For all KO engulfment experiments, 
all analyses were performed blind. 
 
Microglia density quantification  
For quantification of cell density, 2 dLGN were imaged per animal (n=3 per treatment condition 
or genotype). To capture the entire dLGN, a 10X field was acquired. Microglia were 
subsequently counted from each 10X field. To calculate the density of microglia, the area of the 49 
 
dLGN was measured using ImageJ software (NIH). All analyses were performed blind to 
genotype or drug treatment. 
 
Quantification of Synapse Number in RGC cultures 
For synapse quantification of RGCs, we followed a previously developed immunohistochemistry 
(IHC)-based method described and validated in Christopherson et al. (2005) and Ullian et al. 
(2001).  Briefly, synapse numbers were quantified for RGCs at DIV 10.  RGCs grown on glass 
coverslips were washed three times with warm PBS and then briefly fixed (7 min.) in 4% 
paraformaldehyde.  Coverslips were blocked for 1 hr. with 5% BSA +0.2% triton diluted in 
antibody buffer.  Primary antibodies for vglut2 (Millipore, 1:1000) and PSD95 (Zymed, 1:500) 
were diluted as indicted in antibody buffer and added to coverslips to incubate overnight at 4°C. 
Coverslips were washed with PBS and secondary antibody were diluted as described above 
and added to coverslips for 2 hours.  After washing, coverslips were mounted on slides and at 
least 10 RGCs, randomly selected based on DAPI staining, were imaged per coverslip.  Images 
were then analyzed using the PunctAnalyzer ImageJ macro as previously described.  
         
Statistical Analysis  
For all statistical analyses, GraphPad Prism 5 software (La Jolla, CA) was used. Analyses used 
include one-way or two-way ANOVA with Bonferroni post hoc test and Student‘s t-test. Igor was 
used to calculate the R value variance in Chapter 3.  All n and p values and statistical tests are 
indicated in figure legends.  
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TGF-β Signaling Regulates Complement C1q Expression and Developmental Synaptic 
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Introduction 
Increasing evidence implicates immune molecules in synapse development and 
refinement.  Several molecules best known for their functions in the immune system, including 
MHC I(Huh et al., 2000), neuronal pentraxins (NP1 and NP2)(Bjartmar et al., 2006), and 
proteins of the classical complement cascade(Stevens et al., 2007) mediate synapse 
remodeling in the developing visual system, yet surprisingly little is known about the signals that 
regulate the expression and function of these immune molecules at developing synapses.  
The classical complement cascade proteins C1q and a downstream complement 
protein, C3, localize to synapses in the LGN during the synaptic refinement period and mediate 
synapse elimination by a mechanism involving microglia-mediated synaptic phagocytosis(Schafer et 
al., 2012b; Stevens et al., 2007). Prior to synaptic refinement (before P10 in the mouse), the relay 
neurons in the dorsal lateral geniculate nucleus of the thalamus (dLGN) receive inputs from 
RGCs from both eyes that compete for synaptic territory.  After P10, the dLGN becomes 
segregated into discrete eye specific territories, and by P30, each relay neuron receives 
innervations from only 1-2 RGCs.  Genetic deletion of C1q, C3 and the microglia-specific CR3 
results in sustained defects in synaptic refinement indicated by a failure to fully segregate into 
eye specific territories (Schafer et al., 2012b), indicating that these molecules function in a 
common pathway to refine synaptic circuits. Importantly, complement localization to synapses 
and microglial engulfment of retinogeniculate synapses is restricted to a narrow window of 
postnatal development (P5-P8), suggesting that the complement-dependent pruning process is 
tightly regulated.  C1q, the initiating protein of the classical complement cascade, is 
developmentally expressed in retinal ganglion cells (RGCs), peaking during the synaptic 
refinement of retinogeniculate synapses; however, the signals that control the expression and 
function of C1q at retinogeniculate synapses remain elusive.   
As the initiator of the classical complement cascade, C1q is a critical point of regulation 
in the classical complement cascade.  C1q, a large, hexameric, secreted protein composed of 52 
 
C1qA, C1qB, and C1qC peptide chains, is the recognition domain of the initiating protein, C1, in the 
classical complement cascade.  In the immune system, C1q binds to membranes of apoptotic cell or 
pathogens and triggers a proteolytic cascade of downstream complement proteins resulting in C3 
opsonization and phagocytosis by macrophages that express complement receptors.  Recent work 
suggests that microglia in the developing CNS function like macrophages in the immune system and 
engulf inappropriate retinogeniculate inputs in a complement-dependent manner during the 
retinogeniculate pruning period (Schafer et al., 2012b).   Given the precise expression of C1q in 
RGCs during retinogeniculate refinement, I hypothesize that RGC expression and the secretion 
of C1q from RGC inputs in the dLGN initiates the complement cascade and activates microglia-
mediated synaptic pruning.  In the current study, I sought to identify the signals that regulate 
C1q expression in RGCs, and to then manipulate those signals to determine whether C1q 
expression in RGCs is required to initiate complement-dependent synaptic refinement and 
microglia-mediated pruning of retinogeniculate synapses. 
Surprisingly little is known about the signals that regulate C1q transcription in any cell.  Gene 
profiling revealed C1q genes (c1qa, c1qb, and c1qc) were among the genes most highly 
upregulated in purified RGCs upon exposure to astrocytes(Stevens et al., 2007), implicating a 
secreted factor; however, the identity of the astrocyte derived signal(s) that regulate C1q 
expression has not been identified. In the immune system, expression of complement and other 
immune genes can be modulated by rapid cytokine signaling pathways that regulate the 
inflammatory response.  In the developing brain, astrocytes are a major source of cytokines 
several of which  modulate synapse function and plasticity(Boulanger and Shatz, 2004) and are 
among the many astrocyte-derived factors that potently regulate synapse development and 
function(Allen et al., 2012; Christopherson et al., 2005; Ullian et al., 2001).   
The presence of immature astrocytes in the retina corresponds with the period of C1q 
expression in RGCs in vivo, suggesting that the astrocyte-derived factor that upregulates C1q in 
RGC cultures may also regulate C1q expression in RGCs in vivo.  In the current study, I 53 
 
identified transforming growth factor beta (TGF-β) as the factor secreted by astrocytes 
necessary and sufficient for C1q expression in RGCs.  Astrocyte-derived TGF-β induces rapid 
phosphorylation of receptor-associated transcription factors known as R-Smads in RGC cultures 
and promotes C1q transcription.  Blocking TGF-β signaling in retinal neurons resulted in a 
significant reduction in C1q expression in postnatal RGCs as well as reduced synaptic 
localization of complement in the dLGN. Moreover, retinal TGFβRII KO mice showed decreased 
synaptic engulfment by microglia and defects in refinement of retinogeniculate synapses, 
suggesting that TGF-β-dependent regulation of neuronal C1q in the retina regulates 
complement-dependent synapse elimination in the dLGN. Taken together, my  data reveal a 
novel role for the TGF-β cytokine signaling pathway in regulating C1q expression in neurons 
and in initiating complement-dependent synaptic refinement in the developing CNS. 
 
Results 
C1q expression is rapidly and directly upregulated in retinal ganglion cells (RGCs) by a secreted 
factor.   
Previous findings suggested that an astrocyte-derived factor triggers neuronal C1q 
expression. The C1q genes (c1qa, c1qb, and c1qc) were among the most highly upregulated 
genes in purified RGC neurons upon chronic exposure to cortical astrocytes (7 days) that were 
grown on tissue culture inserts (Stevens et al., 2007) (Figure 3.1A).  To determine if bidirectional 
signaling between astrocytes and neurons was required for C1q upregulation, I measured C1q 
mRNA levels in purified postnatal (P8) RGC cultures treated with conditioned medium (ACM) 
collected from cortical astrocytes.  Treatment of RGCs with ACM and astrocyte inserts resulted 
in a comparable 10-20 fold upregulation of C1q in RGCs, implicating a direct, astrocyte-secreted 
factor in neuronal C1q upregulation (Figure 3.1A).  ACM  collected from purified postnatal (P8) 
retinal astrocyte cultures (Foo et al., 2011) resulted in a similar upregulation compared to 
purified or standard cortical astrocytes (Supplemental Figure 1A).   54 
 
 
 
 
 
 
 
 
Figure 3.1. C1q is rapidly transcribed in neurons in response to astrocyte-secreted 
factors. (A) QPCR results for C1q B show an increase in C1q B expression relative to 
control after treatment with astrocyte insert or astrocyte conditioned medium (ACM) for 6 
days, suggesting that C1q is regulated directly by a secreted factor produced by 
astrocytes.  Analysis was done using the ddCt method relative to GAPDH and 
normalized to control C1q B levels (t test, n=3 experiments, p<0.005) (B) Timecourse for 
C1q upregulation shows that C1q is highly upregulated after only 15 minutes of treatment 
with ACM (p<0.001).  C1q levels remain significantly increased up to 3 days after adding 
ACM relative to control C1q levels of RGCs on the same day in vitro.  Significance was 
determined using two way ANOVA followed by post hoc tests, N=3 experiments, 
***p<0.001, **p<0.01, *p<0.05.  (C) Western blot for C1qA showed an increase in C1q 
protein in RGC media after 6 days of treatment with ACM. (D) There is a corresponding 
increase in C1q protein within 6 hours of adding ACM to cultures detected by 
immunohistochemistry (rabbit anti-mouse C1qA).  Increased C1q levels in ACM treated 
cultures were measured as a change in fluorescence intensity relative to control 
untreated cultures (t test, n=3 experiments, p<0.01).  Scale bar = 100um  
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Surprisingly, C1q was upregulated after only 15 minutes of ACM treatment (Figure 3.1B; 
Supplemental Figure 1B,C).  I also observed rapid upregulation of C1r and C1s, the enzymes 
that associate with C1q to initiate the complement cascade (Supplemental Figure 1D).  This 
rapid C1q upregulation was blocked by actinomycin, a transcriptional inhibitor, confirming that 
this effect was a result of transcription (Supplemental Figure 1E), and treating cells with boiled 
ACM failed to upregulate C1q, suggesting that a protein in ACM triggered C1q upregulation 
(Supplemental Figure 1F).  Rapid increases in C1q protein levels were also detected by 
immunostaining in purified RGC cultures using anti-C1q antibodies and were quantified after 6 
hours of ACM treatment (Figure 3.1D).  Media samples from RGC cultures following ACM 
treatment (1 week) showed increased C1q protein levels by western blot (Figure 3.1C).  Media 
samples of ACM alone or from RGCs treated with ACM acutely showed undetectable levels of 
C1q by western blot (data not shown), suggesting that the C1q I detect is produced by the RGC 
cultures and accumulates in the media over time in response to ACM.  Thus, I used this purified 
culture system as a robust assay to screen for secreted signals that rapidly upregulate and 
sustain C1q expression in RGCs. 
 
TGF-β is necessary and sufficient to induce C1q upregulation.   
To identify the astrocyte-derived factor responsible, several candidate molecules were 
screened for the ability to upregulate C1q in RGC cultures. Cytokines, potent modulators of 
immune and neural function, were the main class of molecule tested since astrocytes are a 
major source of cytokines in the brain.  Candidate cytokines measures included IFN-γ, IL-10, IL-
12, IL-1β, IL-6, CXCL1, TNFʱ, and TGF-β1, 2, and 3.  Concentrations of candidate cytokines 
present in ACM were determined using the MSD mouse 7-plex inflammatory cytokine assay and 
individual ELISAs for TGF-β1, 2, and 3 (Figure 3.2A).  TGF-β1, 2, and 3 were among the most 
enriched cytokines in ACM, while IFN-γ, IL-1β, and TNFʱ were detected at the lowest levels.        56 
 
 
 
 
 
 
 
 
Figure 3.2. TGF-β is necessary and sufficient for C1q upregulation in vitro. (A) MSD 
Systems  7-plex  pro-inflammatory  cytokine  assay  was  used  to  determine  the 
concentrations of 7 cytokines in ACM.  Quantification of TGF-β levels in ACM by ELISA 
for active TGF-β (R&D systems TGF-β3 ELISA kit, MSD Systems TGF-β1 and 2) show all 
three  TGF-β  isoforms  are  present  with  enrichment  of  TGF-β1  and  TGF-β3.  (B) 
Immunodepletion  of  TGF-β  with  neutralizing  antibodies  (anti-pan  TGF-β,  1D11,  R&D 
systems) shows a significant reduction in ACM- or TGF-β3-induced C1q upregulation (one 
way ANOVA, n= 3 experiments, ***p<0.001). (C) Dose-response curves for TGF-β1, 2, 
and 3 showed that adding recombinant human TGF-β3 (0.025-0.5ng/ml) is sufficient to 
induce significant C1q upregulation (Two way ANOVA, n= 3 experiments, ****p<0.0001, 
**p<0.01)  relative  to  control,  while  TGF-β1  and  TGF-β2  do  not  upregulate  C1q 
significantly at any concentration tested. (D) RGCs show increased nuclear accumulation 
of phospho-Smad2 after 15 to 30 minutes of ACM treatment.  Quantification shows a 
significant increase in pSmad area (red) contained within the nuclear area (blue) 15 and 
30 minutes after ACM application (one way ANOVA, n= 15 cells/condition, ***p<0.001). 
Scale bar = 20um.  (E) RT-PCR shows expression of all receptors for TGF-β including 
TGF-βRI, TGF-βRII, and TGF-βRIII.  TGF-βRII and its co-receptor TGF-βRI show much 
stronger expression than TGF-βRIII by semi-quantitative methods. (F) Blocking TGF-βR2 
signaling with neutralizing antibodies (R&D systems) or with inhibitors of TGF-βRI (Tocris, 
SB431542) significantly reduced the effects of ACM or TGF-β3 (0.05 ng/ml) on C1q (two 
way ANOVA, n= 3 experiments, **p<0.01, ***p<0.001). 
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Immunodepletion of individual cytokines from ACM was performed to determine if 
specific cytokines were required for astrocyte-dependent C1q upregulation.  Although several 
cytokines, including TNFʱ and IL-6, induced modest C1q upregulation when added directly to 
RGC cultures (Supplemental Figure 2A), immunodepletion of the latter cytokines using 
neutralizing antibodies (R&D systems) failed to affect ACM-induced C1q upregulation (Figure 
3.2B).  In contrast, specific immunodepletion of transforming growth factor beta (TGF-β) from 
ACM completely prevented ACM-induced C1q upregulation as measured by qPCR (Figure 
3.2B).  RGCs were treated for 15 min. with either control ACM or ACM immunodepleted of TGF-
β using an anti-pan TGF-β neutralizing antibody (1D11, R&D Systems) or antibodies specific to 
TGF-β1, 2, or 3 (Supplemental Figure 2B).  Depletion of TGF-β from ACM was confirmed by 
ELISA (Supplemental Figure 2C).  Together these data show that TGF-β is necessary to 
upregulate neuronal C1q in the purified RGC culture system.  
To determine which TGF-β isoform was responsible for upregulating C1q at the 
concentrations measured in ACM, dose-response curves (50ng/ml-25pg/ml) were generated for 
each of the TGF-β isoforms and C1q levels were measured by qPCR.  TGF-β3 was most 
effective at upregulating C1q at concentrations similar to those measured in ACM, whereas 
TGF-β2 treatment resulted in modest upregulation (Figure 3.2C).  In addition, glycine elution to 
release bound TGF-β from anti-pan or anti-TGF-β3 neutralizing antibodies produced an eluate 
which, when added to RGC cultures, could upregulate C1q to the same extent as ACM 
(Supplemental Figure 2D).  Although these isoforms can bind the same receptor and may have 
somewhat redundant functions, I found that TGF-β3 is enriched in retinal astrocytes compared 
with RGCs, cortical astrocytes, and microglia (Supplemental Figure 2E).  These results together 
with my in vitro results that TGF-β3 is most effective at upregulating C1q (Figure 3.2C) suggest 
that TGF-β3 may be the key isoform regulating retinal C1q expression in vivo.   
I next addressed whether activation of TGF-β receptor signaling in RGCs was required 
for developmental expression of C1q in postnatal RGCs.  In the canonical TGF-β signaling 58 
 
pathway, TGF-β1, 2, or 3 binds to TGFβRII which then phosphorylates TGFβRI.  TGFβRI then 
phosphorylates a Smad transcription factor to alter gene expression.  A third receptor, 
TGFβRIII, can also associate with TGFβRII and alters ligand affinity(Massague, 2000).  All of 
the components required for TGF-β signaling are expressed in purified RGCs (Figure 3.2D,E).  
Treatment of RGCs with ACM resulted in rapid (15-30 min.) nuclear accumulation of 
phosphorylated Smads (pSmad 2/3), as measured by immunostaining with phospho-Smad 
(Millipore; AB3849) antibody (Figure 3.2D), consistent with the timing of C1q upregulation.  In 
addition, transcripts for TGFβRII, TGFβRIII, and TGFβRI were present in purified RGCs (Figure 
3.2E).  These data indicate that RGCs express functional TGF-β receptors that can be activated 
with a timecourse consistent with C1q upregulation.  To determine whether the TGF-β 
receptors, I and II, were responsible for this upregulation, TGFβRI and II were blocked in RGC 
cultures with anti-TGFβRII neutralizing antibodies and a TGFβRI-specific inhibitor (Inman et al., 
2002) (SB431542, Tocris, 30uM) for 1 hour followed by a 15-minute treatment with either TGF-
β3 (50 pg/ml) or ACM.  Both TGF-β-induced and ACM-induced upregulation of C1q were 
blocked in the presence of TGFβRII neutralizing antibodies or TGFβRI inhibitors (Figure 3.2F).  
Thus, TGFβRII signaling is required for ACM-induced C1q upregulation, in developing RGCs. 
 
TGF-β signaling is required for regulation of C1q expression in the developing retina.  
C1q is developmentally regulated in the postnatal retina showing a peak expression 
around P5 and sharply decreasing by P10-P15 (Stevens et al., 2007), corresponding with the 
period of synaptic refinement in the retinogeniculate system and with the presence of immature 
astrocytes throughout the developing CNS (Supplemental Figure 3A).  Expression of all three 
isoforms of TGF-β can be detected by RT-PCR at P5 and in the mature retina (Figure 3.3A).  In 
addition, TGFβRII protein can be detected in whole retinal lysates by western blot throughout  59 
 
 
 
 
Figure 3.3.  TGF-β expression corresponds with synaptic refinement period in the 
retinogeniculate system. (A) TGF-β ligand is expressed in the postnatal retina.  RT-
PCR shows that transcripts for all three isoforms of TGF-β are present in the P5 mouse 
retina.  (B) Western blot for TGF-βRII (goat anti-human TGF-βRII, R&D systems) shows 
developmental  expression  of  TGF-βRII  in  the  mouse  retina.    Relative  intensity  is 
normalized to beta-actin control for each age. C1q and TGF-βRII show developmental 
expression in the postnatal mouse retina (one way ANOVA, n=3 experiments, **p<0.01). 
(C) Immunostaining with antibodies against TGF-βRII (R&D systems, goat anti-TGF-βRII) 
shows that the receptor localizes to the RGC layer and the IPL (arrows) and that staining 
intensity is dramatically reduced at P15 relative to P5. Inset shows co-localization of TGF-
βRII with calretinin, a marker of a subset of RGCs (scale bar = 20um). Antibody staining 
was confirm for specificity by staining TGF-βRII retinal KOs.  All images were obtained 
with  set  exposure  times.  Scale  bar  =  50um.  (D)  RT-PCR  confirms  the  absence  of 
TGFβRII  mRNA  in  RGCs  acutely  isolated  from  P5  mice  using  immunopanning.  (E) 
Immunostaining for phosphorylated Smad (pSmad) proteins shows an overall reduction in 
TGF-β signaling in the retina of our TGFβRII retinal KO mouse.  Co-staining for an RGC 
marker, Brn3a, and pSmad2/3 showed a significant reduction in pSmad levels specifically 
in RGCs (t test, n= 3 mice/group, p<0.001). Scale bar = 50um.  
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life; however, the level of TGFβRII protein is highest at P5 and sharply decreases by P15, 
correlating with C1q expression in the postnatal retina (Figure 3.3B).  Immunostaining with 
antibodies against TGFβRII showed TGFβRII localization to the RGC and inner plexiform layers 
(IPL) of the retina at P5 and TGFβRII levels dramatically decreased by P15 (Figure 3.3C).  Co-
staining with anti-calretinin (Millipore), a marker of a subset of RGCs, confirmed localization of 
TGFβRII to RGCs (Figure 3.3C inset).  Taken together, these data show that TGF-β ligands and 
TGF-Β receptors are present at the right time in the retina to regulate C1q expression.   
To determine if TGF-β signaling regulates C1q expression in vivo during retinogeniculate 
refinement, I used genetic and pharmacological approaches to block TGF-β signaling and 
measured C1q expression in vivo.  Retina-specific TGFβRII KO mice were generated by 
crossing floxed TGFβRII mice (MMRC) with CHX10-Cre mice that express Cre in all neurons of 
the retina at E13.5 (de Melo et al., 2003; Rowan and Cepko, 2004).  Knockout was confirmed by 
immunostaining for TGFβRII (Figure 3.3C) and by RT-PCR for TGFβRII using RNA from acutely 
isolated RGCs from P5 transgenic mice (Figure 3.3D).  In addition, indicators of active TGF-β 
signaling were reduced as well.  Transcripts for TIEG, a known TGF-β-dependent gene, were 
significantly reduced in RGCs from the TGFβRII retinal KO compared to WT RGCs 
(Supplemental Figure 3B), and immunostaining for pSmad 2/3 was reduced in the retina and 
specifically in Brn3a-positive RGCs (Figure 3.3E).  These results indicate that my  retina-specific 
knockout was successful and I observed no morphological abnormalities in these transgenic 
retinas (Supplemental Figure 3C,D).  Cell numbers, axon specification, and retinal stratification 
showed no significant difference from WT retinas.     
To test the requirement of retinal TGF-β signaling in developmental C1q expression in 
RGCs, retinas and RGCs from P5 TGFβRII retinal KOs and mice receiving intraocular injection 
of anti-TGF-β were assayed for changes in C1q expression relative to WT or vehicle treated 
littermates.  In situ hybridization for c1qb on P5 retina cryosections revealed a decrease in 
signal for c1qb in the RGC layer of the retina in TGFβRII KO compared to WT (Figure 3.4A;  61 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4. TGF-β signaling is required for neuronal C1q expression in vivo.  (A) In 
situ hybridization for C1q A shows expression of C1q in the RGC layer (arrows) which is 
significantly reduced in the TGF-βRII retinal KO. Scale bar = 100um. (B) RGCs acutely 
isolated  from  P5  WT  (white  bar)  and  TGF-βRII  (grey  bar)  mouse  retinas  using 
immunopanning show a significant reduction in C1q expression (two-way ANOVA, n= 4 
mice/group,  **p<0.01). Microglia  acutely  isolated  using  CD45  immunopanning  did  not 
show  a  significant  difference  in  C1q  levels.    (C)  Immunostaining  for  C1q  shows 
localization of C1q to the RGC (inset a) layer and the IPL (inset b) at P5 (Scale bar = 
50um).  In TGF-βRII retinal KOs, there is reduced C1q localization to these regions (inset 
d and e) relative to WT animals.  Microglia in the retina show no change in C1q levels 
(inset c and f). (D) Quantification of the relative fluorescence intensity in the RGC layer 
(inset a vs. d), IPL (b vs. e), and microglia (c vs. f) of WT littermates and TGF-βRII retinal 
KO mice shows a significant reduction in C1q localization to the RGC layer and IPL when 
TGF-β signaling is blocked (two-way ANOVA, n= 4 mice/group, *p<0.05).  
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anti-TGF-β: Supplemental Figure 4A). To verify that the reduction in C1q expression was in 
RGCs and not other cell types in the RGC layer, such as microglia, RGCs and microglia were 
acutely isolated and purified from P5 retinas using established immunopanning techniques 
(Barres et al., 1988c; Foo et al., 2011).  Acutely isolated RGCs from the retinal TGFβRII KO 
showed a significant reduction in C1q expression by qPCR while microglia showed no change in 
C1q levels (Figure 3.4B), as expected as microglia do not express the retinal neuron-specific 
gene, Chx10.  Interestingly, P5 acutely isolated RGCs from the anti-TGF-β injected retinas also 
showed a significant reduction in C1q expression, while acutely isolated retinal microglia 
showed no change in C1q, suggesting TGF-β regulation of C1q may be specific to neurons 
(Supplemental Figure 4B).  Cell purity was confirmed by qPCR for neuron and microglia specific 
genes, nse and iba1, respectively (Supplement Figure 4C).  Immunostaining for C1q at P5 in 
TGFβRII retinal knockout and anti-TGF-β injected mice also showed a 40-50% reduction in C1q 
immunostaining in the IPL and RGC layers of the retina, but showed no change in microglial 
staining (Figure 3.4C, Supplemental Figure 4D).  Taken together, these data show that TGF-β 
signaling is required for postnatal expression of C1q in RGCs and demonstrate that TGF-β 
upregulates C1q in RGCs, but not microglia. 
 
Retinal TGF-β signaling regulates complement levels in retinogeniculate axons and in the LGN.   
C1q and C3 localize to synapses in the dLGN during the period of synaptic refinement, 
but whether retinal ganglion cell neurons (RGCs) are a key source of C1q in the LGN is not 
known.  One possibility is that neuronal C1q is transported along RGC axons and locally 
secreted into the dLGN to initiate complement-dependent synaptic pruning.  Alternatively, 
microglia, although sparse in the dLGN at this time, may be the key source of secreted C1q in 
the postnatal dLGN during refinement.   
To determine if C1q can be trafficked along RGC axons, I first used retinal explant-LGN 
co-cultures with GFP-labeled RGCs to clearly visualize individual RGC axons.  I immunostained  63 
 
 
   
 
 
 
 
 
Figure  3.5.  Retinal  TGF-β  signaling  regulates  C1q  levels  in  RGC  axons  and  the 
dLGN.  (A)  Z-stack  confocal  image  of  C1q  staining  in  retinal  explant  cultures  show 
punctuate  C1q  staining  along  axons  within  the  explants.    (B)  3-D  reconstruction  and 
surface  rendering  of  GFP-labeled  RGC  axons  and  C1q  immunostaining  in  retinal 
explants.  (C) Mask function in the Imaris program was used to subtract any C1q puncta 
not contained within the volume of the RGC axons.  RGC axons were made translucent to 
allow visualization of internal C1q. (D) Z-stack confocal image of C1q staining in the P5 
dLGN after tracing retinal axons from the left and right eyes with Alexa 594- and 647-
conjugated cholera toxin beta, respectively.  C1q immunohistochemistry shows punctuate 
C1q  staining  some  of  which  co-localizes  with  labeled  RGC  axon  terminals.  (E)  3-D 
reconstruction and surface rendering of labeled RGC inputs in the P5 LGN for WT and 
TGFβRII retinal KO mice show localization of C1q puncta within RGC terminals in the 
LGN.  C1q within RGC terminals is reduced in TGFβRII retinal KOs.  (B) Quantification of 
the  volume  of  C1q  contained  completely  within  RGC  terminals  revealed  a  significant 
reduction in C1q within the volume of RGC inputs in TGFβRII retinal KOs (t test, n= 4 
mice/group, **p<0.01).    
 
 
 
 
 64 
 
these cultures for C1q and used confocal imaging to create z-stacks of the co-cultures (Figure 
3.5A).  3-D reconstructions and surface rendering were done to define the volume of GFP- 
labeled RGC axons and the volume of C1q staining (Figure 3.5B).  I used the mask function in 
Imaris to identify the volume of C1q staining contained completely within the volume of RGC 
axons (Figure 3.5C).  I find that C1q immunopositive puncta can be observed completely within 
the volume of RGC axons (Figure 3.5C), suggesting that C1q can be transported along the 
axon.   
To determine if C1q derived from RGC axons regulates C1q levels in the LGN during 
pruning in vivo, C1q protein levels and localization were examined in the LGN and within RGC 
terminals in the LGN during development in WT and TGFβRII retinal KOs.  I first traced RGC 
axons from the left and right eyes with cholera toxin beta conjugated to Alexa 594 and 647, 
(CTB-594 and CTB-647) respectively, and then performed C1q immunohistochemistry on LGN 
sections.  Confocal imaging was used to create z-stacks of RGC inputs and C1q staining in the 
LGN (Figure 3.5D).  I then used Imaris software as described above to create a volume of RGC 
inputs and a volume of C1q staining and used the mask function to identify all C1q staining 
contained within the volume of the RGC inputs (Figure 3.5E).  To verify that this technique could 
accurately detect proteins within the terminal versus those closely apposed to cell membranes, I 
also stained for vglut2, a vesicular protein enriched in RGC terminals, and PSD95, a 
postsynaptic protein which can be found closely apposed to RGC terminals.  I found that my  
analysis accurately localized these proteins as expected and vglut2 could be detected within 
RGC terminals, while PSD95 puncta were rarely detected within the volume of RGC terminals 
(Supplemental Figure 5).  As shown in Figure 3.5E, C1q puncta (shown in green) could be 
detected within the CTB-labeled RGC terminals in the LGN (red and cyan). These puncta 
disappeared in C1q KO animals, confirming the specificity of this staining (data not shown).  
Importantly, there was a significant decrease in the amount of C1q contained within the RGC 
axonal terminals in retinal TGFβRII KO mice (Figure 3.5E,F) which specifically have a reduction  65 
 
 
 
Figure  3.6.  TGF-β  signaling  is  required  for  eye  specific  segregation  in  the 
retinogeniculate system. (A) Immunostaining for C1q in the LGN and primary visual 
cortex (V1) shows a reduction in C1q fluorescence intensity in the LGN but not in V1 
(scale bar = 100um). (B) Quantification of the relative fluorescence intensity and density 
of C1q puncta shows a significant reduction in the intensity and the number of puncta per 
field of view in the LGN of TGFβRII retinal KO vs. WT (two-way ANOVA, n=4 mice/group, 
**p<0.01,  *p<0.05).  C1q  puncta  density  was  normalized  to  WT  for  each  group  and 
analysis  was  done  using ImageJ  puncta  analyzer.    No  difference  in  intensity  or  C1q 
puncta density was observed in V1. (C) Representative dLGN images for WT, TGFβRII 
retinal  KO,  C1q  KO,  IgG1  control,  and  anti-TGF-β  injected  WT  and  C1q  KO  mice 
pseudocolored to show the R-value for each pixel. R=log10(FIpsi/FContra). (D) Quantification 
of the mean variance of the R-value for each group.  A significant reduction in the mean 
variance of the R value is seen in mice deficient in TGF-β signaling or C1q, indicating a 
decrease in dark blue/purple pseudocolor pixels.  (one way ANOVA, n= 6 animals/group, 
**p<0.01).  (E) There is no additional decrease in the variance when TGF-β signaling is 
blocked in C1q KO mice. Data shown as mean R value variance +/- SEM (one way 
ANOVA, n= 6 animals/group, *p<0.05).  
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in C1q expression in RGCs.  These results suggest that C1q from the retina is transported to 
RGC terminals in the LGN, since when TGF-β signaling is blocked only in retinal neurons, C1q 
cannot be found within RGC terminals.   
If C1q in the LGN is supplied by RGCs, I would predict the retinal TGFβRII KO to show a 
reduction in C1q immunostaining throughout the LGN.  Indeed, immunohistochemisy with a C1q 
antibody revealed a significant decrease in the intensity of C1q staining in the dLGN but not in 
primary visual cortex (V1) (Figure 3.6A), which is not a direct target for RGCs.  Quantification 
showed a significant reduction in fluorescence intensity in the retinal TGFβRII KO as well as a 
significant decrease in the density of C1q puncta in the LGN but not in V1 (Figure 3.6B,C).  
TGFβRII retinal KOs showed no difference in dLGN size or the number of dLGN relay neurons 
as determined by SMI32 staining (data not shown).        
My data suggest that RGC inputs secrete C1q into the dLGN, and previous work has 
shown that C1q localizes to synapses in the dLGN.  While I see a reduction in total C1q levels in 
the dLGN in retinal TGFβRII KO mice, I wondered if there was a significant decrease in synaptic 
localization of complement, or if the amount of C1q remaining in the dLGN was sufficient to 
label the same number of synapses.  To address whether retinal TGF-β regulation of C1q 
regulates complement localization to retinogeniculate synapses, I examined synaptic 
localization of complement in the LGN in TGFβRII retinal KO mice by immunostaining in the 
LGN using antibodies for C1q, C3, and, to mark RGC terminals, vglut2 (Figure 3.7A).  I 
observed approximately 15% of vglut2-positive puncta co-labeled with C1q (Figure 3.7B).  Only 
2% of puncta contained C1q within terminals (Figure 3.5F), suggesting that the rest of the C1q 
staining is extracellular.  Also, 25% of vglut2 puncta co-stained with the downstream 
complement protein, C3 (Figure 3.7B). C1q is upstream of C3 activation in the complement 
cascade and I find that C3 deposition in the LGN is completely absent in the C1q KO mouse 
(data not shown).  In TGFβRII retinal KO dLGNs, I observed a significant reduction in synaptic 
localization of both C1q and C3 (Figure 3.7B), suggesting that retinal TGF-β signaling is  67 
 
 
 
 
 
Figure 3.7. TGF-β signaling and C1q are required for microglia engulfment of RGC 
terminals. (A) C1q and C3 localization to vglut2-positive RGC terminals is reduced in the 
TGF-βR2 retinal KO.  Immunostaining with antibodies against C1q, C3 (Cappell, goat 
anti-C3), and vglut2 (Millipore, guinea pig anti-vglut2) showed a punctuate pattern of C1q 
staining  in  the  P5  WT  LGN  with  many  of  these  C1q  puncta  co-localizing  with  C1q.  
Representative  images  of  WT  and  TGF-βR2  KO  P5  LGNs  show  a  reduction  in  co-
localization of C1q and vglut2. Scale bar = 20um. (B) Quantification of the reduction in 
C1q  and  C3  co-localization  with  vglut2  showed  a  significant  reduction  in  synaptic 
localization  of  C1q  and  C3  in  TGFβRII  retinal  KO  mice.    Co-localized  puncta  were 
identified and counted using ImageJ Puncta Analyzer (t test, n=4 mice, *p<0.05).  (C) 
Microglia show reduced engulfment of RGC terminals in mice deficient in C1q or retinal 
TGF-β  signaling.    3-D  reconstruction  of  surface  rendering  of  microglia  followed  by 
subtraction of all CTB-labeled RGC inputs that are not contained within microglia showed 
a decrease in the %volume of microglia occupied by cholera toxin.  Volume of each 
microglia and the engulfed CTB was quantified in Imaris and the % engulfment defined 
as the volume of CTB/volume of microglia.  Results were normalized to WT engulfment 
levels and C1q KO or TGFβRII retinal KOs both showed a significant reduction in % 
engulfment (one way ANOVA, n= 6 mice/group, **p<0.01). Scale bar = 10um. 
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required for synaptic localization of complement proteins at retinogeniculate synapses.  Given 
that TGFβRII retinal KOs exhibit specific reduction in TGF-β signaling and C1q in the retina, a 
reduction in C1q and C3 co-localization with synaptic puncta in the dLGN suggests that RGC 
derived C1q, and not local C1q from microglia in the LGN, is required to activate C3, allowing it 
to localize to synapses.    
 
TGF-β signaling is required for eye specific segregation.   
In C1q KOs, RGC axons do not segregated into eye specific territories normally as 
assessed by anterograde tracing techniques (Stevens et al., 2007). If regulation of C1q by 
retinal TGF-β signaling is required for eye specific segregation, then TGFβRII retinal KO mice 
should exhibit a phenotype similar to the C1q KO. To test this hypothesis, I used established 
anterograde tracing techniques to visualize the formation of eye specific territories in the LGN 
and to assay eye specific segregation in TGFβRII retinal KO mice and in mice injected with anti-
TGF-β. Mice received intraocular injections of CTB-488 and CTB-594 at P9 in the left and right 
eyes respectively and mice were sacrificed at P10.  I assayed eye specific segregation using an 
unbiased assay in which the degree of segregation is defined as the variance of the distribution 
of the logarithm of the ratio of fluorescence intensity from each fluorescence channel (R value) 
(Torborg and Feller, 2004).  Using this assay, high variance signifies a high degree of 
segregation in the LGN, while low variance corresponds to increased overlap between 
contralateral and ipsilateral territories.  Compared to WT controls, my  results showed a 
significantly lower variance in C1q KO mice, as expected, and in TGFβRII retinal KOs (Figure 
3.6D,E) and mice injected with anti-TGF-β, indicating a defect in eye specific segregation in 
these mice (Figure 3.6F).  I also confirmed these results by quantifying the percent overlap 
using the original method used to identify the C1q KO phenotype (Supplemental Figure 6A,B).   
To address whether TGF-β regulates synaptic refinement independently of C1q, I 
performed intraocular injection of anti-TGF-β neutralizing antibodies in WT and C1qA KO 69 
 
animals to determine if blocking TGF-β disrupts synaptic refinement in the absence of C1q.  If 
TGF-β and C1q regulate pruning by different mechanisms, blocking TGF-β in the C1qA KO 
should lead to a more severe phenotype, or increased overlap compared to vehicle-injected 
C1qA KOs.  If TGF-β and C1q are in the same pathway, blocking TGF-β signaling in the C1qA 
KO mouse should have no effect.   Blocking TGF-β in the C1qA KO did not result in a more 
severe phenotype, consistent with TGF-β exerting its effect on synaptic refinement via 
regulation of C1q (Figure 3.6D,F; Supplemental Figure 6A-B).  Taken together, these results 
show that retinal TGF-β signaling is required for eye specific segregation and that TGF-β and 
C1q likely work in the same pathway regulating this process. 
 
Retinal TGF-β signaling and C1q regulate microglia engulfment of RGC terminals.   
Recent work has demonstrated that microglia engulf RGC terminals during the pruning 
period in a complement-dependent manner (Schafer et al., 2012b).  Microglia engulfment of 
retinogeniculate synapses is thought to be the final step in complement-dependent synapse 
elimination; therefore, if RGC-derived C1q regulates this process, I predict TGFβRII retinal 
knockout mice to show a reduction in microglial engulfment of RGC terminals.  To test this 
hypothesis, I used an established microglia engulfment assay to quantify microglial 
phagocytosis of RGC inputs in C1qA KO mice and retinal TGFβRII KO mice.  P4 mice received 
intraocular injection of CTB-594 and CTB-647 in the left and right eyes respectively. Mice were 
sacrificed at P5 and brains were sectioned and stained with antibodies against Iba1, a microglial 
marker.  Using established methods, CTB labeled RGC inputs within microglia in the dLGN 
were imaged using confocal microscopy and the volumes of the microglia and RGC inputs were 
reconstructed in the Imaris program to determine the percentage of microglia volume occupied 
by CTB (Schafer et al., 2012b).  I found a significant reduction in the engulfment of RGC inputs 
in C1q KO and TGFβRII KO mice as compared to littermate controls (Figure 3.7C).  I found no 70 
 
differences in the number, distribution, or morphology of microglia in the LGNs in WT vs. C1q or 
TGFβRII KO conditions (supplemental Figure 5D).  These results show that reduction of retinal 
TGF-β signaling, and hence C1q expression in RGC neurons, significantly reduced the 
microglial phagocytosis of RGC terminals in the LGN. Together these data support the 
hypothesis that RGC-derived C1q is required to initiate the process of complement-dependent 
synapse elimination.    
 
Discussion  
This study establishes that TGF-β signaling in RGC neurons plays a key role in 
refinement of RGC synapses on their target relay neurons in the dLGN neurons. Taken together 
these experiments demonstrate that retinal TGF-β signaling is necessary for C1q- and 
microglia-mediated pruning to occur in the LGN.  I demonstrated that TGF-β signaling is 
necessary and sufficient for transcriptional upregulation of C1q in purified RGCs (Figure 
3.2B,C).  Consistent with in vitro studies, conditional knockout of TGFβRII in retinal neurons led 
to reduced C1q expression in RGCs during the period of active refinement of retinogeniculate 
synapses in the thalamus (Figure 3.4).  Importantly, inhibition of TGF-β signaling in the 
postnatal retina resulted in significant defects in eye specific segregation in the dLGN that 
mimicked the phenotype observed in global C1q KOs (Figure 3.6).  My findings support a model 
in which retinal TGF-β signaling controls expression and local release of C1q in the dLGN to 
regulate microglia-mediated, complement dependent synaptic pruning (Figure 5.1). In support of 
this model, specific disruption of retinal TGF-β signaling resulted in a significant reduction in the 
deposition of C1q and downstream C3 (Figure 3.7) at retinogeniculate synapses.  Microglia 
engulfment of RGC terminals was also significantly reduced in retinal TGFβRII KOs, which 
phenocopied the engulfment defects observed in C1q, C3, and CR3 KOs (Schafer et al., 71 
 
2012b).  Together, these data suggest that TGF-β regulation of C1q expression in the retina is 
critical for complement-dependent synapse elimination in the developing CNS. 
 
C1q Regulates Microglia-Mediated Pruning in the Thalamus 
  Increasing evidence implicates microglia in developmental synaptic pruning (Paolicelli et 
al., 2011a; Schafer et al., 2012b; Tremblay et al., 2010); however, the mechanisms that control 
the timing and location of microglia-mediated engulfment remain elusive.  Process bearing 
phagocytic microglia in the postnatal LGN engulf RGC inputs during this period in a manner 
dependent on complement C3/CR3 signaling and neuronal activity (Schafer et al., 2012b).  
These findings suggest that microglia, expressing complement receptor 3, recognize and 
phagocytose inappropriate synapses that are tagged by the opsonin and ligand for CR3, C3.  
C3 becomes an active opsonin and ligand for CR3 as a result of activation of the classical 
complement cascade.  C1q is the initiator of the classical complement cascade, and thus, a 
critical regulator of C3 activation.  My findings suggest that retinal C1q activates the classical 
complement cascade in the dLGN resulting in C3 deposition and microglia-mediated pruning. In 
support of this model, microglial engulfment of RGC terminals decreases when retinal C1q 
expression is reduced in TGFBRII retinal KO mice (Figure 3.7C). Moreover, I observed a 
significant decrease in microglial engulfment of RGC inputs and a complete absence of C3 
deposition at synapses in C1q KOs (Figure 3.7).  These findings are consistent with the normal 
role for C1q in the immune system, where C1q is required for C3 deposition on apoptotic debris 
or pathogens, tagging this material for engulfment by phagocytic macrophages.  In the 
developing CNS, I find that neuronal C1q is required to activate C3 and localize it to synapses, 
initiating microglia-mediated, complement-dependent synaptic refinement.  
  Previous work revealed that microglia-mediated pruning is regulated by neuronal activity 
(Schafer et al, 2012) raising the question of whether neuronal activity regulates the expression, 
local trafficking, or targeting of C3 to specific synapses.  During the retinogeniculate pruning 72 
 
period, microglia preferentially engulf less active RGC inputs (Schafer et al, 2012) in the dLGN, 
suggesting microglia can sense/read out  local changes in synaptic activity.  Later in 
development during experience dependent refinement, microglia dynamics and association with 
synapses and dendritic spines in visual cortex are modulated by visual experience (Tremblay et 
al., 2010), suggesting that microglia can ‗sense‘ local changes in neuronal activity.    Many of 
the molecules implicated in synaptic refinement, such as MHC I(Corriveau et al., 1998a) and 
neural pentraxins (Tsui et al., 1996), show activity-dependent transcriptional regulation.  C1q 
expression corresponds with the onset of retinal wave activity and the phenotype observed in 
C1q KO mice closely mimics the phenotype observed when spontaneous activity is disrupted in 
the retina.  Thus, I envision a model in which C1q is locally secreted from synaptic terminals in 
an activity-dependent manner to regulate C3-CR3 dependent synaptic phagocytosis by 
microglia. Whether and how neuronal activity regulates complement expression and function 
are open areas of investigation. 
 
Retinal C1q is Required for Retinogeniculate Refinement 
  In the postnatal retinogeniculate system, C1q expression can be detected in both 
microglia, macrophage-like cells of the brain, and in retinal ganglion cells.  Intriguingly, my  
results demonstrate that RGCs contribute significantly to C1q levels in the LGN for complement-
dependent synaptic refinement.  In TGFβRII retinal KO mice, which only have defects in C1q 
expression in RGCs and not microglia, I observe defects in retinogeniculate refinement and 
microglial engulfment (Figures 3.6 and 3.7), suggesting that microglial expression of C1q cannot 
compensate for the loss of RGC-derived C1q.  Microglia, like peripheral macrophages, express 
C1q throughout life and do not change expression levels in response to TGF-β (Supplemental 
Figure 3.4B).  Although microglia are present in the LGN during the refinement period and 
express C1q at this time, microglia are relatively sparse in the postnatal dLGN (Supplemental 
Figure 3.6A) versus older ages.  As development progresses, microglia density increases in the 73 
 
LGN and throughout the brain (Schafer et al, 2012), yet circuits stabilize over time, suggesting 
that microglial C1q expression is insufficient to initiate synaptic refinement.   
In support of a role for retinal C1q in synaptic refinement, retinal ganglion cells (RGCs) 
exhibit a unique developmental expression of C1q restricted to the first week of postnatal 
development during the peak of complement-dependent synaptic refinement in the dLGN 
(Stevens et al, 2007; Supplemental Figure 3A).   Indeed, C1q levels in the LGN are significantly 
reduced in the retina-specific TGFβRII KO mice, demonstrating that a significant portion of C1q 
is supplied by RGCs (Figure 3.5C).  Moreover, I observe C1q within RGC terminals in the dLGN 
(Figure 3.5A) and can detect C1q within RGC axons in retinal explant cultures (Figure 3.4D).  
While utilizing local C1q secreted by microglia in the dLGN would seem to be a simpler 
mechanism for complement-dependent synaptic refinement, my results suggest that a 
significant portion of C1q in the LGN comes from RGC inputs and that this portion of C1q is 
critical for synaptic refinement.  Given the importance of spontaneous retinal activity in driving 
synaptic refinement, it is intriguing to speculate that secretion of C1q from RGC inputs is a 
molecular cue linking information about the retina to the LGN to ensure proper circuit 
development.   
Interestingly, C1q and TGF-β expression are also expressed in embryonic and postnatal 
spiral ganglion neurons (Lu et al., 2011), raising the question of whether TGF-β signaling 
regulates complement expression in other neurons and brain regions as well.  Very little is 
known about synaptic refinement in the auditory system; however, there is a characterized 
elimination of spiral ganglion inputs to outer hair cells that occurs in the first postnatal week 
(Huang et al., 2007). C1q expression increases in spiral ganglion neurons around this window of 
refinement, suggesting that C1q may have a more general role in refining sensory systems 
throughout the CNS.  Future studies using conditional neuronal and microglia C1q KO mice will 
be needed to definitively answer this question in the developing visual system and throughout 
the CNS.   74 
 
TGF-β: a key regulator of neuronal C1q expression and function in the developing CNS. 
In the immune system, TGF-β is characterized as an anti-inflammatory cytokine that 
dampens the immune response.  In the mammalian nervous system, TGF-β signaling pathways 
regulate diverse developmental processes, including regulation of neuronal survival and 
programmed cell death, axon specification, and synaptogenesis.  Embryonic and postnatal 
periods of programmed cell death in the mouse retina are modulated by TGF-β signaling (Beier 
et al., 2006) and also the efficacy of neurotrophic factors critical for cell survival, such as GDNF, 
is amplified by TGF-β signaling (Peterziel et al., 2002).  In the developing rodent neocortex, 
TGF-β signaling is necessary and sufficient for axon specification.  Recent work has also shown 
that TGF-β regulates synaptogenesis in cortical neurons in vitro (Diniz et al., 2012; Yi et al., 
2010) and at the Drosophila and Xenopus NMJs (Feng and Ko, 2008b).  At the Drosophila NMJ, 
glia are the source of the TGF-β ligand (Fuentes-Medel et al., 2012) and they direct 
synaptogenesis via regulation of a neuron-derived TGF-β family member and the downstream 
RacGEF Trio (Ball et al., 2010).   TGFβ also affects synaptic function at excitatory and inhibitory 
synapses in the pre-Bötzinger complex in the mouse brainstem (Heupel et al., 2008a) and 
modulates sensory neuron excitability and synaptic efficacy at sensorimotor synapses in the sea 
slug Aplysia (Chin et al., 2002a).   
In the present study, TGF-β signaling in RGCs is a key regulator of developmental 
synaptic refinement through regulation of C1q expression.  I found TGFβRII signaling in the 
retina did not dramatically affect the number of retinal neurons or retinal morphology.  Moreover, 
disruption of TGFβRII signaling does not alter axon specification in transgenic retinas, despite 
the role for TGFβRII in axon specification in cortex.  I observe normal axon initial segment 
staining (Supplemental Figure 3D) and can effectively use anterograde tracers in retinal 
TGFβRII KO mice (Supplemental Figure 6A), suggest that either RGCs use a different 
mechanism to specify axons or that the process is complete by time TGFβRII is deleted in my  
TGFβRII retinal KO mice (E13.5).  Although I have not quantified synapses in the dLGN of my  75 
 
TGFβRII KO mice, it is unlikely that defective synaptogenesis would contribute to decreased 
synapse refinement measured as increased overlap between eye specific territories.  In 
addition, previous studies have reported that TGF-β is not synaptogenic in RGC cultures 
(Christopherson et al., 2005), further supporting that synaptogenesis is likely to be normal in 
these mice.   
 
Astrocytes Regulate Synaptic Refinement via TGF-β  
Astrocytes potently regulate synapse development and function.  Astrocytes secrete a 
number of synaptogenic factors, including thrombospondins, glypicans, hevin, and SPARC.  In 
the postnatal mammalian CNS, astrocytes are a major source of cytokines including TNFa, 
TGF-β, IL-6, IL-1 beta, IL-2, IL-18, IL-8, and interferon-alpha and –beta (Boulanger and Shatz, 
2004) many of which have been implicated in synapse development and plasticity.  At the 
Drosophila NMJ, glia modulate synaptogenesis by releasing a TGF-β family ligand, Maverick, 
that stimulates neuronal expression of Gbb, a retrograde signal from the postsynaptic cell that 
triggers synaptogenesis (Fuentes-Medel et al., 2012).  My results suggest that astrocytes also 
modulate synaptic refinement in the mammalian CNS through the regulation of C1q expression.   
I provide evidence that astrocyte-secreted TGF-β is necessary and sufficient to 
upregulate C1q in purified RGCs in vitro.  Immunodepleting TGF-β from astrocyte conditioned 
media prevented C1q upregulation and TGF-β3 in particular was sufficient to upregulate C1q at 
concentrations measured in ACM.  My in vivo data demonstrate that postnatal retinal astrocytes 
produce all isoforms of TGF-β, but TGF-β3 is enriched in postnatal astrocytes compared to 
RGCs and microglia, implicating astrocytes as the likely source of TGF-β required for C1q 
expression in RGCs. I did find that RGCs and microglia purified from the postnatal retina 
express TGF-β to a lesser extent than retinal astrocytes and that astrocytes from other regions 
can also produce TGF-β.  My data show that retinal TGF-β plays a key role in regulation of C1q 
expression and complement-mediated synaptic pruning in the dLGN; however, the contribution 76 
 
of local astrocyte and microglia-derived TGF-β and the specific isoforms of TGF-β that are 
required to regulate neuronal C1q expression and function in vivo are still open questions  
In addition to relevance in remodeling of circuits in the healthy brain, my findings have 
important implications for understanding mechanisms underlying synapse elimination in the 
diseased brain.  Dysregulation of immune system components including complement 
components and cytokines has been demonstrated in many CNS disorders and diseases 
including epilepsy, schizophrenia, and neurodegenerative disorders such as glaucoma and 
Alzheimer‘s disease.  Many of these disorders have been associated with synapse loss or 
dysfunction, suggesting that aberrant complement upregulation may reactivate the 
developmental synapse elimination pathway in disease to promote synapse loss.  In particular, 
TGF-β localizes to beta-amyloid plaques and has been linked to the formation of these plaques 
in Alzheimer‘s disease (Wyss-Coray et al., 1997) and blocking TGF-β and Smad2/3 signaling 
mitigates plaque formation in mouse models of Alzheimer‘s (Town et al., 2008).  C1q has been 
found associated with plaques in Alzheimer‘s brain as well (Afagh et al., 1996), and in mouse 
models of Alzheimer‘s, C1q-deficiency has been shown to be neuroprotective (Fonseca et al., 
2004b).  My work demonstrating a new link between TGF-β signaling, complement, and 
synapse elimination opens up new avenues of investigation into the role of this regulatory 
mechanism for C1q in these disorders and in other regions of the healthy CNS during 
development. 
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Retinal Ganglion Cells Exhibit Developmental Activity-dependent Expression of C1q 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Contributions:  All experiments were designed by Beth Stevens and Allison Bialas.   All experiments and 
data analysis were performed by Allison Bialas. 
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Introduction 
 
During development, patterns of spontaneous and experience driven neuronal activity 
sculpt developing neural circuits, in part, by regulating neuronal gene expression.  Calcium- and 
activity-dependent transcription have been implicated in multiple neuronal processes including 
neuronal survival (Mao et al., 1999), dendrite formation (Vaillant et al., 2002), regulation of 
synapse number (Flavell et al., 2006; Lin et al., 2008; Margolis et al., 2010), and synaptic 
plasticity (Barco et al., 2002; Bourtchuladze et al., 1994; Etkin et al., 2006).  Patterned 
spontaneous retinal activity plays an instructive role in the refinement of retinogeniculate 
synapses, yet surprisingly little is known about how differences in neuronal activity are linked to 
the specific removal of certain synapses.  Activity-dependent transcription of synaptic 
refinement cues is thought to be critical for this process; however, the identities of the activity-
dependent genes required for synaptic refinement are largely unknown. 
    Recently, components of the classical complement cascade, a critical innate immune 
pathway, were implicated in synapse elimination (Stevens et al., 2007).  The first clue that 
complement proteins played a role in synapse development came when the genes encoding 
C1q, the initiating protein of the classical complement cascade, were identified in an unbiased 
screen for genes that were upregulated in purified postnatal retinal ganglion cell neurons 
(RGCs) by  astrocytes (Stevens et al., 2007).  Chronic exposure to astrocytes promotes 
synaptogenesis and increases spontaneous activity in RGCs, suggesting a link between 
synaptic activity, C1q, and synapse development. 
  In the developing retina, expression of C1q in RGCs is restricted to the period of activity-
dependent synaptic remodeling in the retinogeniculate system, implicating this immune 
molecule in developmental retinogeniculate refinement.  Based on the role of the classical 
complement cascade in the innate immune system (Figure 1.3), complement proteins were 
thought to be critical for eliminating inappropriate synapses.  Indeed, C1q and the downstream 82 
 
complement component, C3, localize to synapses in the LGN during this period (Stevens et al., 
2007) and mediate synapse elimination in the retinogeniculate system by a mechanism 
involving microglia-mediated synaptic phagocytosis (Schafer et al., 2012a).  Importantly, in vivo 
manipulations of spontaneous retinal activity revealed that microglia in the dLGN preferentially 
engulf RGC inputs projecting from the less active eye, demonstrating that microglia-mediated 
pruning is an activity-dependent process (Schafer et al., 2012a).  A major question raised by 
these findings is whether complement expression and complement mediated synapse 
elimination are regulated by neuronal activity.  My recent work has revealed that RGC-derived 
C1q is critical for initiating the process of complement-dependent synapses elimination (Chapter 
3), therefore C1q, the initiating protein of the classical complement cascade, could be a key 
point of activity-dependent regulation.   In Chapter 3, I also identified astrocyte -derived TGF-β 
as a key signal regulating C1q expression in RGCs (Chapter 3; Figured 3.3, 3.4); however, it 
remains unclear how TGF-β signaling throughout the retina can result in complement-
dependent elimination of specific synapses.         
I hypothesize that activity-dependent regulation of C1q is necessary for complement-
dependent synapse elimination in the retinogeniculate system.  Indeed, there are several key 
pieces of evidence that support link between complement and activity.  First, developmental 
expression C1q in the postnatal retinal corresponds to the period of spontaneous retinal wave 
activity, an established regulator of  retinogeniculate refinement (Feller, 2009; Penn et al., 1998; 
Stellwagen and Shatz, 2002; Stevens et al., 2007).  Moreover, C1q KO and C3 KO mice show 
sustained defects in synapse elimination that closely resemble the phenotype observed when 
spontaneous retinal wave activity is perturbed (Huberman, 2007; Rossi et al., 2001; Stevens et 
al., 2007).  In addition, chronic astrocyte exposure is known to trigger increases in neuronal 
activity and C1q upregulation triggered by chronic astrocyte exposure corresponds with these 
increase in neuronal firing (Pfrieger and Barres, 1997; Ullian et al., 2004).  Finally, several 
components of the complement system, including C3, C2, and multiple complement regulatory 83 
 
proteins were recently found to be upregulated in the hippocampus after in vivo high frequency 
stimulation (Håvik et al., 2007).  Interestingly, C1q and C3 are both upregulated during periods 
of aberrant neuronal activity in epilepsy (Aronica et al., 2007; Vezzani, 2008); however, it is not 
clear whether activity directly triggers this upregulation.   
Here, I show for the first time that expression of C1q, the initiating protein of the classical 
complement cascade, can be rapidly induced in an activity-dependent and calcium-dependent 
manner in neurons in vitro and in vivo.  I find that acutely exposing RGCs to astrocyte-secreted 
factors leads to increased neuronal activity and intracellular calcium levels that mediate, in part, 
astrocyte- and TGF-β -induced upregulation of C1q.  I also show that neuronal activity 
modulates the expression of C1q in the retina and LGN during the period of synaptic refinement 
in the retinogeniculate system.  Lastly, I find that the activity-dependent process of microglia-
mediated synaptic pruning requires C1q, suggesting that complement is an important cue to 
help microglia properly target RGC inputs for engulfment.  Together, these results identify a new 
activity-dependent molecule in synaptic refinement and provide novel insight into the 
mechanism of activity-dependent microglial synaptic pruning.      
 
Results 
Astrocytes Trigger Acute Changes in Neuronal Activity 
  One of the many features distinguishing neurons from glia is that neurons are electrically 
excitable and can fire action potentials.  Interestingly, adding astrocytes or ACM to RGC 
cultures has been shown to increase neuronal firing over the course of several days, further 
suggesting a link between neuronal activity and C1q upregulation (Pfrieger and Barres, 1997; 
Ullian et al., 2001).  However, my recent findings revealed that C1q can be induced in RGCs 
within 15 minutes of adding ACM and acute astrocyte-induced increases in neuronal firing have 
not been previously reported.  This finding was unexpected and suggested that C1q 
transcription in neurons can be induced in the order of minutes, similar to classic activity-84 
 
dependent transcription factors such as cFos (Greenberg et al., 1986).  To determine if unique 
pathways were regulating C1q expression in neurons and glia, I added astrocyte conditioned 
medium (ACM) to purified RGC, microglia, and astrocyte cultures acutely (15 minutes) and 
assayed changes in C1q expression by qPCR.  ACM treatment only triggered C1q upregulation 
in RGCs (Figure 4.1A), and not glial cells, suggesting activity-dependent pathways may 
contribute to C1q expression in neurons.      
To determine if acute treatment with ACM changed neuronal firing in RGCs, I   
performed qPCR to assay changes in a known activity-dependent immediate early gene, arc 
(Lyford et al., 1995).  I observed significant increases in arc expression 15 min. after the 
addition of ACM (Figure 4.1B) that were blocked in the presence of activity blockers (500nM 
TTX, 20µM CPP, and 20µM NBQX).  By immunostaining, I detected a significant increase in  
arc protein levels within the first few hours of exposing RGCs to ACM (Figure 4.1C).  
Interestingly, there was a strong correlation between robust immunostaining for C1q and 
increased arc staining, suggesting that C1q is more highly expressed in actively firing neurons.         
 
Neuronal C1q Upregulation Is Activity-dependent and Calcium-dependent 
To determine if neuronal activity is required for C1q upregulation, I treated RGCs +/- 
ACM with a cocktail of activity blockers (500nM TTX, 20µM CPP, and 20µM NBQX) to 
completely silence neuronal firing.  I confirmed that ACM-induced upregulation of Arc and cFos 
were significantly reduced in silenced neurons as a control for activity-dependent gene 
expression (Figure 4.1B).  I found that silenced neurons treated with ACM showed a 
significantly reduced upregulation of C1q by qPCR (Figure 4.1D).   
In addition, I previously found that TGF-β was necessary and sufficient for C1q 
upregulation (Figure 3.2), therefore, I hypothesized that TGF-β-dependent regulation of C1q  85 
 
   
 
 
 
Figure 4.1. ACM-induced Neuronal C1q Expression Is Activity-dependent. (A) QPCR 
results for C1q B show an increase in C1q B expression relative to control in RGC cultures 
but not in microglia or astrocyte cultures after treatment with astrocyte conditioned medium 
(ACM) for 15 min., suggesting that C1q is differentially regulated in neurons and glia.  
Analysis was done using the ddCt method relative to GAPDH and normalize to control C1q 
B levels (two way ANOVA, n=3 experiments, p<0.005).  (B) Activity-dependent genes, such 
as Arc, are upregulated with ACM  within 15 min. and are blocked in the presence of 500nM 
TTX, 20µM CPP, and 20µM NBQX (silenced) (two way ANOVA, n= 3 experiments, 
**p<0.001). (C) 6 hours after ACM treatment, Arc levels were determined to be elevated by 
immunostaining and RGCs with increased Arc were also found to have increased C1q levels 
by immunostaining, suggesting that C1q expression increases with activity. Scale bar = 
30um.  (D) To test if C1q expression is activity dependent, RGCs were treated with ACM or 
TGFb +/- activity blockers as in (B).  RGCs that were silenced showed significantly less C1q 
upregulation (~50% reduction) compared to non-silenced controls.  Results were obtained 
by qPCR and analysis was done using the ddCT method as in (A) (two way ANOVA, n= 3 
experiments, p<0.001).    
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is also activity-dependent.  To address this question, I treated RGCs with recombinant TGF-β3 
(50pg/ml) with the same cocktail of activity blockers (500nM TTX, 20µM CPP, and 20µM NBQX) 
to completely silence neuronal firing.  My results showed that upregulation of C1q by adding 
recombinant TGF-β3 (50pg/ml) was also significantly blocked when neurons were silenced 
(Figure 4.1D), suggesting that the TGF-β pathway of C1q upregulation in neurons is modulated 
by neuronal activity.  The rapid kinetics of C1q upregulation and the effects of activity on C1q 
expression levels suggested that calcium-dependent pathways could be regulating C1q 
expression.  Calcium is a well-known modulator of activity-dependent gene transcription, but it 
was unknown whether acute ACM application could trigger calcium increases in neurons.  To 
address this question, I used the ratiometric calcium-sensitive dye Fura-2 to measure changes 
in calcium levels in RGCs during ACM application.  I found that ACM induced a significant 
increase in intracellular RGC calcium levels within 1 minute of ACM application (Figure 4.2A).  
To test if C1q transcription was calcium-dependent, I treated cultures with ACM in the presence 
or absence of 2 mM EGTA to chelate calcium in culture media.  In the presence of EGTA, 
neither ACM nor TGF-β produced a significant upregulation of C1q (Figure 4.2B).  Similar 
effects were observed when 100µM CdCl2 was added to the culture medium to block calcium 
influx through voltage-gated calcium channels (Figure 4.2B).  In addition, I found that treating 
RGC cultures with 55mM KCl, which depolarizes neurons and promotes calcium-influx through 
voltage-gated calcium channels, also upregulated C1q in a calcium-dependent manner (Figure 
4.2B).  I verified that this result was not specific for KCl-induced depolarization by treating with 
20µM glutamate, 20µM forskolin, and by transfecting RGCs with the Designer Receptors 
Exclusively Activated by Designer Drugs (DREADD) HM3d construct to drive GPCR activated 
calcium-increases (Armbruster et al., 2007)(Figure 4.2C).  All 3 treatments gave a similar, 
significant upregulation of C1q by qPCR, suggesting that increasing intracellular calcium levels 
is sufficient to upregulate C1q expression.  Increased C1q protein levels also were observed by 
immunohistochemistry in KCl-depolarized versus control RGC cultures after a six hour  87 
 
 
 
 
 
Figure 4.2. Expression of C1q in RGCs Is Modulated by Neuronal Firing and Calcium. 
(A) Calcium imaging of RGCs treated with ACM and KCl showed an increase in intracellular 
calcium with acute application of either treatment. Representative trace of 17 responding cells 
of 50 recorded.  Of all the cells recorded over 4 experiments, 34% of cells responded to ACM 
with  an  increase  in  calcium.  Significant  upregulation  was  detected  within  1  min.  of  ACM 
application  (one  way  ANOVA,  N=  17  cells,  P<0.01)  and  with  KCl  stimulation  (one  way 
ANOVA, n=17 cells, p<0.001). (B) C1q was highly upregulated after 15 min. of treatment with 
ACM, TGFb (50pg/ml) or 55mM KCl, but in the presence of EGTA (2 mM) or CdCl2 (100µM), I   
found that C1q upregulation was blocked (one way ANOVA, n=3 experiments, ****p<0.001). 
(C)  Depolarizing  RGCs  or  increasing  neuronal  firing  by  various  treatments  induced  C1q 
upregulation.    RGCs  were  treated  with  55mM  KCl,  20µM  glutamate,  20µM  forskolin,  or 
transfected with HM3d and treated with 10µM CNO.  All treatments were found to significantly 
increase C1q levels and were confirmed to induce cFos, a known activity-dependent gene 
(not shown).  (one way ANOVA, n= 3 experiments,*p<0.05, **p<0.01). (D) Immunostaining 
with anti-C1q showed an increase in C1q protein within 6 hours of treatment with ACM.  Scale 
bar= 100um. 
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treatment (Figure 4.2D).   To determine if activity-dependent C1q expression was a general 
phenomenon in all neurons, I treated cultures of hippocampal neurons and cortical neurons, 
along with my purified RGCs, with 55mM KCl for 15 minutes to stimulate activity-dependent 
transcription in all three cell types.  To verify that neurons were depolarized with this treatment, 
qPCR was used to assay cFos levels.  As expected, cFos levels were significantly increased in 
all three neuronal cultures (Supplemental Figure 8A), but qPCR for C1q showed a dramatic, 
significant upregulation of C1q only in RGCs (Supplemental Figure 8B).  My results suggest that 
activity-dependent C1q upregulation may be specific to RGCs or that my purification method, 
which exclusively isolates RGCs (Barres et al., 1988b), excitatory neurons in the retina, may 
help to bring out C1q changes in these cultures versus mixed cortical or hippocampal cultures. 
 
Neural Activity Modulates C1q Expression in the Developing Retina 
To determine if neuronal activity regulates C1q expression in vivo at the peak of the 
retinogeniculate refinement period (P5), I first blocked or increased spontaneous retinal activity 
via intravitreal injection of 200nl of 500µM TTX or 20mM forskolin in P4 animals.  I assayed C1q 
levels using multiple techniques at P5.  First, I confirmed that my activity manipulations were 
effective by performing qPCR for the known activity-dependent gene, cFos, on cDNA prepared 
from P5 RGCs acutely isolated by immunopanning 24 hours after intraocular injection.  In initial 
experiments, cFos levels were increased with forskolin treatment as expected, but TTX-treated 
mice showed no change in cFos, suggesting that the effects of TTX may have worn off (data not 
shown).  I then shortened my treatment time to 2 hours, and at this time point, cFos levels were 
increased in forskolin-treated mice and decreased in TTX-treated mice (Figure 4.3A).  C1q 
expression levels assayed by qPCR in acutely isolated P5 RGCs also showed a similar 
increase and decrease with respective forskolin and TTX treatments at 2 hours (Figure 4.3B).  
Interestingly, C1q expression levels in microglia were not affected by these treatments   89 
 
      
 
 
 
 
Figure 4.3. Spontaneous Retinal Activity Regulates Neuronal C1q Expression in vivo. 
(A)  QPCR  for  cFos  on  acutely  isolated  RGCs  and  microglia  2  hours  after  intraocular 
injection of forskolin (200nl of 10mM) or TTX (200nl of 0.5uM).  cFos expression levels 
were significantly increased with forskolin treatment and reduced in TTX treated RGCs, as 
expected. There was no effect on microglial cFos mRNA levels (N=3 animals, P<0.001, 
ANOVA). (B) QPCR for C1q showed a significant increase in C1q mRNA in RGCs from 
forskolin-injected retinas and a significant reduction in C1q levels in TTX treated retinas.  
No change in C1q expression was observed in microglia isolated from treated retinas (N= 3 
experiments,  **P<0.01,  ***P<0.001,  ANOVA).  (C)  Forskolin  or  TTX  injection  modulated 
C1q localization to the IPL and RGC layer of the retina after 12 hours. (D)  Quantification 
showed  a  40%  decrease  in  C1q  staining  intensity  in  the  IPL  after  TTX  injection  (E) 
Quantification  showed  a  two-fold  increase  in  C1q  levels  with  forskolin.    (N=3  animals/ 
condition, P<0.05, t test). 
 90 
 
(Figure 4.3A,B).  By immunostaining, I observed a 40% reduction in C1q protein levels in TTX-
treated retinas and a two-fold increase in fluorescence levels in forskolin-treated retinas (Figure 
4.3C-E).  Taken together, these results suggest that C1q expression levels in the retina are 
modulated by neuronal activity during the peak of developmental synaptic refinement.  
 
Retinal Activity Modulates Complement Localization in the dLGN during Synaptic Refinement. 
I  next determined if activity-dependent regulation of C1q in the retina affected C1q 
localization and function in the LGN.  Immunostaining for C1q in the P5 LGN, at the peak of 
synaptic refinement, showed a significant reduction in C1q staining in mice 12 hours after 
binocular TTX injection (200nl of 500µM), while binocular intraocular injection of forskolin 
resulted in increased C1q staining in the LGN (Figure 4.4A), suggesting that manipulating 
spontaneous retinal activity modulates C1q secretion from RGC axons into the LGN.   
As shown in Figure 4.4A, immunostaining for C1q resulted in a punctate staining pattern 
in the LGN.  Many of these puncta co-localized with RGC terminals, as shown in the previous 
chapter (Figure 3.7A), consistent with the idea that C1q tags synapses for removal.  However, I 
also found that C1q can be detected within CTB-labeled RGC inputs in the LGN (Figure 3.5A).  
Given my data that C1q expression increases in RGCs in vivo with forskolin treatment, I  
wondered if forskolin treatment would also result in increased C1q levels within RGC terminals 
in the LGN.  To address this question, I injected forskolin (200nl of 20mM) and vehicle into the 
left and right eyes of P4 mice, respectively, and also injected CTB-594 and CTB-647 to the 
respective eyes to label RGC projections from forskolin and vehicle treated eyes (Figure 4.4B).  
I then performed immunostaining for C1q in the LGN at P5 and collected Z-stack confocal 
images of the LGN in regions innervated by both forskolin (red labeled) and vehicle (blue 
labeled) RGC inputs (Figure 4.4C).  Using Imaris (Bitplane) software, I then performed 3-D 
reconstructions and surface rendering of the terminals and C1q staining within the LGN as in  91 
 
 
 
Figure 4.4. Neuronal Activity Modulates C1q Levels in the dLGN and within RGC 
Terminals. (A) Immunostaining for C1q in the P5 mouse dLGN showed a strong reduction in 
C1q when retinal activity was reduced with TTX and increased with forskolin compared to 
vehicle controls (N= 4 mice, **P<0.01, ANOVA). (B) Monocular injections of forskolin and 
vehicle (DMSO) were done at P4 and eyes were labeled with CTB-594 (red) and CTB-647 
(blue), respectively, to create a difference in retinal activity between the two eyes.  At P5, 
projections from more active (forskolin; red) and less active (vehicle; blue) could then be 
observed in the dLGN.  (C) Immunostaining was done for C1q (green) in the P5 dLGN after 
monocular forskolin (red) and vehicle (blue) injections to label RGC projections.  Z-stack 
confocal images were collected.  Inset shows co-localization of C1q puncta with red and blue 
puncta. Gridlines= 10um.  (D) To determine if C1q was localized within RGC terminals, 3-D 
reconstruction and surface rendering were done as described in chapter 3.  (E) Quantification 
of the volume of RGC terminal occupied by C1q showed significantly more C1q in terminals 
from forskolin-treated RGCs. (N=4 mice, P<0.05, t  test). 
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chapter 3.  Using the mask function, I determined the volume of C1q staining completely within 
the volume of forskolin-treated or vehicle-treated terminals (Figure 4.4D).  To verify that this 
technique could accurately measure C1q within the terminal and exclude C1q that could be 
closely apposed to the cell membrane, I also stained with antibodies against vglut2 and PSD95.  
Vglut2, a presynaptic protein, could be detected completely within RGC terminals using this 
method, while PSD95, a postsynaptic protein, though closely apposed to RGC terminals, was 
detected at very low levels within CTB-labeled terminals using my method of analysis 
(Supplemental Figure 5).  My results showed that increasing spontaneous retinal activity with 
forskolin injection significantly increased the volume of C1q puncta within the RGC terminals 
(Figure 4.4E), suggesting that more active RGCs transport more C1q to the LGN than their less 
active counterparts.   
 
C1q Is Required for Activity-dependent Microglial Engulfment of RGC Terminals 
  Microglia have recently been identified as critical mediators of activity-dependent 
synapse elimination (Schafer et al., 2012a).  When retinal activity was perturbed by intraocular 
injection of forskolin or TTX, microglia preferentially engulfed CTB-labeled RGC terminals from 
the less active eye (Schafer et al, 2012).  Microglia engulfment of RGC terminals is also 
dependent on complement C3-CR3 signaling; however, whether complement was required for 
the observed activity-dependent engulfment was still not clear.  To address this question, I   
performed forskolin injections in one eye as in Figure 4.4B and quantified the CTB-labeled RGC 
inputs from forskolin- and vehicle-treated eyes engulfed by microglia in C1q KOs and WT 
littermates.  I immunostained LGN sections for Iba1 (Wako, 1:500) to label microglia and 
collected Z-stack images to measure microglia engulfment as in the TGFb chapter.  I focused 
on regions of the LGN with equal innervations from the contralateral and ipsilateral eyes where 
microglia had equal chances of contacting either vehicle or forskolin treated inputs  93 
 
 
 
 
 
Figure 4.5. Complement is required for activity-dependent microglia engulfment of 
RGC inputs.  (A) Representative raw image of microglia in a field of view with 
approximately equal amounts of forskolin and vehicle treated inputs.  Each channel was 
surface rendered and the red and blue puncta outside the volume of the microglia were 
subtracted to generate the images in (C).  Grid lines= 5um. (B) Quantification of % 
engulfment analyzed the volume of vehicle or forskolin inputs engulfed over the total 
number of inputs engulfed.  Results were normalized to vehicle (N=4 mice/group, *P<0.05, 
ANOVA).  (C) Representative surface-rendered images used for the analysis quantified in 
(B). WT mice show significantly more blue (vehicle) puncta within the microglia than red 
(forskolin) puncta, as expected. C1q KOs and Retinal TGFβRII KOs show reduced 
engulfment overall and no significant preference for red or blue inputs. Grid lines= 5um.            94 
 
(Figure 4.5A).  In WT mice, I found that, consistent with published work, microglia preferentially 
engulfed RGC inputs from the vehicle-treated eye (Figure 4.5B,C); however, in C1q KO mice, 
microglia showed no preference for inputs from either eye and engulfed vehicle- and forskolin-
treated inputs with equal frequency.  Further, TGFβRII retinal KO mice that show reduced C1q 
levels (Chapter 3) also showed a similar phenotype in which microglia had no preference for 
weaker RGC inputs (Figure 5B,C).  Taken together, these results suggest that C1q is required 
for activity-dependent microglial engulfment of RGC inputs.           
 
Discussion 
My results demonstrate for the first time that C1q expression in neurons is upregulated 
by neuronal activity and suggest that C1q may be a critical link between neuronal activity and 
microglia-mediated pruning of inappropriate synapses.  In purified RGC cultures, I found that 
C1q upregulation by astrocytes or by TGF-β, the previously identified component of ACM 
required for C1q upregulation, are both blocked when cells are silenced with a cocktail of activity 
blockers (Figure 3.1D).  Furthermore, I found that C1q upregulation is calcium-dependent and 
that many treatments that increase intracellular calcium levels can upregulate C1q in RGCs 
(Figure 4.2).  Moreover, developmental retinal C1q expression in RGCs in vivo was found to be 
modulated by spontaneous retinal activity (Figure 4.3). Importantly, C1q levels in the dLGN 
were also modulated by activity and analysis of C1q levels within RGC terminals in the dLGN 
showed that C1q was specifically increased in RGC terminals of more active neurons (Figure 
4.4).  Finally, my results provided evidence that activity-dependent microglial engulfment of 
RGC inputs is C1q-dependent.  In both the C1q KO and in TGFβRII retinal KOs that have 
reduced C1q expression in RGCs, microglia showed no preference for less active RGC inputs 
while WT microglia preferentially engulfed RGC inputs from the less active eye (Figure 4.5).  
Together, my results show that C1q expression is activity dependent and suggest that activity-
dependent regulation of C1q guides microglial engulfment of RGC terminals.    95 
 
C1q: a Link between Retinal Activity and the Elimination of Specific Synapses 
Although there are other molecules that have been implicated in synaptic refinement, it 
is still unclear how activity-dependent regulation of these molecules is linked to the elimination 
of specific synapses.  One hypothesis that has been proposed for how synapse elimination 
could occur is known as the ―Punishment Model‖ (Jennings, 1994; Lichtman and Colman, 2000) 
(Figure 1.1).  This model suggests that synapse elimination could be accomplished by the 
activity-dependent expression of two signals: a punishment signal secreted by strong inputs to 
punish weaker neighbors and a protective signal that shields strong inputs from this punishment 
signal.  Interestingly, the complement cascade fits nicely into the framework of this punishment 
model.  My results show that C1q expression is activity-dependent (Figure 4.3), that more C1q 
can be found within the terminals of more active RGCs (Figure 4.4), and that microglia lose their 
preference for less active RGC inputs in the absence of C1q (Figure 4.5).  While we still do not 
know if C1q is directly tagging synapses for elimination or ―punishing‖ weaker inputs by 
activating C3 to tag weaker inputs, my results suggest that C1q is required for microglia to 
properly target less active inputs.  Ongoing work in the lab, using a newly developed in vitro 
model of activity-dependent synaptic competition, will allow us to further investigate whether 
C1q and/or C3 are specifically targeting ‗weaker‘ retinogeniculate synapses. 
 An open question is whether there is also a protective signal in complement-dependent 
synapse elimination. In the immune system, there are several ―don‘t eat me‘ signals that protect 
healthy or self cells from inappropriate macrophage-mediated phagocytosis.  In addition, there 
are a number of complement inhibitor proteins in the immune system and many of these 
proteins are expressed in the CNS (Elward and Gasque, 2003), including CD59, DAF, Crry, and 
CSMD1 (Davoust et al., 1999; Kim and Song, 2006; Kraus et al., 2006).  Moreover, C1q itself 
may have additional roles in the nervous system outside of just triggering complement 
deposition.  C1q-like molecules, such as Cbln1 and C1ql1-4, are expressed in the CNS and 
have been demonstrated to regulate synapse formation and synapse density (Bolliger et al., 96 
 
2011; Iijima et al., 2010; Yuzaki, 2010).  Could C1q have similar properties to the C1q-like 
molecules and actually work to strengthen some synapses and eliminate others?  This idea is 
intriguing given the broad distribution of C1q staining that I observed throughout the dLGN 
(Figure 4.4).  C1q does not seem to localize exclusively to inappropriate synapses, suggesting 
that it may have other functions.   C1q also does not appear to be regulated in the same way in 
all neurons, consistent with my results that depolarizing cortical or hippocampal neurons did not 
trigger significant C1q upregulation (Supplemental Figure 8B).  Recent work has shown that 
C1q expression in dorsal spinal neurons decreases slightly with activity, suggesting that an 
alternative mechanism may be at work in this system (Simonetti et al., 2013).  RNAi 
experiments knocking down C1qC in spinal neurons led to an increase in spine number while 
adding C1q reduced spine number (Simonetti et al., 2013), suggesting that C1q may function to 
limit synapse number in these cells.  Interestingly, in RGC cultures, I have noticed a similar 
effect, discussed further in chapter 5 (Supplemental Figures 9-12), although I observe an 
increase in C1q expression with neuronal activity. 
 
C1q Is Required for Activity-dependent Microglia-mediated Synaptic Engulfment 
  Microglia have recently emerged as critical mediators of synapse development and 
function.  Work from our lab revealed that microglia prune retinogeniculate projections C3-CR3 
dependent phagocytosis.  Interestingly, when retinal activity was modulated during microglial 
mediated pruning, microglia preferentially engulfed inputs originating from the less active eye, 
suggesting a link between neuronal activity and microglial engulfment. Thus, both complement 
signaling and activity were established as regulators of microglia-mediated engulfment of RGC 
inputs, but it was not clear if the activity-dependent component of engulfment was also 
complement dependent.  Moreover, it was unclear if C1q was needed for this process or if C3 
could auto-activate via alternative complement pathway signaling to eliminate synapses.   97 
 
  My recent findings revealed defects in microglial engulfment of RGC inputs in C1q KO 
mice and in TGFβRII retinal KO mice (Figure 3.7), suggesting that initiation of the complement 
cascade by TGF-β dependent expression of C1q in RGCs is the trigger upstream of microglia-
mediated synaptic refinement.  This finding, combined with my discovery that C1q expression is 
activity-dependent (Figure 4.3, 4.4), suggested that C1q may be a cue linking differences in 
neuronal activity levels with microglial engulfment.  To test this idea, I assayed microglial 
preference for weak inputs after retinal activity manipulation in C1q KO mice and in TGFβRII 
retinal KO and found that microglia lost their preference for less active inputs in these mice 
(Figure 4.5).  Given that C3 is downstream of C1q in the complement cascade, it will be 
intriguing to determine if C3 deficient mice exhibit similar defects or if activity-dependent 
expression of C1q is enough in the absence of C3 to accurately guide microglia to preferentially 
engulf less active inputs. 
  Interestingly, roles for microglia in synapse development and function have been 
described in other brain regions as well.  In visual cortex, recent in vivo live imaging studies 
have highlighted the highly dynamic way in which fine microglial processes survey the CNS 
environment (Nimmerjahn et al., 2005; Wake et al., 2009).  Many recent studies have supported 
changes in microglial dynamics in response to neuronal activity and sensory experience 
(Ransohoff and Stevens, 2011; Schafer et al., 2012c; Tremblay et al., 2011).  In visual cortex, 
manipulating sensory experience through short-term light deprivation and re-exposure led to 
changes in microglial dynamics such that light re-exposed mice had an increase in microglial 
apposition to synaptic clefts and increased microglial engulfment of ―synapse-associated 
elements‖ in an electron microscopy study (Tremblay et al., 2010).  Interestingly, light 
deprivation was associated with reduced microglial motility and large dendritic spines contacted 
by microglia during light deprivation shrank over time (Tremblay et al., 2010).  These results 
suggest intriguing experience-dependent changes in microglial dynamics; however, the 
molecular mechanisms driving this process are unknown.   98 
 
In the hippocampus, transient deficits in synaptic pruning have been observed in the 
CX3CR1 KO mice corresponding with a transient decrease in microglial density in these mice 
(Paolicelli et al., 2011a). Importantly, this phenotype was thought be attributed to decreased 
microglial numbers rather than to a specific role for CX3CR1 signaling in synapse development.  
Indeed, while many studies have reported interesting connections between microglia, neuronal 
activity, and synapse development, few molecular mechanisms have been proposed to explain 
these interactions.  Thus, whether and how activity-dependent expression of complement 
proteins influences microglial dynamics in other brain regions is an active area of research.   
 
TGF-β and Activity Cooperatively Regulate C1q           
I previously found that TGF-β regulates C1q (Chapter 3), but here I have reported that 
C1q expression can also be stimulated directly by depolarizing RGCs and increasing 
intracellular calcium.  These findings suggest three possibilities: 1) TGF-β signaling pathways 
can be directly stimulated by neuronal activity in the absence of TGF-β ligand.  2) TGF-β ligand 
is secreted by neurons in an activity-dependent manner.  3) TGF-β- and activity-dependent 
pathways represent two parallel mechanisms for C1q induction.  While my  experiments have 
not completely ruled out any of these possibilities, I find that TGF-β upregulation is activity 
dependent and calcium dependent, suggesting that these pathways are likely to be linked and 
not two alternative mechanisms of C1q expression.   
If TGF-β signaling and activity can upregulate C1q by some common pathway, there are 
many possible points of intersection, which are illustrated in Figure 4.6.  One possibility is that 
TGF-β ligand is secreted by neurons or neighboring astrocytes in response to increased 
neuronal activity.  Indeed, activity-dependent secretion of TGF-β has been reported in mixed 
cortical cultures, but given the speed at which C1q upregulation is observed upon depolarization 
(within 15 minutes), this option seems unlikely.  Another possibility is that activity modulates the 99 
 
 
 
 
Figure 4.6. Model for Cooperative Regulation by TGF-β and Activity.  There are 
several possible levels at which TGF-β and neuronal activity may interact to regulate C1q 
transcription.  Activity may change receptivity for TGF-β by modulating receptor 
expression levels or trafficking to the cell membrane.  Alternatively, TGF-β and neuronal 
activity may stimulate common downstream kinase pathways or activate transcription 
factors that interact in the nucleus to drive C1q transcription.   100 
 
receptivity for TGF-β by increasing the number of TGFβRs on the RGC cell membrane.  My 
experiments have shown that TGFβRII expression does not change with activity in RGCs in 
vivo; however, I have not ruled out the possibility that activity enhances TGFβRII trafficking.  
Downstream of TGFβRII signaling, it is possible that Smad transcription factors are activated by 
activity.  Indeed, certain activity-dependent kinases can directly phosphorylate Smad proteins 
(Derynck and Zhang, 2003; Engel et al., 1999).  Furthermore, Smads can interact with other 
activity-dependent co-factors in the nucleus, such as cfos and CREB (Topper et al., 1998; 
Zhang et al., 1998).  In particular, Smads can interact with cFos and cJun to regulate gene 
transcription at AP-1 sites (Zhang et al., 1998).  Very little is known about the promoter 
elements driving expression of the three C1q genes, but it is intriguing to speculate that specific 
sequences recruiting both Smads and activity-dependent co-factors, such as AP-1 sites, may be 
present in the C1q promoter regions. In addition, TGF-β and activity both activate some 
common kinase pathways, including MAPK, which could explain my  results that either TGF-β or 
activity can stimulate C1q transcription (Derynck and Zhang, 2003; Massague, 2000).  Although 
the work presented here does not distinguish at which level TGF-β and activity are working 
together, my results do show that activity is required for TGFβ-dependent upregulation of C1q 
and the level at which TGF-β and activity work together is an open area of research.   
 
Calcium-dependent Transcription in Synapse Development   
Neuronal activity enhances and represses distinct subsets of genes to drive many 
neurodevelopmental processes.  During the initial phases of synapse development, activity-
dependent gene transcription helps to establish neuronal networks and, later, it functions to 
adapt connectivity based on sensory experience.  Activity-dependent transcription is initiated 
when evoked potentials in the postsynaptic cell trigger calcium influx, which activates pathways 
such as the Ras/MAPK pathway, the calcium/calmodulin-dependent protein kinases, the 
phosphatase calcineurin, and Rac GTPases (Greer and Greenberg, 2008).  Differences in 101 
 
patterns of neuronal activity preferentially drive certain pathways over others and consequently 
activate the transcription of specific subsets of activity-dependent genes to effect synaptic 
changes (Greer and Greenberg, 2008; Itoh et al., 1995). 
Previous work has implicated a number of activity-dependent genes in synapse 
formation and development, but just a handful of activity-dependent genes have been implicated 
in synaptic refinement.  Interestingly, two of these genes are associated with immune system 
function, MHC I and neuronal pentraxins (Bjartmar et al., 2006; Corriveau et al., 1998a; Huh et 
al., 2000).  Class I MHC molecules were first identified as activity-dependent when infusion of 
tetrodoxtoxin to block all action potential activity in the LGN significantly reduced expression of 
class I MHC molecules (Corriveau et al., 1998a).   Furthermore, increasing neuronal firing with 
kainic acid induced seizure resulted in dramatic increases in class I MHC expression (Corriveau 
et al., 1998a).  The role for class I MHC in activity-driven structural remodeling and synaptic 
plasticity was discovered by examining mice lacking three molecules required for class I MHC 
signaling: β 2 – microglobulin, CD3 δ and TAP1.  All three mouse mutants showed defects in 
synaptic refinement in the retinogeniculate system (Huh et al., 2000).   
Neuronal pentraxins (NP1and 2) were also found to be involved in retinogeniculate 
refinement.  As with class I MHC molecules, mice deficient in neuronal pentraxins showed 
defected in eye specific segregation at P10, but these defects were not maintained into 
adulthood and the RGC inputs to the LGN became segregated by P30 (Bjartmar et al., 2006).  A 
similar age-dependent phenotype results when spontaneous activity in the retina is blocked 
from P1-P10 and then allowed to recover.  When retinal activity was measured in mice deficient 
in neuronal pentraxins, levels of RGC spiking activity were dramatically increased which may 
explain the phenotype in eye specific segregation (Bjartmar et al., 2006).  Neuronal pentraxins 
represent an immune system molecule that is required for normal acetylcholine mediated retinal 
wave activity during development.  NP1 can also interact with another neuronal pentraxin, Narp, 
to influence synaptogenesis and synaptic plasticity (Xu et al., 2003).  Narp was identified as an 102 
 
activity-dependent immediate early gene and is itself synaptogenic (O'Brien et al., 1999; Tsui et 
al., 1996).  When complexed with NP1, Narp has an enhanced synaptogenic effect, mediating 
both activity-dependent and activity-independent clustering of AMPA receptors (Xu et al., 2003).  
These interesting acute phase proteins seem to have critical roles in both synaptogenesis and 
synaptic refinement. 
My work has identified C1q as another activity-dependent immune system gene required 
for synaptic refinement; however, it is unclear whether or how C1q interacts with MHC1 or other 
immune system proteins during retinogeniculate refinement.  Recent work has shown that C1q 
co-localizes with MHC I at synapses in the LGN during the pruning period, suggesting that these 
proteins might be interacting (Datwani et al., 2009).  Another possibility, however, is that these 
proteins co-localized because they were both working by independent mechanisms at an 
inappropriate synapse to eliminate it.  In the immune system, MHC I and C1q are not known to 
interact, thus any nervous system interactions would be a novel finding for both the CNS and 
the immune system.  Intriguingly, a class of pentraxins has been shown to interact with C1q in 
the bloodstream and can work to inhibit C1q, although nothing is known about interactions 
between pentraxins and complement in the CNS (Jeon et al., 2010).  An exciting future area of 
research will be to determine whether and how these immune molecules work together to sculpt 
neural circuits.  
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The formation of precise mature neural circuits requires selective pruning of inappropriate 
synapses as well as the strengthening and maintenance of appropriate synaptic connections.  
Synapse elimination is thought to result from competition between neighboring axons for postsynaptic 
territory based on differences in patterns or levels of activity.  Hebb‘s rule applies in this context 
such that inputs that successfully and reproducibly drive the postsynaptic cell are maintained 
(Butts et al., 2007; Hebb, 1949; Hooks and Chen, 2006; Katz and Shatz, 1996; Sanes and 
Lichtman, 1999).  Synaptic maintenance and maturation are accomplished via activity-
dependent gene products, including neurotrophins such as BDNF (Tao et al., 1998), cell 
adhesion molecules such as NCAM (Fields and Itoh, 1996), and cytoskeletal associated 
proteins such as Arc (Lyford et al., 1995).   A longstanding mystery in the field of synaptic 
refinement, however, is the mechanism by which neural activity drives the selective elimination 
of weaker synapses.  Based on studies at the NMJ, the ―Punishment Model‖ proposes that 
synapse elimination could be accomplished by the activity-dependent expression of two signals: 
a punishment signal to eliminate nearby weaker inputs and a protective signal to block removal 
of strong inputs (Figure 1.1) (Jennings, 1994; Lichtman and Colman, 2000).  The identities of 
these signals have remained elusive; however, my findings support a ―punishment signal‖-like 
role for C1q in complement-dependent synapse elimination.   
The findings presented in this dissertation identified C1q as a critical link between retinal 
activity and the selective elimination of less active RGC inputs.  I found that C1q expression by 
RGCs is regulated by activity- and TGF-β- dependent signaling pathways and that modulating 
C1q expression in RGCs by manipulating spontaneous retinal activity or TGF-β results in 
significant local changes in C1q levels in the LGN.  Furthermore, mice deficient in C1q showed 
a failure to preferentially target weaker inputs during microglia-mediated engulfment of RGC 
inputs.  Taken together, these results suggest that C1q is required for microglia to sense 
differences in neuronal activity and, consequently, C1q links differences in retinal activity with 
the selective elimination of less active synapses.  Many intriguing questions remain including: 1) 109 
 
How does activity regulate complement-dependent tagging of synapses? 2)What are the 
protective signals and other punishment signals in synaptic pruning?  3) Is C1q unique in its 
retinal expression and trafficking to the LGN to mediate refinement or is this a general 
characteristic of other refinement cues?  4) Is neuronal activity an important modulator of TGF-β 
signaling throughout the CNS?  5) Does complement mediate synaptic refinement throughout 
the CNS? 6) What role does complement play in CNS injury and disease?  These questions, 
which I will discuss in this chapter, represent some of the exciting future directions for my 
dissertation research.  Given the many associations between immune molecules such as 
complement and nervous system dysfunction, my results identifying novel regulatory 
mechanisms for C1q expression in neurons may have broad implications for basic 
neurodevelopmental research and clinical studies.    
 
Model for Complement-dependent Synapse Elimination   
In this dissertation, I proposed the hypothesis that C1q acts as an activity-dependent  
“punishment signal” that triggers local complement-dependent synapse elimination at less active 
synapses.  My results, presented in Chapters 3 and 4, support regulation of RGC-derived C1q 
as a critical point in complement-dependent synaptic refinement and identify astrocyte-derived 
TGF-β and neuronal activity as modulators of neuronal C1q expression.  Moreover, I find that 
C1q deficient mice fail to preferentially target weaker RGC inputs during microglia-mediated 
engulfment of synapses and show reduced microglial engulfment overall.  This reduction in 
microglial engulfment and preference for weaker inputs is thought to underlie the 
retinogeniculate refinement defects I observe in C1q KOs and TGFβRII retinal KOs.   
These data suggest a model, illustrated in Figure 5.1, in which expression of C1q in 
RGCs is triggered by astrocyte-secreted TGF-β and neuronal firing in the retina.  110 
 
 
 
 
 
 
 
 
Figure 5.1. Model of Complement-dependent Synapse Elimination.  Complement-
dependent synapse elimination begins with the induction of C1q gene expression in RGCs 
regulated by neuronal activity and TGF-β.  C1q expressed by RGCs is transported along 
down the RGC axons of the optic nerve and is secreted locally into the LGN by RGC axon 
terminals on relay neurons.  C1q released from more active inputs (blue) binds to nearby 
weaker inputs (red) to trigger complement activation and C3 deposition.  Microglia (light 
green) expressing CR3 recognize C3b-tagged inputs and engulf these tagged inputs to 
remove inappropriate connections.  
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C1q is then transported to the dLGN in the thalamus where it is secreted from axon terminals, in 
the form of the entire C1 complex, and localizes to synapses.  Binding of C1q at synapses then 
activates downstream C3, generating the C3b opsonin thought to selectively tag inappropriate 
connections to promote CR3-dependent engulfment by phagocytic microglia. 
 
Spontaneous Activity and Complement-dependent Synaptic Refinement 
    The focus of my dissertation has been to determine how C1q becomes upregulated in 
RGCs and whether expression of C1q by RGCs is critical for complement-dependent 
retinogeniculate refinement.  My data demonstrate that C1q is regulated by neuronal activity 
and that C1q is required for activity-dependent targeting of less active synapses by microglia.  In 
our experimental paradigms, we drive competition such that one eye is more active than the 
other; however, during normal development, the ―winner‖ and ―loser‖ axons may not have such 
dramatically different levels of activity.  During postnatal development prior to eye-opening and 
the development of visual responses, the retina exhibits highly correlated spontaneous firing 
patterns termed retinal waves.  These waves of spontaneous activity are required for eye 
specific segregation and the refinement of retinogeniculate synapses (see Introduction).  
Although all RGCs are spontaneously active during waves, the bursts of action potential of two 
nearby RGCs are more highly correlated than two distant RGCs. Thus, individual RGC patterns 
of activity are quite different between eyes, and even within eyes.  The retinogeniculate system 
exhibits Hebbian plasticity during this period and activity is thought to have an instructive role in 
shaping neural circuits, but the molecular mechanisms of Hebbian plasticity that eliminate a less 
active synapse over a more active synapse are not clear.   
Given my results that C1q expression is activity-dependent, the complement cascade 
could be one of the molecular mechanisms driving this activity-dependent process. My results 
demonstrate that activity regulates C1q transcription in the retina and affects overall C1q levels 
in the LGN (Figures 4.3,4.4); however, we still do not know whether or how activity regulates 112 
 
complement -mediated  elimination of specific (ie. less active) retinogeniculate synapses.  There 
are several levels at which neuronal activity could regulate complement-dependent synapse 
elimination:  1) Transcription of  C1q and downstream complement components could be 
activity-dependent,(Chapter 4); 2) Secretion of complement proteins could be activity-
dependent, and 3) The localization  or targeting of complement  proteins to specific synapses 
may be activity-dependent.  These three levels of regulation are not mutually exclusive and it is 
possible that complement is regulated by activity at all of these levels. We hypothesize that 
activity-dependent regulation of C1q expression could be a mechanism to initiate and activate 
complement at specific synapses in response to changes in neuronal firing. 
In this dissertation, my data support the hypothesis that neuronal activity and TGF-β 
cooperatively regulate C1q transcription to initiate complement-dependent retinogeniculate 
refinement.  In Chapter 3, I found that TGF-β signaling is required for the developmental 
expression of C1q in the postnatal retina, and in Chapter 4, I found that C1q transcription is also 
activity-dependent.  Interestingly, when neuronal activity was silenced, TGF-β was far less 
effective at upregulating C1q (Figure 4.1), suggesting that TGF-β and neuronal activity work 
together to regulate C1q expression (see Figure 5.1).  Based on my data, we hypothesize that 
TGF-β is the developmental cue that turns C1q on at the right time and place, but that activity-
dependent regulation of C1q expression helps to guide C1q function in eliminating less active 
synapses.  My data show that perturbing retinal C1q expression results in changes in C1q levels 
in the LGN, supporting the idea that regulation of RGC-derived C1q is critical for 
retinogeniculate refinement and suggesting that C1q is secreted from RGC axons into the LGN.  
It remains unclear, however, how and if C1q selectively targets less active synapses.  Is activity-
dependent regulation of C1q transcription alone sufficient to accurately target the right synapses 
for elimination?  This is an especially intriguing question since during the retinogeniculate 
refinement period, all RGCs are spontaneously active and do not differ greatly in their levels of 
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differential C1q expression, but how less active synapses could then specifically get eliminated 
remains unclear.  Given that C1q is a secreted protein and that C1q can interact with many 
other complement molecules, it is likely that the precise elimination of less active synapses is 
accomplished by activity-dependent regulation of C1q and the process of complement-
dependent synaptic refinement at many different levels.   
  The role of neuronal activity in regulating C1q trafficking and secretion is still an active 
area of research in the lab.  My data in Figures 3.5 and 4.4 suggest that C1q is transported 
along RGC axons and is secreted into the LGN by RGC terminals; however, direct evidence of 
C1q transport and secretion happen in RGC axons requires additional experiments.  To further 
validate my findings in Figures 3.5 and 4.4, I am currently validating that C1q can be found 
within RGC terminals using Immuno Electron Microscopy for C1q.  In addition, our lab is 
developing constructs to express fluorescently-tagged C1q protein under a CMV promoter in our 
RGC cultures, our retina-LGN co-cultures, and potentially in vivo.  These constructs will take 
activity-dependent transcription out of the equation, since C1q transcription will be driven by a 
constitutively active promoter.  We then can directly ask if just transport and secretion change in 
response to activity manipulations.  With these constructs, we hope to observe C1q transport in 
real time by live imaging or to show that when we transfect labeled C1q into RGCs, we indeed 
can detect this labeled C1q in the LGN or secreted into the culture medium from axons.  Once 
we establish that we can observe transport and secretion, we can then use activity 
manipulations to ask how both transport and secretion are affected when neuronal activity is 
perturbed.  We can also use various blockers of active axonal transport to determine which if 
any of these mechanisms are required for C1q transport.  In the immune system, C1q transport 
and secretion have not been rigorously investigated since C1q is constitutively secreted by 
macrophages and this question is not especially relevant to the immune response.  In neurons, 
however, and particularly in this case where RGCs are secreting this protein into the LGN far 114 
 
away from the RGC cell body, this question becomes extremely interesting and important to 
understanding C1q function in retinogeniculate refinement.  
  Another important unanswered question is whether and how C1q works directly as a tag 
at synapses to indicate synapses meant for elimination.  My results and published work have 
shown that C1q localizes to synapses during the pruning period, and in Chapter 4, I showed that 
C1q-deficient mice have a failure to preferentially engulf less active RGC inputs.  While these 
results suggest that C1q helps in recruiting microglia to engulf less active synapses, we still do 
not know if C1q directly tags synapses or whether downstream molecules like C3b (see Figure 
5.1) are the actual tag required for engulfment.  We hypothesize that C1q is an activity-
dependent ―punishment signal‘ that locally cleaves C3 and activate the complement cascade at 
or near specific synapses (see Figure 1.1).  To address these questions, our lab has turned to a 
newly-developed retina-LGN co-culture system (see Figure 3.5) that allows imaging of activity-
dependent synaptic competition in real time.   Immunostaining for C1q and C3 to can be 
performed retrospectively ask whether the less active or the ―losing‖ axon is specifically labeled 
or tagged with complement C1q and/or C3.  We can also manipulate activity in subsets of RGCs 
and determine if C1q and/or C3 specifically localize to the less active axons.  In addition, C1q 
KO and C3 KO mice have defects in synapse elimination and microglial engulfment, but 
microglia still do engulf some RGC inputs and some degree of synaptic refinement still occurs in 
these mice.  Thus, it is likely that there are other complement-dependent and -independent 
synapse elimination cues.  Using this new co-culture system, our lab also will be able to screen 
for novel candidate molecules.  The results presented in this dissertation will inform these future 
studies to determine what additional cues regulate synaptic refinement and how they interact 
with C1q. 
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Alternative Punishment Signals 
My results support a role for C1q in initiating complement-dependent synapse 
elimination as in my model (Figure 5.1); however, there are several alternative molecules that 
could cooperate with or inhibit C1q during synapse elimination.  I have focused on C1q and C3 
as punishment factors, but there could be additional complement factors that work as 
punishment signals.  There are two potential classes of complement molecules that I predict 
could act as ―punishment‖ signals:  opsonins (such as C3b or C4b) and anaphylatoxins (such as 
C3a and C5a) (Figure 1.3 B).  While C3b is considered the primary opsonin in the immune 
system, C4b can also opsonize and potentially tag synapses for elimination.  I have not 
investigated the role for other opsonins in this process.  Anaphylatoxins, including C3a or C5a, 
could work to recruit phagocytic microglia to the sites of synaptic refinement and potentially 
could induce apoptosis at synapses expressing the C3a or C5a receptors (Mattson and Duan, 
1999; Nataf et al., 1999).  In this case, the anaphylatoxin could trigger apoptosis in a weak 
synapse (or a process containing a weak synapse) and microglia would phagocytose the 
apoptotic blebs.  Intriguingly, activated caspases, mediators of apoptosis, have been detected 
locally within dendrites, axons, synaptic terminals, and growth cones in non-apoptotic cells (Kuo 
et al., 2006; Li et al., 2010; Williams et al., 2006).  Activation of apoptotic pathways locally at 
synapses has been proposed as a potential mechanism of synapse loss in neurodegenerative 
disorders (Mattson et al., 1998); however, recent work has implicated apoptotic signaling 
pathways involving caspase-3/7 and caspase-9 in the weakening of synapses by long-term 
depression (LTD) (Li et al., 2010), suggesting a potential role for local apoptosis in 
developmental synapse elimination.  It is not yet known whether a similar mechanism is at play 
during developmental axonal pruning; however, preliminary data from our lab suggests a local 
‗synaptosis‘ of weaker retinogeniculate synaptic boutons involving caspase-dependent 
signaling. In future studies it will be important to investigate whether C1q or C3 selectively target 
less active boutons through this or other mechanisms.      116 
 
Lastly, the specific binding partners for C1q and C3b on the surface of RGC inputs have 
yet to be identified.  In the immune system, antigen-antibody complexes, including IgG and IgM 
complex, bind C1q to trigger cascade activation, but C1q can also be activated by some 
proteins on the surface of bacteria and by some viruses in an antibody-independent manner.  
Some of these proteins bind the C1q globular domain but other activating molecules such as 
DNA, C-reactive protein (CRP), serum amyloid protein (SAP), decorin, and some putative C1q 
receptors are thought to bind C1q via the collagen domain (Kishore et al., 2004; Kishore and 
Reid, 2000).  Perhaps some of these non-traditional activators of C1q are regulated on RGC 
inputs in an activity-dependent manner and work to eliminate weaker synapses.  Alternatively, 
C1q can recognize apoptotic cells by the presence of phosphatidylserine on the cell membrane 
(Païdassi et al., 2008).   If, as discussed earlier, local apoptotic pathways become activated at 
synapses meant for elimination, perhaps phosphatidylserine could appear on the cell membrane 
specifically at weak synapse and promote C1q deposition and cascade activation.         
 
Complement Regulatory Proteins as “Protective Signals” 
  The ―Punishment Model‖ also suggests that an activity-dependent protective cue may 
prevent elimination of strong connections.  In this case, the production and secretion of 
complement proteins by neurons may not be the only cue controlling the ―tagging‖ process.  
Instead, complement secreted during the pruning period may non-specifically bind to all or most 
synapses and the protective cues may regulate which synapses are engulfed.  Complement 
regulatory proteins are good candidates for protective signals.  There are two classes of 
complement regulatory proteins:  Membrane bound (such as CR1, DAF, MCP, and CD59) and 
secreted (C1 INH, Factor H, and C4BP) (Elward and Gasque, 2003; Iida and Nussenzweig, 
1981).  Some of these molecules including CR1 were recently shown to be upregulated in 
response to in vivo high frequency stimulation, suggesting activity-dependent regulation (Håvik 
et al., 2007).  Based on the broad distribution of C1q immunostaining that I observe in the 117 
 
dLGN, C1q may be deposited at all synapses; however, my  data demonstrating that microglia 
cannot distinguish between weak and strong inputs in the absence of C1q suggests that C1q 
conveys some information about neuronal activity to microglia. 
Molecules outside of the complement system could also work as punishment or 
protective cues in complement-dependent synapse elimination via regulation of microglial 
activation state.  Resting microglia, which predominate in the mature brain, downregulate their 
phagocytic receptors, while earlier in development and in response to injury or inflammation, 
microglial phagocytic capacity is greatly increased.  Many cytokines such as TNF-ʱ and IFN-γ 
(Meda et al., 1995; von Zahn et al., 1997), as well as classes of molecules known as ―eat me‖ 
and ―don‘t eat me‖ signals (Elward and Gasque, 2003), such as CD47 and CD200, function to 
regulate phagocytosis by immune cells in the periphery.  In the brain, many of these same cues 
regulate microglial activation state and phagocytosis (von Zahn et al., 1997), which could 
prevent microglia from engulfing too many or too few synapses. 
The models I have outlined detailing specific ways in which punishment and protective 
cues modulate synaptic refinement are by no means mutually exclusive mechanisms.  In our 
lab, we hypothesize that these various punishment and protective cues work together to 
regulate synaptic refinement at multiple levels.  Future studies will determine which of these 
punishment and protective cues are required for synaptic refinement and how their functions are 
coordinated during this process.      
 
Retina-derived versus Local LGN Cues in Retinogeniculate Refinement 
My findings implicate TGF-β as an activity-dependent retinal cue that regulates synapse 
elimination locally in the dLGN during retinogeniculate refinement.  In my model for 
complement-dependent synaptic refinement, TGF-β cytokine signaling and neuronal activity 
regulate C1q expression in RGCs, which modulates the targeting of C1q and C3 to synapses 
and microglia-mediated pruning in the dLGN.  These findings raise the question as to whether 118 
 
RGCs are a critical source of other refinement cues.  Other molecules, such as MHCI and NP1, 
have also been implicated in retinogeniculate refinement.  Interestingly, in the fly, TGF-β 
signaling triggers the dramatic neuronal remodeling that occurs during metamorphosis (Awasaki 
et al., 2011).  Could retinal activity and TGF-β work together to initiate a synaptic refinement 
gene program specifically in RGCs or is this regulatory mechanism unique to C1q?  
Furthermore, are cues expressed by RGCs that function in the LGN trafficked there along the 
axon or is there local axonal translation to produce some of these proteins during the refinement 
period (Brittis et al., 2002; Martin, 2004)? 
Molecules required for retinogeniculate refinement could drive this process in several 
different ways.   First, RGC terminals could secrete the molecule that promotes refinement into 
the dLGN, as I observed with C1q.  Another possibility is that cues are locally secreted from 
neurons and glia in the dLGN.  Lastly, a molecule could function to regulate retinal activity, and 
indirectly influence refinement in the dLGN.  My data suggest that C1q expressed by RGCs is 
required for synaptic refinement and that local secretion of C1q during the refinement period in 
the dLGN, from microglia or other sources, cannot compensate for the loss of RGC-derived 
C1q.  I hypothesize that C1q is transported along RGC axons to the dLGN, but local translation 
and synthesis of C1q within RGC axons in the optic nerve or dLGN is also a possibility, although 
local translation of C1q has not previously been reported.  I have not assessed retinal wave 
activity in retinal TGFβRII KO or C1q KO mice, so I cannot rule out the possibility that C1q 
regulates retinal activity.  However, my findings that microglia lose their preference for engulfing 
less active inputs in both C1q KO mice and retinal TGFβRII KO mice provide evidence that C1q 
has a local function in the LGN that cannot be accounted for by any potential functions that C1q 
might have in the retina (Figure 4.5).  Thus, even in C1q and TGF-β have other functions in the 
retina coinciding with the refinement period, C1q would still need to be functioning in the LGN 
for microglial targeting of weaker inputs to be disrupted in C1q-deficient mice.     119 
 
Interestingly, other immune molecules implicated in refinement do not necessarily follow 
this same pattern of expression in the retina and function in the LGN.  For example, C3 and 
CR3, which work downstream of C1q, are thought to be locally expressed in the LGN (Schafer 
et al., 2012a).  CR3 is expressed on the surface of microglia, but the source of C3 remains 
unclear.  Other immune proteins implicated in synaptic refinement, MHC I and NP1, seem to 
have local regulation and functions as well.  MHC I was first identified as an activity-dependent 
gene in the LGN, not the retina.  MHC I was downregulated after infusion of TTX into the fetal 
cat LGN (Corriveau et al., 1998a), suggesting that postsynaptic relay neuron expression of 
MHCI may be more important than RGC-derived MHCI.  A receptor for MHCI, however, 
CD3zeta, is expressed by RGCs and is required for eye specific segregation as well (Huh et al., 
2000; Xu et al., 2010).  CD3zeta deficient mice have defects in GluR-mediated synaptic 
transmission in RGCs (Xu et al., 2010), which suggests that the role of CD3zeta in the retina 
versus at RGC terminals in the LGN may be critical for pruning.  Whether MHC I also regulates 
retinal activity is unclear, but other receptors for MHC I, such as PirB, could be more important 
for their local functions in the LGN (Syken et al., 2006).  NP1 functions as a regulator of 
spontaneous acetylcholine-dependent retinal activity, which drives a transient pruning 
phenotype in the LGN in NP1-deficient mice (Bjartmar et al., 2006); however, no clear function 
for NP1 in the LGN has been described.  Thus, these data suggest that RGCs are not the only 
source for refinement molecules and suggest that there are multiple mechanisms that work in 
parallel to refine retinogeniculate circuits.  It will be interesting to investigate if these pathways 
somehow work together and to determine if C1q is indeed the only cue regulated in this manner 
to directly link spontaneous retinal activity with synaptic pruning in the LGN.     
 
TGF-β and Activity-dependent Transcription. 
My results demonstrate that TGF-β and activity-dependent signaling pathways interact to 
regulate  C1q  expression  and  complement-dependent  synapse  elimination.    Does  neuronal 120 
 
activity also modulate TGF-β signaling  in other contexts during development throughout the 
nervous system?  Activity-dependent gene transcription has been implicated in many of the 
same processes as TGF-β, including neuronal survival and proliferation (Lu et al., 2005; Spitzer, 
2006), synaptogenesis (Diniz et al., 2012), and synapse function and plasticity (Fukushima et 
al., 2007; Greer and Greenberg, 2008; Heupel et al., 2008a).     
As  discussed  in  Chapter  4,  there  are  many  possible  points  of  intersection  between 
activity-dependent pathways and TGF-β signaling pathways (Figure 4.6).  It has been proposed 
that many cytokines, including TGF-β, signal in a cell-specific manner such that TGF-β itself 
serves  only  as  a  source  of  activated  Smads  and  the  downstream  effect  of  Smad 
phosphorylation is based on the convergence of many other cues (Massague, 2000), such as 
potentially activity-dependent factors.  Patterns of neuronal activity change dramatically over 
development; for example, in the retina, RGCs undergo waves of spontaneous activity before 
the onset of vision, but change their firing pattern after eye opening based on photoreceptor 
activation (Huberman et al., 2008a; Katz and Shatz, 1996; Penn and Shatz, 1999; Stellwagen et 
al.,  1999).    Thus,  in  the  retina  and  throughout  the  brain,  it  is  possible  that  the  pool  of 
transcriptional  co-factors  that  can  interact  with  Smads  may  change  dramatically  over 
development and can help to diversify neuronal responses to TGF-β.   Interestingly, Smads 
alone have a low affinity for their DNA binding sequence and therefore seem to require co-
factors to successfully stimulate transcription.  Smads have been shown to interact with activity-
dependent co-factors in the nucleus, such as cFos, Mef2 and CREB (Quinn et al., 2001; Topper 
et al., 1998; Zhang et al., 1998).  In addition, TGF-β and activity both activate some common 
kinase pathways, including the MAPK pathway (Massague, 2000).  Although it is not yet clear at 
what level neuronal activity and TGF-β signaling are interacting to regulate C1q transcription, it 
is  intriguing  to  speculate  that  many  activity-dependent  pathways  may  be  cooperatively 
regulating other critical TGF-β dependent processes throughout the nervous system.   
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Evidence for Complement-dependent Synaptic Refinement in Other Brain Regions 
Synaptic refinement occurs throughout the brain at different time points.  The developing 
visual system is one of the best studied systems; however, recent work has characterized 
synaptic refinement in other brain regions as well, including the cerebellum and the auditory 
system.  In the cerebellum, climbing fiber projections from the inferior olive initially synapse onto 
purkinje cell bodies (Hashimoto et al., 2009; Hashimoto and Kano, 2005).  In the second and 
third postnatal weeks in the mouse, climbing fibers undergo refinement resulting in a single 
climbing fiber driving activity in a single purkinje cell, much like the 1:1 connectivity between 
RGCs and relay neurons that is generated in the mature dLGN.  The ―winning‖ climbing fiber 
elaborates and moves distally, ―climbing‖ to the purkinje cell dendrites, while remaining ―losing‖ 
fibers are eliminated (Hashimoto et al., 2009; Hashimoto and Kano, 2005).  Roles for 
complement and microglia have yet to be explored in the cerebellum; however, microglia do 
regulate purkinje cell survival (Marin-Teva et al., 2004) in the cerebellum and branched, 
phagocytic microglia are present in the cerebellum around the time when synapse elimination is 
occurring.  Moreover, the C1q-like protein, Cbln1, has been implicated in synapse formation and 
maintenance at parallel fiber-purkinje cell synapses, but, interestingly, Cbln1 KO mice also 
exhibit persistent multiple climbing fiber innervations onto purkinje cells (Hirai et al., 2005).  This 
intriguing result suggests a role for this C1q-like molecule in cerebellar synaptic refinement.  
Given this finding, perhaps C1q does not regulate refinement globally, but rather C1q family 
members, including Cbln1 and C1qL1-4 (Bolliger et al., 2011; Yuzaki, 2010), regulate this 
process in specific brain regions.   
A stereotyped refinement process also occurs in the auditory system.  Spiral ganglion 
neuron inputs onto outer hair cells undergo refinement in the first postnatal week (Huang et al., 
2007).  Initially, neurons from both classes of spiral ganglion neurons innervate all hair cells, but 
from P3-P6 neurites from type I spiral ganglion neurons retract and synapses on outer hair cells 
are eliminated while inner hair cell innervation is maintained (Huang et al., 2007).   Interestingly, 122 
 
C1q and TGF-β expression are also expressed in embryonic and postnatal spiral ganglion 
neurons (Lu et al., 2011), raising the question of whether TGF-β signaling regulates 
complement expression and synapse elimination in spiral ganglion neurons as well.  Very little is 
known about the mechanisms of synaptic refinement in the auditory system; however, 
developmental expression of C1q is detected in spiral ganglion neurons, the sensory neurons 
that transmit auditory signals from the cochlea to the brain much like RGCs connect the retina 
with the brain, around the time when synapse elimination occurs from outer hair cells (Lu et al., 
2011).  Interestingly, although C1q is enriched in microglia throughout CNS, C1q expression in 
sensory neurons, both RGCs and spiral ganglion neurons, is developmentally regulated and 
restricted to periods of developmental synaptic remodeling.  These results are consistent with 
my findings that neuron-derived C1q is specifically required for complement-dependent synaptic 
refinement (Chapter 3).    
Recent work has also implicated C1q in the refinement of cortical circuits in that C1q KO 
mice show increased synaptic connectivity and experience spontaneous seizures (Chu et al., 
2010).  In particular, the axonal bouton density was significantly increased in layer V pyramidal 
neurons of C1q KO mice, and C1q KOs had frequent seizures consisting of behavioral arrest 
associated with bihemispheric spikes and slow wave activity (Chu et al., 2010). This 
hyperexcitability is thought to be attributed to a failure to prune excessive excitatory synapses 
during development, although it is difficult to rule out the possibility that C1q could alternatively 
work as a negative regulator of synaptogenesis in the cortex as well. 
 
Cascade-dependent and -independent Functions for C1q in the CNS 
  C1q-like molecules regulate synapse density and act as synaptic organizers in the 
cerebellum (Bolliger et al., 2011; Yuzaki, 2010), as discussed briefly above.  These interesting 
proteins closely resemble the globular domains found in C1q, but lack the C1q collagen domain 
(Kishore and Reid, 1999) (Figure 1.3).  The putative receptors thought to bind C1q-like family 123 
 
members to regulate synapse development, including BAI3 and GluD2, recognize the globular 
domains of these proteins (Bolliger et al., 2011; Matsuda et al., 2010), suggesting that C1q may 
also bind to these receptors or similar proteins to potentially execute functions independently of 
complement cascade activation.  My findings support a role for C1q in synapse elimination; 
however, the process of synaptic refinement involves the strengthening and maturation of 
certain synapses with the concurrent elimination of weak, immature synapses.  Could C1q play 
a role in the selective strengthening and maturation of synapses as well?  One of the C1q-like 
molecules, Cbln1, binds to Neurexin presynaptically and GluD2 postsynaptically to act as a 
synaptic organizer in the cerebellum (Yuzaki, 2009).  Cbln1 rapidly induces synapse formation 
but is also required during synapse maturation and maintenance (Yuzaki, 2010), processes 
which are a critical part of synaptic refinement in the LGN.  Other C1q-like molecules are also 
expressed throughout the developing CNS and work to limit synapse density in vitro (Bolliger et 
al., 2011), although their functions in vivo remain unclear.     
To explore whether C1q had functions independent of cascade activation for neurons, I 
characterized the formation and development of synapses in purified RGCs isolated from global 
C1qA KO mice.  These purified RGC cultures are devoid of microglia, suggesting that any 
results I observed could not be the result of complement-dependent microglia engulfment of 
synapses.  I developed RNAi constructs and C1qA rescue constructs to specifically knock down 
or rescue C1qA expression in RGCs in vitro.  My results showed that RGCs deficient in C1qA 
have significantly more synapses per cell compared with WT RGCs (Supplemental Figure 9).  I 
detected synapses by immunostaining for the presynaptic protein, vglut2, and a postsynaptic 
protein, PSD95, and quantified the number of synapses as co-localized puncta.  Co-localized 
puncta were quantified in ImageJ using the PunctAnalyzer macro.  In normal WT cultures, 
RGCs do not form many synapses; however, my C1q KO RGCs showed a six- to eight-fold 
increase in synapse number compared to WT cultures (Supplemental Figure 9A), suggesting 
that a normal function for C1q might be to inhibit synapse formation or to eliminate synapses in 124 
 
the absence of microglia.  Adding back C1qA expression using a rescue construct expressing 
C1qA under the control of a CMV promoter (Open Biosystems, Clone 3592169) resulted in 
almost WT synapse numbers in C1qA transfected C1q KO neurons (Supplemental Figure 9B), 
suggesting that this effect is specific for C1q.  Furthermore, sparse transfections of purified 
RGCs with C1qA-shRNA resulted in an increase in synapses only in C1q-shRNA transfected 
neurons, but not in other non-transfected control neurons in the same culture (Supplemental 
Figure 9C).  These results suggest that the effects of C1q are either locally restricted and/or cell 
autonomous.  To address this question, I added WT RGC media to C1q KO RGCs and was 
able to partially rescue the increase in synapse number, suggesting that the effects I observed 
in transfected cells were not cell-autonomous (Supplemental Figure 10).  A possible explanation 
for this result is that in the transfected cultures, C1q does not diffuse very far in undisturbed 
cultures in the incubator, while adding C1q exogenously to the cultures gives a more even 
distribution of C1q protein.   
Given that I observed novel functions for C1q in RGC cultures, I next wanted to 
determine if TGF-β regulated this function for C1q in RGC cultures as well.  To address this 
question, I cultured WT RGCs in the presence of anti-TGFβ neutralizing antibodies.  Although I 
hypothesize that astrocytes are the main source of TGF-β in the retina, given that they express 
much higher levels of TGF-β than RGCs (Supplemental Figure 2E), RGCs do express TGF-β 
and could potentially maintain the basal level of C1q expression I observe in purified RGC 
cultures.  Interestingly, I found that blocking TGF-β chronically with neutralizing antibodies 
partially phenocopied the increase in synapses that I observed in the C1q KO RGC cultures 
(Supplemental Figure 11), suggesting that TGF-β regulates C1q function in this context as well.  
These findings suggest that the refinement defects I observed in C1q-deficient mice may be 
partially attributed to a novel microglia-independent refinement process.           
  I also looked at neurite outgrowth and polarization in C1q KO RGCs and RGCs 
transfected with C1q shRNAs as a control to determine if any morphological defects in RGCs 125 
 
could account for the phenotypes I observed in vivo.  Surprisingly, I found that RGCs deficient in 
C1q had a similar number of total neurites and overall outgrowth; however, many of these 
RGCs had multiple axons, as indicated by immunostaining for Map2 (to label dendrites), 
neurofilament, and βIV spectrin (axon initial segment marker).  In C1q KO RGCs (Supplemental 
Figure 12) and in RGCs transfected with C1q-shRNA (data not shown), there was a significant 
increase in the number of cells with multiple axons indentified by positive immunostaining for 
βIV spectrin and neurofilament, but Map2 negative.  These results suggest that C1q may play a 
role in neurite polarity, although multiple axons were not observed in C1q KO mice in vivo, 
suggesting that this phenotype may be an artifact of the culturing process.  RGCs are known to 
sprout additional axons after axotomy (Cho and So, 1992) and recent findings suggest a role for 
C1q in stroke and optic nerve crush (Ohlsson et al., 2003; Zai et al., 2009).  Perhaps the cell 
culture process mimics some aspects of injury and, in that case, my data would be consistent 
with a role for C1q to inhibit sprouting. 
  Together these findings suggest several possible cascade-independent roles for C1q, 
raising the intriguing question of whether C1q has functions independent of complement 
cascade activation in vivo.  Could the presence of downstream complement proteins such as C3 
help to drive C1q function toward synapse elimination, while, in the absence of C3, C1q may 
serve other functions?  This possibility is particularly interesting in the context of injury and 
disease in which there are opposing reports showing that C1q is neuroprotective in some cases 
and harmful in other cases.  Dysregulation of immune system components, including 
complement components and cytokines, has been demonstrated in many CNS disorders and 
diseases including epilepsy (Aronica et al., 2007), schizophrenia (Mayilyan et al., 2008), and 
neurodegenerative disorders such as glaucoma (Howell et al., 2011; Rosen and Stevens, 2010; 
Stevens et al., 2007) and Alzheimer‘s disease (Afagh et al., 1996; Fonseca et al., 2004a; 
Zanjani et al., 2005; Zhou et al., 2008).  Many of these disorders have been associated with 
synapse loss or dysfunction (Arnold, 1999; Rosen and Stevens, 2010; Selkoe, 2002), 126 
 
suggesting that aberrant complement upregulation may reactivate the developmental synapse 
elimination pathway in disease to promote synapse loss.  In glaucoma, C1q localizes to the 
synaptic layers of the retina and the RGC layer early in the disease before significant loss of 
RGCs is observed (Stevens et al., 2007).  Complement upregulation in Alzheimer‘s disease also 
occurs very early in the disease around the onset of mild symptoms.  The rapid upregulation of 
C1q that I observed (Figure 3.1), as well as reports of complement activation in the early stages 
of neurodegeneration suggest that complement upregulation may be one of the earliest 
pathological events in these disorders (Rosen and Stevens, 2010; Zanjani et al., 2005).  Thus, 
C1q upregulation and perhaps TGF-β signaling may be an important target for early therapeutic 
intervention.  Indeed, TGF-β localizes to beta-amyloid plaques and has been linked to the 
formation of these plaques in Alzheimer‘s disease (Wyss-Coray et al., 1997) and blocking TGF-
β and Smad2/3 signaling mitigates plaque formation in mouse models of Alzheimer‘s (Town et 
al., 2008).  C1q has been found associated with plaques in Alzheimer‘s brain as well (Afagh et 
al., 1996), and in mouse models of Alzheimer‘s, C1q-deficiency has been shown to be 
neuroprotective (Fonseca et al., 2004b).   
In the above cases, C1q and complement activation are thought to contribute to 
neuropathology.  Conversely, other results have shown that complement activation after injury 
or in disease may help to clear harmful debris to promote recovery (Alexander et al., 2008a). 
For example, inhibiting C3 with a soluble form of the complement inhibitor, Crry, exacerbated 
some aspects of neuropathology, including neurodegeneration and plaque formation, in 
Alzheimer‘s disease (Wyss-Coray et al., 2002; Zhou et al., 2008).  Moreover, recent work has 
shown that adding C1q to neuronal cultures upregulated genes that promote survival and 
outgrowth and also increased the nuclear translocation of cAMP response element-binding 
(CREB) protein and CCAAT/enhancer-binding protein-ʴ (C/EBP-ʴ), two transcription factors 
involved in nerve growth factor (NGF) expression (Benoit and Tenner, 2011).  The conflicting 
reports of harmful and helpful roles for complement in injury and disease are difficult to 127 
 
reconcile; however, my results suggesting both cascade-dependent and -independent functions 
for C1q may be one explanation.  Another possibility is that complement proteins have 
detrimental roles in some stages of injury and disease, but may have protective roles at different 
stages.  For example, in neurodegenerative disease, complement proteins may contribute to 
synapse loss early but help to clear debris at later stages.  Thus, complement-deficient mice 
may show an overall slower progression of the disease because of inhibited synapse loss; 
however, adding inhibitors for complement after the onset of symptoms may result in more 
severe neuropathology since this approach may only block this later-stage complement 
function.   
Interestingly, the functions that have been identified for C1q in the CNS during 
development, disease, and injury are largely based on studies conducted using C1q-deficient 
mice.  These mice were made by deleting C1qa (Botto et al., 1998), one of the three C1q 
genes.  Interestingly, c1qb and c1qc are still expressed in these mice, but the C1 complex which 
activates the classical complement cascade cannot be formed.  It is not clear, however, whether 
C1qB and C1qC peptides are still produced and secreted.  If so, could these peptides have 
unique functions?  Individual C1qB and C1qC peptide monomers have not been reported in the 
literature, but given the novel functions recently identified for C1q-like molecules, it would be 
interesting to investigate whether C1q A, B, and C triple knockout mice have phenotypes not 
observed in the C1qA-deficient mice.           
 
Complement Dysregulation in Neurodevelopmental Disorders 
  In addition to the roles for complement in neurodegeneration and injury, complement 
dysregulation and microglial dysfunction have also been linked to neurodevelopmental disorders 
such as autism, epilepsy, and schizophrenia.  Recent work has shown elevated cytokine levels 
and other signs of neuroinflammation in the brains of autistic individuals (Li et al.; Vargas et al., 
2005).  Particularly of interest are increases in specific cytokines with the potential ability to 128 
 
upregulate C1q:  IL-6, TNF-ʱ, IFN-γ, and TGFβ isoforms.  If one of the factors elevated in ASD 
triggers C1q upregulation in neurons and influences pruning, then synaptic refinement may not 
occur properly.  One theory about the etiology of ASD is that there is a cortical imbalance in 
excitation and inhibition (Chao et al., 2010; LeBlanc and Fagiolini, 2011; Rubenstein and 
Merzenich, 2003). In support of this theory, recent work has suggested abnormal development 
of inhibitory circuits in two mouse models of autism, suggesting hyperexcitability contributes to 
autism (Gogolla et al., 2009).  Conversely, in mouse models of Rett Syndrome, a genetic 
disorder in which patients exhibit many autistic-like symptoms (Amir and Zoghbi, 2000; 
Chahrour and Zoghbi, 2007), MeCP2 deficiency results in decreased excitation, but normal 
levels of inhibition (Dani et al., 2005).  This deficit results in an overall shift in the neocortical 
excitatory/inhibitory balance in favor of inhibition.  Interestingly, recent work has shown that the 
progressive visual system defects in MeCP2 KO mice can be rescued by decreasing levels of  
NR2A, a glutamate receptor subunit highly upregulated in these mice, and consequently, 
helping to restore the excitatory/inhibitory balance (Durand et al., 2012).   
These results indicate that shifting activity in either the excitatory or inhibitory direction 
can have dramatic effects on cortical development, thus precise regulation of synaptic pruning is 
required to prevent this imbalance.  This fact is particularly evident in a recent study revealing 
that C1q KO mice have increased synaptic connectivity in neocortex, as shown by both 
physiological and anatomical analysis, and experience spontaneous seizures (Chu et al., 2010).  
This finding suggests that complement-dependent pruning defects can result in the type of 
hyperexcitability thought to underlie epilepsy and other developmental disorders.  Interestingly, 
a major risk factor for autism is maternal inflammation, and many autistic-like behaviors can be 
induced in mice by inducing inflammation in the pregnant dam.  Many cytokines increase as a 
result of this inflammatory insult, including TGF-β, suggesting that complement dysregulation 
may account for some of the defects observed in these mice.  In support of this hypothesis, a 
recent microarray study analyzing changes in gene expression in human autistic brain samples 129 
 
versus controls revealed several immune and inflammatory response genes, including the C1q 
genes and components of the TGF-β signaling pathway, that were upregulated in autistic brains 
relative to controls (Voineagu et al., 2011).  Intriguingly, genes associated with synapses were 
among the downregulated genes in this same study (Voineagu et al., 2011).  Given these 
intriguing genetic associations between immune dysfunction and autism, unraveling the 
mechanistic details of complement-dependent synapse elimination may provide insight into a 
new type of auto-immune, neurodevelopmental defect (Careaga et al., 2010; Enstrom et al., 
2009; Garay and McAllister, 2010). 
Conclusion 
  My findings and the work of many others have shattered the dogma of the brain as a 
traditional site of ―immune privilege‖ and suggest a new view of the CNS as an ―immune 
specialized‖ site.  This immune specialization is particularly evident in the case of complement-
dependent synapse elimination.  Here, the cytokine TGF-β is ―specialized‖ in the retina to trigger 
activity-dependent upregulation of C1q, while in the immune system this cytokine traditionally 
suppresses inflammatory cues like C1q.  Furthermore, C1q expression and secretion are 
―specialized‖ in retinal ganglion cells to locally activate complement in the LGN and selectively 
tag synapses meant for elimination.  In the bloodstream, C1q is constitutively produced and 
secreted by circulating macrophages and is prevented from binding to healthy cells of the body 
by complement inhibitors, but in the brain it actually seeks to elimination parts of healthy, non-
apoptotic cells.  Interestingly, local secretion of C1q from microglia in the LGN does not 
compensate for the loss of RGC-derived C1q, and the cues that regulate C1q in RGCs, TGF-β 
and neuronal activity, have no effect on microglial C1q expression, again emphasizing 
―specialized‖ roles for neurons and microglia in this system.  In addition, postnatal microglia, 
which can be approximated as process-bearing macrophages, are uniquely ―specialized‖ to 
phagocytose RGC inputs in an activity- and complement-dependent manner precisely during 130 
 
the retinogeniculate refinement period and not in the mature visual system (Schafer et al., 
2012a).   
Despite these specializations, it is quite striking how similar complement-mediated 
synapse elimination in the brain is to complement function in the immune system.  Both 
processes use some the same proteins (C1q, C3, and CR3) and similar phagocytic cells, 
macrophages in the periphery and microglia in the brain.  Further study is required to identify 
the synaptically localized binding partner for C1q; however, the mechanism of complement-
dependent synapse elimination currently represents one of the most comprehensive molecular 
mechanisms for synaptic refinement in the CNS yet to be described.  For this reason, 
determining to what extent this process is a global mechanism for synapse elimination 
throughout the brain will be a priority for future studies.  If C1q is indeed regulated similarly and 
functioning to initiate synapse elimination throughout the brain, future work to conditionally 
knock out C1q or inhibit TGF-β and disrupt the pruning process in key brain regions 
systematically could have broad implications. 
  In addition to the direct parallels between complement function in the immune system 
and the developing CNS, my results demonstrating cascade-independent roles for C1q in 
polarity and controlling synapse number hint toward evolved mechanisms that may be unique to 
the brain.  These findings suggests that, despite identifying C1q as the initiator of complement-
dependent synapse elimination and determining the key regulators of neuronal C1q expression, 
we have only begun to understand the complexities of the many neural-immune interactions that 
regulate almost every stage of nervous system development.  
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Contributions:  All experiments were designed by Beth Stevens and Allison Bialas.  All experiments and 
data analysis were performed by Allison Bialas.  Arnaud Frouin assisted in preparing C1q-shRNA and 
C1qA overexpression constructs. 149 
 
 
 
 
 
 
 
 
 
 
 
Supplemental Figure 1. In vitro characterization of ACM-induced C1q upregulation. (A) 
ACM  prepared  from  traditional  mixed  astrocytes  or  purified  cortical  or  retinal  astrocytes 
upregulate C1q to the same extent (one way ANOVA, n=3 experiments, *p<0.05) (B) QPCR 
analysis of C1qA expression shows the timecourse for C1q A upregulation closely mimics the 
timecourse for C1q B and shows rapid, significant upregulation 15 min. after adding ACM (two 
way ANOVA, n=3 experiments, *p<0.05, **p<0.01, ***p<0.001). (C) QPCR timecourse analysis 
of C1qC expression show rapid upregulation that closely mimics the timecourse for C1qA and B 
(one way ANOVA, n=3 experiments, *p<0.05, **p<0.01, ***p<0.001). (D) C1r and C1s, the two 
other components of C1 that associate with C1q, are also significantly upregulated at 15 min by 
qPCR (one way ANOVA, n=3 experiments, **p<0.01, ***p<0.001). (E) A transcriptional inhibitor, 
actinomycin,  blocks  C1q  upregulation,  supporting  that  C1q  upregulation  is  a  transcriptional 
event (two way ANOVA, n= 3 experiments, ***p<0.001). (F) Boiled ACM does not upregulate 
C1q, suggesting that a protein in ACM upregulates C1q (two way ANOVA, n=3 experiments, 
***p<0.001).  
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Supplemental Figure 2. TGF-β is necessary and sufficient for C1q upregulation. (A) RT-
PCR analysis of C1qA and B expression a robust upregulation of C1q by insert (I) versus control 
(C), while IL-6 or TNFa treatment induces a modest increase in C1q. (B) TGF-β3 is specifically 
required in ACM vs. TGF-β1 and TGF-β2. Specific immunodepletion of each isoform of TGF-β 
was performed and only pan-TGF-β depletion and depletion of TGF-β blocked C1q upregulation 
(two way ANOVA, n=3 experiments, ***p<0.001). (C) TGF-β2 and 3 are completely neutralized 
by anti-pan TGF-β (1D11, R&D systems) at concentrations present in ACM represented by the 
black (TGF-β3) and grey (TGF-β2) dotted lines.  Only doses >2ng/ml of TGF-β3 were not fully 
neutralized.  %Neutralization represents (the concentration of TGF-β- concentration of TGF-β 
after depletion)/initial concentration of TGF-β.  TGF-β concentrations were measured by isoform 
specific ELISAs. (D) Glycine elution of TGF-β from neutralizing antibodies demonstrates that the 
material immunodepleted from ACM is sufficient to induce C1q upregulation.   Both anti-pan 
TGF-β  and  anti-TGF-β3  eluates  upregulated  C1q  (one  way  ANOVA,  n=  3  experiments, 
***p<0.001). (E) TGF-β3 mRNA is enriched in retinal astrocytes compared to other astrocytes 
(McCarthy and Devellis (MD) preparation and purified cortical astrocytes (cortical) , RGCs, and 
microglia (Mg).  
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Supplemental  Figure  3.  Validation  of  TGFβRII  retinal  KO  (A)  Confirmation  of  published 
results that C1q immunostaining is developmentally regulated in the IPL and RGC layer of the 
retina.  (B)  Validation  that  a  known  TGF-β-dependent  gene,  TIEG,  is  downregulated  in  the 
TGFβRII  retinal  KO  and  when  anti-TGF-β  is  injected  into  the  eye  (one  way  ANOVA,  n=3 
samples/group,**p<0.01,  ***p<0.001).  (C)  There  is  no  difference  in  the  number  of  RGCs  in 
TGFβRII retinal KO mice vs. WT littermates. Tuj1-positive cells were counted on whole mount 
retina preparations per 63X field of view (t test, n=4 mice/group, no significance). (D) Whole 
mount retina immunostaining for Tuj1  and βIV spectrin shows the presence of axons in the 
TGFβRII retinal KO and in WT littermates, suggesting that RGCs specify axons normally in the 
absence of TGFβRII signaling. 
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Supplemental  Figure  4.  Blocking  TGF-β  signaling  with  anti-TGF-β  reduces  C1q 
expression levels. (A) In situ for C1q A shows expression of C1q in the RGC layer which is 
significantly reduced in the TGF-βRII retinal KO and shows a patchy reduction in anti-TGF-β 
injected mice. (B) RGCs acutely isolated from P5 WT saline injected (white bar) and anti-TGF-β 
injected (grey bar) mouse retinas using immunopanning showed a significant reduction in C1q 
expression (two way ANOVA, n= 4 mice/group, *p<0.05).  Microglia acutely isolated using CD45 
immunopanning did not show a significant difference in C1q levels.  (C) Acutely isolated RGCs 
and microglia were checked for the expression of neuron specific and microglia specific genes, 
NSE and Iba1, respectively.  RGCs were significantly enriched for NSE compared to microglia 
and microglia were significantly enriched for Iba1 compared to RGCs (two way ANOVA, n=5 
samples/group, **p<0.01,***p<0.001). (D) Quantification of the relative fluorescence intensity in 
the IPL anti-TGF-β injected and WT vehicle injected littermates shows a significant reduction in 
C1q localization to the IPL when TGF-β signaling is blocked, similar to what is seen in the 
TGFβRII retinal KO (one way ANOVA, n= 4 mice/group, *p<0.05). 
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Supplemental  Figure  5.  Synaptic  proteins  are  accurately  localized  using  Imaris  3-D 
analysis.  (A) Immunohistochemistry for vglut2 was performed on P5 dLGNs after tracing RGC 
inputs from the left and right eyes with CTB-594 and CTB-647, respectively.  Z-stack confocal 
image  shows  vglut2  co-localization  with  the  CTB-labeled  RGC  axon  terminals.    (B)  3-D 
reconstruction, surface rendering, and subtraction of all vglut2 staining not contained within the 
volume of the RGC inputs was done to reveal vglut2-positive RGC inputs.  As expected, vglut2 
is localized within RGC inputs.  (C) Immunohistochemistry for PSD-95 was performed on P5 
dLGNs  after  tracing  RGC  inputs  from  the  left  and  right  eyes  with  CTB-594  and  CTB-647, 
respectively.  Z-stack confocal image shows some PSD-95 co-localization with the CTB-labeled 
RGC axon terminals. (D) 3-D reconstruction, surface rendering, and subtraction of all PSD-95 
staining not contained within the volume of the RGC inputs was done to reveal vglut2-positive 
RGC inputs.  As expected, PSD-95 was rarely localized within RGC inputs. (E) Quantification of 
C1q, vglut2, and PSD-95 volume within RGC terminals reveals that the volume of C1q detected 
within RGC terminals is much higher than PSD-95 (a postsynaptic protein), but not as high as 
vglut2, a protein highly enriched in RGC axon terminals.          
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Supplemental Figure 6. Retinal TGF-β signaling is required for eye specific segregation. 
(A)  Representative  images  of  anterograde  tracing  (Alexa  conjugated  b-cholera  toxin)  of 
contralateral (green, top row) and ipsilateral (red, second row) retinogeniculate projections and 
their overlap (yellow, bottom row) in the dorsal LGN for WT, TGF-β retinal KO, C1q KO, and 
anti-TGF-β  injected WT  and  C1q  KO  mice.  (B)  Quantification  of  percentage  of  dLGN  area 
receiving input from both contralateral and ipsilateral eyes (yellow area). Data shown as mean 
yellow area +/- SEM.  Mice deficient in TGF-β signaling (blue and green lines) show significantly 
more overlap between contralateral and ipsilateral inputs at P10 at every threshold measured 
compared to WT vehicle injected littermate mice (red) (two way ANOVA, n= 6 animals/group, 
***p<0.001, **p<0.01, *p<0.05).  Mice deficient in C1q only, TGF-β only, and both C1q and TGF-
β  show  similar  amounts  of  overlap  (green,  pink,  and  purple  lines)  show  significantly  more 
overlap  between  contralateral  and  ipsilateral  inputs  at  P10  at  every  threshold  measured 
compared  to  WT  littermate  mice  (red)  (two  way  ANOVA,  n=  6  animals/group,  ***p<0.001, 
**p<0.01, *p<0.05), but C1q KO mice injected with vehicle do not differ from C1q KO mice 
injected with anti-TGF-β. 
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Supplemental  Figure  7.  Microglia  numbers  and  localization  are  unaffected  in  TGFβRII 
retinal KO mice. (A) Representative images stained for Iba1 show that microglia morphology 
and distribution are similar in WT, TGFβRII retinal KOs, and C1q KOs. (B) Quantification of 
microglia density within the LGN shows similar densities in WT, TGFβRII retinal KOs, and C1q 
KOs (one way ANOVA, n= 4 animals/group, no significance). Density was calculated as the 
number of microglia divided by the dLGN area, excluding optic tract.  Numbers were normalized 
to WT.   
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Supplemental Figure 8. KCl-induced C1q Upregulation Is Specific for RGCs.   (A) RGCs, 
cortical neurons, and hippocampal neurons were depolarized with 55mM KCl.  All three neuron 
types showed upregulation of cFos, a known activity-dependent gene.  (B) Of the three neuronal 
cultures tested, only RGC showed a significant upregulation of C1q in response to KCl. (N=3 
experiments, *P<0.05, t test).    
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Supplemental Figure 9. C1q Regulates Synapse Number.   (A) C1q KO RGCs show 
increased synapse number compared to WT (B) Transfection of C1q A into C1qA KO RGCs 
rescues the synaptic phenotype. (C) ShRNA against C1qA shows that increase in synapses in 
C1q KO RGCs is cell autonomous (N=3 experiments, *P<0.05, **P<0.01, ***P<0.001, t test).    
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Supplemental Figure 10. Extracellular C1q Can Partially Rescue C1q KO Defects.   (A) C1q 
KO RGCs show increased synapse number (indicated by a co-localization of immunostaining for 
vglut2 and PSD95) compared to WT that is reduced when WT mouse RGC conditioned media is 
added to C1q KO cultures. (B) Quantification showed a significant increase in the number of 
synapses per cell in C1q KO RGCs that is partially rescued by the addition of WT RGC 
conditioned media (N=3 experiments, *P<0.05, **P<0.01, ANOVA).    
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Supplemental Figure 11.TGF-β Regulates C1q Function at Synapses in vitro.   (A) WT 
mouse RGCs grown in the presence of anti-TGF-β neutralizing antibodies showed an increase 
in synapse number as indicated by co-localized puncta for vglut2 and PSD95.  (B) 
Quantification of the number of synapses per cell showed a significant increase in the number of 
synapses in WT mouse RGCs grown in the presence of anti-TGF-β (N=3 experiments, *P<0.05, 
t test).    
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Supplemental Figure 12. C1q Regulate Neuronal Polarity in RGC Cultures.   (A) 
Immunostaining for MAP2 and neurofilament (NF) showed an increase in axons in C1q KOs.  
(Axons =MAP2-negative, NF-positive neurites). (B) Immunostaining for a marker of axon initial 
segments, βIV spectrin, and MAP2, a dendritic marker, was used to validate that the neurites in 
(A) were indeed functional axons.  (C) Quantification of the percentage of cells with no axon 
(red), a single axon (blue), and 2 or more axons (green) in WT and C1q KO RGC cultures 
showed a significant increase in the % of cells with multiple axons and a significant decrease in 
the number of cells with one axon in the C1q KOs. (N=3 experiments, *P<0.05, **P<0.01, Two 
way ANOVA).    
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Role of Glial Cells and Immune Molecules in Visual Development 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Contributions:  This review was written by Allison Bialas and Beth Stevens.   
Publications:  This review on the role of glial cells and immune molecules in visual development 
will appear as chapter 96 in the New Visual Neurosciences published by MIT press.   
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Introduction 
The proper development of the visual system is dependent on communication between 
remarkably diverse cell types with specialized roles at each developmental stage. Until recently, 
visual development had been viewed largely through a ―neurocentric‖ lens. However, new 
research is revealing that glia, the ―other‖ cells of the visual system, actively communicate with 
neurons and one another to influence nervous system development and brain wiring. 
Much of our general knowledge of glial function has come from seminal studies carried out in 
the visual system. In particular, the mammalian retina and optic nerve have been critical model 
systems for studying neuron–glia communication during development for many reasons. First, 
all major glial cell types are represented (see figure 96.1), and their anatomical interactions and 
biological functions can be studied in vitro and in vivo. Second, the accessibility of the eye is 
particularly amenable to pharmacological and molecular manipulations of neuron–glia 
interactions in vivo. Importantly, development of pioneering methods to purify and culture retinal 
neurons and each of the main glial cell types has been a major advance in the field (B.  Barres 
et al., 1988; Foo et al., 2011; Mi & Barres, 1999; Shi, Marinovich, & Barres, 1998). This 
approach allows for investigation of specific questions about how neurons and glia influence 
each other and the mechanisms involved, which are often difficult to address in vivo. Isolation of 
highly purified visual system neurons and glia has led to the elucidation of the astrocyte, 
oligodendrocyte, neuron, and Muller glial transcriptomes (Cahoy et al., 2008; Lovatt et al., 2007; 
Roesch et al., 2008), rich resources that continue to provide important insight into molecular 
mechanisms governing glial roles in the visual system. Together, these and other studies have 
revealed a prominent role for glia in wiring the visual system by regulating diverse functions 
including neuronal survival, axon guidance, myelination, synapse development, and plasticity.  
The goal of this chapter is to introduce glia, their functional roles in visual system development, 
and critical neuron–glia signals involved, including several immune-related signaling pathways  
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Figure 96.1. Glia of the visual system. (A) Distribution of types of glia found in the 
layers of the retina. PRL, photoreceptor layer; OPL, outer plexiform layer; INL, outer 
nuclear layer; IPL, inner plexiform layer; GCL, retinal ganglion cell layer. (B) Many glial 
subtypes can be found in the optic nerve, including specialized optic nerve head 
astrocytes with unique functions and morphologies. RGC, retinal ganglion cell. LC, 
lamina cribrosa 
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that help refine immature synaptic circuits. Here, we will highlight some of the recent discoveries 
that brought these long-overlooked cells into the spotlight. 
 
Glia of the Visual System 
From the specialized Muller glia of the retina that act as living optic fibers to direct light to 
the photoreceptors (Franze et al., 2007) to the astrocytes of the visual cortex that help define 
receptive fields (Schummers, Yu, & Sur, 2008), virtually every level of visual processing is in 
some way dependent on glia. Unlike neurons, glia are electrically inexcitable cells; however, 
they still actively communicate with neurons and one another by chemical signals, secreted 
proteins, and contact-dependent molecular interactions. Before exploring glial function during 
visual development, it is important to define the types of glia in the visual system, which exhibit 
remarkable diversity with respect to their origin, morphology, and function. 
In general, glia fall into three main classes (see figure 96.2): (1) Astrocytes, which 
extend processes that intimately associate with synapses, blood vessels, and axons; (2) 
oligodendrocytes, which ensheath and myelinate axons; and (3) microglia, the resident 
―immune‖ cells in the brain that rapidly respond to changes in the extracellular milieu. These 
general classes and functions of glia have been observed and characterized in many model 
systems, from flies and worms to vertebrates, suggesting that many glial functions are widely 
conserved (Freeman et al., 2003; Freeman & Doherty, 2006). Although it is convenient to place 
glia into morphological groups, it is becoming increasingly clear that the current categories fail to 
represent the extraordinary diversity and heterogeneity of glial morphology and function. This 
issue will be discussed in the sections below. 
Astrocytes 
Astrocytes, named for their star-like appearance, are a numerous and diverse class of 
glia. In addition to performing ―neural support roles,‖ such as buffering the ionic environment 
and removing excess glutamate via glutamate transporters, astrocytes are active participants at 165 
 
 
Figure 96.2. Main classes of glia. (A) Oligodendrocytes (red) are the myelinating cells of 
the brain. They produce large sheets of fatty myelin (yellow) that wrap axons. (B) 
Astrocytes (green) have many diverse functions including ensheathing synapses and 
interacting with neurons (red) to modulate activity. (C) Microglia (green) are the immune 
cells of the brain and recently have been shown to help prune synapses (red and blue) 
during synaptic refinement (Schafer et al., 2012). 
 
each major stage of neural development. They maintain neuronal survival, contact vasculature 
to modulate blood flow, stimulate neurite outgrowth, guide axons, and promote the formation 
and plasticity of synapses. 
Astrocytes come in two general classes: fibrous (white matter/type 2) astrocytes and 
protoplasmic (gray matter) astrocytes. Fibrous astrocytes associate longitudinally with white 
matter tracts, such as the optic nerve (see figure 96.1B), whereas protoplasmic astrocytes are 
uniformly distributed throughout gray matter and synaptic regions (see figures 96.1 and 96.2B) 
(Oberheim, Goldman, & Nedergaard, 2012). Until recently, our understanding of astrocyte 
morphology was based largely on immunostaining for a protein highly expressed by astrocytes, 
glial fibrillary acidic protein (GFAP). While this protein is found in most astrocytes in the brain, its 
localization is hardly representative of astrocytic morphology, as previously assumed. Recent in 
vivo imaging and three-dimensional reconstructions of astrocytes revealed that, despite their 
name, both fibrous and protoplasmic astrocytes are not ―star-shaped‖ after all and have 
complex branching patterns (see figure 96.2B). 166 
 
Protoplasmic astrocytes are heterogeneous and diverse in their functions, many of which 
have yet to be discovered (Oberheim, Goldman, & Nedergaard, 2012; Zhang & Barres, 2010). 
They classically buffer ions and neurotransmitters in the extracellular space, but astrocytes also 
express receptors for most neurotransmitters and can release a variety of neuroactive, 
synaptogenic, and trophic factors at synapses. The term ―tripartite synapse‖ has become a well-
known phrase to denote the important contribution of an synapse-ensheathing astrocytic 
process to synapse function (Haydon, 2001). A single protoplasmic astrocyte can extend 
thousands of processes that intimately associate with synapses. In fact, it has been estimated 
that a single astrocyte can associate with an average of four neurons (Halassa et al., 2007) and 
contact over 100,000 synapses (Bushong et al., 2002)! Moreover, the densely packed 
processes of adjacent astrocytes are organized into large, nonoverlapping anatomical domains, 
the functional significance of which is unknown. It has been hypothesized that astrocytic tiling 
helps connect neurons into microcircuits, especially as astrocytes are tightly coupled via gap 
junctions (Nagy & Rash, 2000). Astrocytic processes from a single protoplasmic astrocyte can 
contact blood vessels as well as synapses, placing them in the perfect position to regulate blood 
brain barrier development and neurovascular coupling as well (Haydon & Carmignoto, 2006; 
Rubin & Staddon, 1999). 
Fibrous astrocytes can be distinguished by morphology and molecular markers, 
including ganglioside and GFAP expression, and they are also quite heterogeneous (Raff et al., 
1983; Zamanian et al., 2012). Even in the optic nerve, one can observe substantial 
morphological diversity (see figure 96.1B). Recent imaging studies using GFAP reporter mice 
have identified that individual optic nerve head (ONH) astrocytes are more elaborate and 
extensive than most fibrous astrocytes. In fact, the processes of ONH astrocytes span most of 
the width of the nerve and overlap domains of other astrocytes (see figure 96.1B). The function 
of these specialized astrocytes has yet to be characterized during development, but they are 167 
 
particularly of interest in glaucoma research, where abnormalities in the ONH are thought to be 
early signs of pathology (Sun et al., 2010). 
Oligodendrocytes 
Oligodendrocytes, the myelinating glia of the CNS, are active participants in visual 
system development (see figures 96.1B and 96.2A). The myelin sheath regulates action 
potential propagation, axon diameter, as well as the expression and distribution of voltage-gated 
sodium channels (Rasband & Shrager, 2000; Sánchez et al., 1996; Schafer et al., 2006). 
Myelinating oligodendrocytes also provide trophic support for axons (Nave, 2010) and are 
potent regulators of neurite outgrowth and structure (Bandtlow, Zachleder, & Schwab, 1990; 
McKerracher et al., 1994). Moreover, myelin has been proposed to play a role in limiting 
regeneration and visual system plasticity (McGee et al., 2005; Schwab, 1990). 
During postnatal development, different types of oligodendrocytes associate with axons 
in discrete waves of myelination throughout the CNS. Myelinating oligodendrocytes are derived 
from oligodendrocyte precursor cells (OPCs), which are born during late embryonic and early 
postnatal development. OPCs undergo a precise developmental program driven by 
environmental and intrinsic cues described later in this chapter that regulate their development 
into myelinating oligodendrocytes (Dugas et al., 2006). Interestingly, early studies suggest that 
OPC proliferation may be regulated by neuronal activity (Barres & Raff, 1993), among other 
molecular cues. 
Recent studies also demonstrate that a subset of OPCs expressing the chondroitin 
sulfate proteoglycan, NG2, have unique characteristics. These ―NG2‖ cells are multipotent and 
can give rise to neurons, astrocytes, and oligodendrocytes (Nishiyama et al., 2009; Zhu, 
Bergles, & Nishiyama, 2008), but perhaps their most unique property is the fact that they can 
receive synaptic input from neurons and may be integrated into the neural circuitry of the brain 
(Bergles et al., 2000; Lin & Bergles, 2003). These synaptic junctions can be associated with 
either glutamatergic or GABAergic neurons and exhibit all the characteristics of a typical 168 
 
neuron–neuron synapse. The significance of these synapses is still unknown, but it has been 
suggested that these connections enable rapid communication between neurons and these glial 
progenitors to alter the behavior of these cells (Bergles, Jabs, & Steinhäuser, 2010). 
Mature myelinating oligodendrocytes are also remarkably heterogeneous. They are 
generally classified into subtypes based on their branching pattern (del Río-Hortega, 1928), the 
type of axon they myelinate, and the thickness of myelin formed (Butt et al., 1995). 
Oligodendrocytes are excluded from the retina; therefore retinal ganglion cell (RGC) axons 
within the eye are unmyelinated (Boiko et al., 2001). There are also nonmyelinating 
oligodendrocytes throughout the CNS, but their role in visual system development is unclear, 
although the close proximity of these cells to neurons and synapses suggests they may help to 
regulate the microenvironment around neurons. 
Microglia 
Microglia are the primary immune and phagocytic cells of the CNS (see figures 96.1 and 
96.2C). Microglia are myeloid-derived cells and, until recently, they were thought to develop 
from peripheral macrophages that entered and colonized the brain throughout development and 
into adulthood. We now know that most microglia arise from a unique pool of yolk-sac derived 
myeloid progenitors and migrate into the CNS by embryonic day E10.5 (Ginhoux et al., 2010). 
Following migration into the CNS, microglia undergo a slow maturation and differentiation 
process that persists through late postnatal development (Ransohoff & Perry, 2009). Microglia 
start as highly phagocytic, amoeboid cells and maintain this morphology through the period of 
programmed cell death when they actively remove debris and dead cells (Ferrer et al., 1990). 
By the first postnatal week in mouse, these cells develop branches which are used to 
continually survey the environment and down-regulate their phagocytic receptors (see figure 
96.2C) (Ling & Wong, 1993). In the event of injury or infection, microglia quickly adopt a more 
classically ―reactive‖ state and migrate to the site of injury where they shield the injury site, 
engulf pathogenic material or debris, and release many cytokines and chemokines (Davalos et 169 
 
al., 2005; Nimmerjahn, Kirchhoff, & Helmchen, 2005). While past work had focused on the role 
of microglia during disease, recent studies have revealed dynamic interactions between 
microglia and synapses in the healthy brain, particularly during developmental synaptic pruning 
(Schafer, Lehrman, & Stevens, 2012; Tremblay et al., 2011). 
The preponderance of glia throughout the visual system and their seemingly endless 
array of functions have led developmental neurobiologists to ask how these diverse cells 
influence visual system development. Understanding how glia communicate with neurons and 
each other to wire up the visual system has evolved into a broad and prolific area of research in 
developmental neurobiology. In the following sections, we will explore some of the major 
neuron–glia signaling interactions that help guide each major stage of visual system 
development. 
How Are the Diverse Neurons and Glia of the Visual System Generated? 
One of the earliest roles for glia in the developing brain is the generation of neurons and 
other glial cells. In fact, it is well established that radial glia in the ventricular zone serve as 
precursors to neurons and some glia, including astrocytes and oligodendrocytes (Alvarez-Buylla 
& Garc  a-Verdugo, 2002; Doetsch, 2003). Radial glia, as their name suggests, each extend a 
long process toward the pial surface that guides the outward migration of newly born neurons. 
In the retina, specialized radial glia called Muller cells give rise to many of the cells of the retina, 
including amacrine cells, horizontal cells, photoreceptors, Muller glia, and bipolar cells (Prada et 
al., 1991) (see figure 96.1A). Unlike radial glia of the ventricular zone which are transient, Muller 
glia persist throughout life and have unique functions in the retina. Their radial processes extend 
throughout the layers of the retina and act as ―living optic fibers,‖ allowing light to be transmitted 
to the photoreceptors without distortion (Franze et al., 2007) (see figure 96.1). In addition to 
their important role in light transmission, Muller glia, a type of specialized astrocyte, perform 
many of the functions carried out by astrocytes in the rest of the brain, including modulation of 
blood flow and neuronal activity (de Melo Reis et al., 2008; Newman & Zahs, 1998). 170 
 
Interestingly, recent work has also uncovered neurogenic potential for adult Muller cells from 
many organisms including humans, suggesting novel therapeutic potential for these cells for eye 
diseases (Bhairavi et al., 2011; Fischer & Reh, 2001; Ramírez & Lamas, 2009; Takeda et al., 
2008). 
Where do the rest of visual system glia come from, and how are they guided to their 
appropriate territories? Early in development, pools of glial precursor cells residing in the 
ventricular zones follow one of several migratory streams to their appropriate location. During 
gliogenesis, six individual glial precursor cell types have been identified (Lee, Mayer-Proschel, & 
Rao, 2000); however, rigorous fate-mapping studies following glial development have yet to be 
performed. Glial precursor cells are derived from the same radial glia that generate neurons. 
The birth of oligodendrocytes and astrocytes begins as neurogenesis ends; however, astrocytes 
and oligodendrocytes remain in an immature state in the first few weeks of life. 
The arrival and maturation of the various glial subtypes differs significantly. The majority 
of microglia seem to migrate into the CNS by embryonic day E10.5 (Ginhoux et al., 2010; 
Saederup et al., 2010); however, they do not reach their mature branched state until the second 
postnatal week. OPCs are the first glial cells born from radial glia after neurogenesis. OPCs 
undergo a maturation process that is not fully complete in all areas of the brain until adulthood 
(see myelination section). Astrocytes are the last cells born in the brain, and they are derived 
from radial glia. They migrate along the optic nerve and arrive in the optic nerve fiber and RGC 
layers of the retina, along with the rest of the visual system, toward the end of embryonic and 
early postnatal development (Watanabe & Raff, 1988). These cells also have an immature 
phenotype with a distinct gene expression profile including increased expression of intermediate 
filaments such as nestin and vimentin, some synaptogenic cues, and other neuroactive 
substances (Cahoy et al., 2008; Christopherson et al., 2005). 
As glia populate the nervous system, they profoundly affect neuronal function; however, 
newborn neurons play an active role in regulating gliogenesis and glial function as well. In the 171 
 
retina, for example, RGC axons secrete Shh and additional growth factors which promote 
expansion of astrocyte precursors in the embryonic and postnatal optic nerve (Burne & Raff, 
1997; Dakubo et al., 2003). Another progenitor cell pool that is modulated by neuronal signaling 
is the NG2 cell pool, discussed earlier in this chapter. These cells retain the potential to 
generate neurons and astrocytes into adulthood, and it is postulated that special synaptic 
connections between neurons and NG2 cells may be a way in which neurons can rapidly trigger 
proliferation of this population (Nishiyama et al., 2009; Zhu, Bergles, & Nishiyama, 2008). 
How Are Neurons and Axons Guided to Their Proper Locations? 
It has long been thought that glia play a key role in neuronal migration and guidance. 
Indeed, not only do radial glia give rise to neurons but also their processes serve as roadmaps 
guiding newborn neurons to their appropriate locations. Once neurons populate the visual 
system, they next must specify axons and dendrites to connect with appropriate targets. Glia 
play an important role in guiding axons along their path by secreting guidance cues and 
providing structural support for axons. 
Glia-derived cues have been shown to influence axon structure and guidance in vivo. In 
Drosophila, for example, photoreceptor axons are guided along their appropriate path by a 
stream of glial cells, known as retinal basal glia (RBG), migrating from the optic stalk into the 
optic disc (Rangarajan, Gong, & Gaul, 1999). When migration of RBG cells into the optic disc is 
blocked, as in the gish loss-of-function mutant, photoreceptor cells extend axons away from 
instead of into the optic stalk (Hummel et al., 2002). Once photoreceptor cell axons reach their 
targets, another Drosophila glial cell type, the lamina glia, help guide these axons to the 
appropriate lamina of the optic lobe, reminiscent of classic guidepost cells (Bentley & Caudy, 
1983; Poeck et al., 2001; Suh et al., 2002). Interestingly, however, lamina glia initially require 
axonal cues to migrate to their stereotyped laminar positions. They migrate along optic lobe 
axons to their correct position. Absent or aberrant projections from optic lobe neurons result in a 
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In the mammalian visual system, glia also are critical for RGC axon guidance. Radial glia 
localized to a region of the ventral midline known as the ―glial palisade‖ secrete molecular cues 
which guide RGC axons to form the optic chiasm at this position (Mason & Sretavan, 1997). 
Glial Ephrin-B2 and EphB1 signaling have been identified as critical guidance cues at the 
chiasm. During development of RGC ipsilateral projections, ephrin-B2 is expressed by radial 
glial cells at the midline. Ipsilaterally projecting RGCs, which express EphB1, are repelled by 
ephrin-B2-producing radial glia of the midline. Consistent with a role for ephrin-B2 and EphB1 
signaling in axon guidance at the chiasm, blockade of ephrin-B2 prevents the formation of 
ipsilateral projections in mice and mice deficient in EphB1 show a dramatic reduction in the 
number of ipsilateral projections (Williams et al., 2003). 
The target neurons for RGCs in the lateral geniculate nucleus (LGN) also appear to be 
guided into their appropriate positions by glia. In most mammals, the LGN is divided into several 
cell layers including magnocellular and parvocellular layers that receive input from distinct types 
of RGCs. The cues that regulate the formation of these layers are not well understood; however, 
laminations in the distribution of glial proteins such as GFAP and vimentin were observed prior 
to the development of neuronal layers, suggesting that a glial-derived cue may direct neurons to 
their locations (Hutchins & Casagrande, 1988). 
How Does Myelin Form and Function in the Developing Visual System? 
Myelination is one of the most complex cellular interactions in biology. The process 
requires recognition, association, ensheathment, and elaboration of glial membrane around an 
appropriate axon at precisely the right time in development. The end result is the formation of 
compact myelin sheath, which is essential for rapid propagation of nerve impulses along axons. 
Much of our understanding of the formation and function of myelin comes from studies carried 
out in the visual system. In particular, the vertebrate optic nerve (see figure 96.1B) has served 
as an excellent model system in which the stages of myelination have been extensively studied 
both in vitro and in vivo. These and other studies have uncovered critical molecular pathways 173 
 
regulating oligodendrocyte maturation and myelination (Emery, 2010a; Pogoda et al., 2006). 
The process begins with the differentiation of an OPC into a postmitotic, premyelinating 
oligodendrocyte. Once oligodendrocytes mature, environmental cues drive the progression of 
myelination. The factors promoting myelination, therefore, include both intrinsic oligodendrocyte 
factors that promote maturation and extrinsic factors from the axon or other cell types (Emery, 
2010a, 2010b). A recently developed coculture system that enables rapid myelination of CNS 
axons offers new opportunities for molecular dissection of multiple stages of myelination 
(Watkins et al., 2008). 
Oligodendrocytes are critically dependent on continual communication with axons during 
embryonic and early postnatal development. A number of molecular pathways have been 
identified that regulate myelination either directly or indirectly. For example, Wnt/β-catenin 
signaling is critical to drive terminal oligodendrocyte differentiation. Wnt signaling is specifically 
activated as terminal oligodendrocyte differentiation begins, but in mature oligodendrocytes, 
down-regulation of Wnt signaling appears to be necessary for myelination as mutations 
preventing Wnt down-regulation lead to myelination defects (Fancy et al., 2009; Fu et al., 2009). 
Conversely, cues such as Jagged (Wang et al., 1998), polysialyated-neural cell adhesion 
molecule (PSA-NCAM) (Grinspan & Franceschini, 1995), and LINGO-1 (Mi et al., 2005), all 
inhibit either OPC differentiation or myelination. 
In addition to these molecular cues, neural activity is thought to regulate myelination. 
Early studies in the optic nerve demonstrated that mice reared in the dark developed fewer 
myelinated axons compared with control mice (Gyllensten & Malmfors, 1963). Hypomyelination 
was also observed in optic nerve of the naturally blind cape-mole rat (Omlin, 1997) whereas 
prematurely opening the eyes in rabbit accelerated myelination (Tauber, Waehneldt, & Neuhoff, 
1980). A number of recent in vitro studies have provided additional information on activity-
dependent myelination. Activity-dependent regulation of axon-derived cues is one proposed 
mechanism (Itoh et al., 1995). For example, axonal release of ATP and adenosine is thought to 174 
 
stimulate purinergic receptors on OPCs promoting oligodendrocyte maturation and myelination 
(Stevens et al., 2002). More recent experiments suggest that astrocytes influence activity-
dependent regulation of myelination via ATP-dependent production of leukemia inhibitory factor 
(LIF). LIF could then promote OPC maturation and myelination (Ishibashi et al., 2006, 2009; 
Watkins et al., 2008). The precise molecular mechanisms underlying activity-dependent effects 
on myelination remain an active area of investigation (Emery, 2010a). 
What are the intrinsic signals controlling myelination? The oligodendrocyte transcriptome 
has revealed many highly expressed, oligodendrocyte-specific molecules whose roles are 
mostly unknown (Cahoy et al., 2008; Nielsen et al., 2006). One such key factor is myelin 
regulatory factor (MRF). MRF is a nuclear protein developmentally expressed specifically in 
postmitotic oligodendrocytes. RNA interference knockdown of MRF in oligodendrocytes 
suppresses expression of CNS myelin genes while overexpression of MRF promotes myelin 
gene expression. Mice in which MRF has been knocked out specifically in oligodendrocytes fail 
to generate myelin, display severe neurological abnormalities, and die in the first few postnatal 
weeks (Emery et al., 2009). Moreover, oligodendrocytes in these mice are arrested in the 
premyelinating stage, suggesting MRF is a master switch for myelination. Several other 
transcription factors have been identified that either promote or inhibit maturation of OPCs 
(Dugas et al., 2010). The transcription factor Olig2 is initially responsible for specifying the 
oligodendrocyte lineage (Lu et al., 2002; Zhou, Choi, & Anderson, 2001). Downstream 
transcription factors including Olig1, Ascl1, Nkx2.2, Sox10, YY1, and Tcf4 as well as MRF then 
promote maturation of OPCs into myelinating oligodendrocytes while cells expressing Id2, Id4, 
Hes5, and Sox6 maintain an OPC phenotype (Wegner, 2008). 
Other Functions of Myelin 
In addition to increasing the efficiency and speed of action potentials, myelinating 
oligodendrocytes wear many other hats. They appear to regulate axon structure, neurite 
outgrowth, and the expression and localization of ion channels along axons (Sánchez et al., 175 
 
1996; Starr et al., 1996). For example, recent work has shown that contact between RGCs and 
myelinating oligodendrocytes enhances axon function by altering voltage-gated sodium channel 
(Nav) expression and distribution. In mature RGCs, the voltage-gated sodium channel, Nav1.2, 
exclusively localizes to unmyelinated portions of RGC axons within the eye while a different 
type, Nav1.6, is localized to nodes of Ranvier along the myelinated axon. Interestingly, during 
development, Nav1.2 is first expressed throughout the axon, including at nodes of Ranvier. As 
myelination progresses, however, Nav1.2 channels are replaced at mature nodes of Ranvier 
with Nav1.6 channels, suggesting that myelin-derived cues guide channel expression and 
localization (Boiko et al., 2001). 
Myelin is also a potent inhibitor of neurite outgrowth. As myelination proceeds in waves 
in the CNS, regions that become myelinated early may act as repulsive guidance cues for CNS 
tracts that form later in development (Schwab & Schnell, 1991). Candidate myelin-derived 
proteins that inhibit axon growth include Nogo, NI-35, NI-250, and myelin-associated 
glycoprotein (MAG) (Caroni & Schwab, 1988a, 1988b; McGee et al., 2005; McKerracher et al., 
1994), and these molecules have been extensively studied in vitro and in vivo. Interestingly, 
peripheral nervous system myelin does not inhibit regeneration or growth, suggesting that 
unique components of CNS myelin underlie growth inhibition (Mukhopadhyay et al., 1994). 
Understanding the mechanisms of growth inhibition in the CNS is an area of active research in 
the regeneration field and may also be relevant to critical period plasticity, which we will discuss. 
What Do Astrocytes Do at Developing Synapses? 
Establishment of the correct numbers and types of synapses is crucial for proper visual 
system development and function. We know a great deal about the neuronal proteins required 
for the assembly and maturation of CNS synapses; however, pioneering studies in the 
mammalian visual system have identified astrocytes as critical mediators of CNS 
synaptogenesis through several secreted signals. The spatiotemporal correlation between the 
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suggested that astrocytes might provide important synaptogenic cues. For example, in the 
rodent visual system, RGC axons innervate the superior colliculus by birth (Lund, 1972). 
However, there is a 1-week delay before the majority of synapses are formed. This delay 
coincides with the birth and proliferation of astrocytes. 
Do astrocytes promote synaptogenesis? The establishment of methods to purify and 
culture rodent RGCs allowed Pfrieger and Barres to ask whether synapses could form in the 
absence of astrocytes (Pfrieger & Barres, 1997). Purified RGCs were healthy, elaborated 
dendrites and axons but formed few synapses when cultured without astrocytes. In contrast, 
addition of a feeding layer of astrocytes or astrocyte-conditioned medium significantly increased 
RGC synaptic activity and the number of structural synapses that formed (Pfrieger & Barres, 
1997; Ullian et al., 2001). These and other findings indicated that secreted factors from 
astrocytes strongly enhance pre- and postsynaptic function in developing RGCs (Ullian et al., 
2001) and prompted further exploration into the specific molecules that control this process. 
What Are the Astrocyte-Secreted Synaptogenic Factors? 
One class of astrocyte-secreted molecules that was recently identified are 
thrombospondins (TSPs) (Christopherson et al., 2005), a large multimeric family of extracellular 
matrix proteins (see table 96.1). In vivo, TSP-1 and -2 localize to astrocytic processes and 
synapses during development. Using purified RGC cultures, it was later found that astrocyte-
derived TSPs are necessary and sufficient for the assembly of structural synapses. The 
synapses induced by TSPs are ultrastructurally normal, presynaptically active, but 
postsynaptically silent. Mice deficient for both TSP-1 and -2 exhibited fewer synaptic puncta by 
immunostaining, demonstrating the importance of this molecule in normal development in vivo. 
Further investigation revealed that a calcium channel subunit, alpha2delta-1, is the receptor for 
TSP required for synaptogenesis (Eroglu et al., 2009). The molecular mechanism by which 
TSP-alpha2delta-1 interaction mediates synaptogenesis has yet to be fully elucidated. 
Interestingly, alpha2delta-1 is also the receptor for an anti-epileptic drug, gabapentin. Treating 177 
 
cultured RGCs or mice with gabapentin during synaptogenesis significantly reduced the number 
of synapses formed, identifying gabapentin as a potent inhibitor of synaptogenesis (Eroglu et 
al., 2009). 
 
Are There Other Astrocyte-Derived Synaptogenic Signals? 
Recent work has identified additional astrocyte-secreted proteins, hevin and SPARC, 
that regulate synaptogenesis (Kucukdereli et al., 2011). Both of these proteins are enriched in 
the superior colliculus coinciding with robust synaptogenesis during the postnatal period. Hevin, 
like TSP, promotes the formation of ultrastructurally normal synapses that are postsynaptically 
silent. Conversely, SPARC inhibits synaptogenesis by specifically antagonizing hevin. Although 
SPARC does not directly interact with hevin, it appears to compete with hevin for a common 
binding partner. Consistent with in vitro results, mice deficient in SPARC show an increase in 
synapse number in the superior colliculus while hevin-deficient mice show a reduction (see table 
96.1). The discovery of these molecules and their interaction demonstrates that astrocytes can 
both positively and negatively regulate synaptogenesis to influence synapse number. 
Table 96.1: Astrocyte-derived Molecules Regulate Synaptogenesis 
Molecule  Effect on Synapses  Citation 
Thrombospondins  + Structural synapses 
+ Presynaptic function 
Christopherson et al. (2005) 
Hevin  + Structural synapses 
+ Presynaptic function 
Kucukdereli et al. (2011) 
SPARC  – Structural synapses  Kucukdereli et al. (2011) 
ApoE/cholesterol  + Synapse number and 
efficacy 
Mauch et al. (2001) 
Glypican  + Structural and functional 
synapses 
+Pre- and postsynaptic 
function 
Allen et al. (2012) 
 
 178 
 
What is the elusive factor that converts silent synapses into fully functional connections? Recent 
work has identified glypicans as a novel class of astrocyte-derived proteins that regulate the 
maturation of postsynaptic machinery, specifically by inserting GluR1 subunits into the 
postsynaptic membrane (Allen et al., 2012). Glypican-4 and -6 (see table 96.1) were identified 
as molecules sufficient to induce fully functional synapses in RGC cultures and in vivo (Allen et 
al., 2012). Glypicans are the first astrocyte-derived molecules to be identified that can induce 
fully functional synapses, raising many questions about the underlying mechanisms. 
Since the initial finding that astrocytes regulate synaptogenesis, the list of astrocyte-
derived synaptogenic factors continues to grow. For example, cholesterol complexed with apoE 
enhances presynaptic function in RGC cultures by regulating presynaptic release machinery 
and potentially enhancing dendritic maturation (Goritz, Mauch, & Pfrieger, 2005; Mauch et al., 
2001). Understanding how these astrocyte-derived factors cooperate to regulate synapse 
formation is an area of active investigation. One hypothesis is that astrocytes regulate distinct 
phases of synaptogenesis (i.e. initial adhesion vs. maturation) via different factors and signaling 
pathways. Alternatively, many of these signals could act in a complex to initiate a common 
downstream pathway required to assemble functional CNS synapses. 
 
How Is Connectivity Refined? 
Glia and Immune Molecules Sculpt Developing Circuits in the Visual System 
The circuitry established during synaptogenesis is initially imprecise and includes many 
weak synapses which compete with each other for postsynaptic territory. This activity-
dependent competition leads to synaptic refinement—the selective pruning of inappropriate 
synapses and strengthening of appropriate synaptic connections (reviewed in Hua & Smith, 
2004; Huberman, Feller, & Chapman, 2008; Katz & Shatz, 1996). While the role of neuronal 
activity in developmental synaptic pruning is well established (Hua & Smith, 2004; Katz & Shatz, 
1996; Sanes & Lichtman, 1999) (and covered in more detail in other chapters), the molecular 179 
 
mechanisms linking neuronal activity with synaptic pruning are less clear. Recent studies 
implicate glia and immune molecules in sculpting synaptic circuits in the visual system. 
The previous section discussed a role for astrocytes in forming new synapses. Could 
they also influence synapse elimination? A screen to determine how astrocytes influence 
neuronal gene expression first identified the innate immune protein, C1q, as one of the few 
genes that was highly up-regulated in purified retinal ganglion neurons (RGCs) in response to 
astrocyte-derived secreted factors (Stevens et al., 2007). This was a surprising finding since 
C1q was not thought to be expressed by neurons in the healthy brain and microglia were 
presumed to be the only source of C1q in the brain. Perhaps even more unexpected was the 
finding that C1q and downstream complement protein C3 localize to subsets of synapses 
throughout the postnatal brain and retina (Stevens et al., 2007). In the immune system, C1q is 
the initiating protein in the classical complement cascade. The complement cascade opsonizes 
or ―tags‖ pathogenic microbes and cellular debris for rapid elimination by phagocytic 
macrophages or complement-mediated cell lysis. Could these classic immune molecules be 
similarly opsonizing or tagging immature synapses for elimination? 
This idea was tested in the mouse retinogeniculate system—a classical model for 
studying activity-dependent developmental synapse elimination (reviewed in (Guido, 2008; 
Hong & Chen, 2011; Huberman, 2007; Sretavan & Shatz, 1986). Early in development, RGCs 
form transient synaptic connections with relay neurons in the dorsal LGN (dLGN) of the 
thalamus (see figure 96.4). During the first 2 postnatal weeks, many of these transient 
retinogeniculate synapses are permanently eliminated (Campbell & Shatz, 1992; Hooks & 
Chen, 2006; Sretavan & Shatz, 1984). Consistent with a role for the classical complement  
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Figure 96.4. Immune molecules regulate refinement and plasticity of 
the visual system. Immune system molecules have been implicated in 
synaptic refinement of the retinogeniculate system. When NP1/2, 
complement (C1q or C3), or major histocompatibility complex (MHC) I 
signaling are disrupted, eye specific territories fail to form. Ocular 
dominance plasticity can be assessed by monocular deprivation during the 
critical period for ocular dominance (~postnatal day 24–28) and seeing a 
shift in cortical responses toward the nondeprived eye. Mice deficient in 
MHC I, tumor necrosis factor alpha (TNF-alpha), PirB, or Nogo show 
various phenotypes in ocular dominance plasticity, showing that immune 
molecules regulate multiple levels of this process.  
*The phenotype in NP1/2 knockout (KO) mice is transient. LGN, lateral 
geniculate nucleus; SC, superior colliculus; CP, critical period. 
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cascade in synaptic pruning, mice deficient in C1q and downstream C3 exhibit sustained 
defects in synapse elimination, as shown by the failure to segregate into eye-specific territories 
and the retention of multi-innervated LGN relay neurons (Stevens et al., 2007) (see figure 96.4). 
These mice still undergo a substantial degree of synaptic refinement (Stevens et al., 2007), 
suggesting that complement proteins cooperate with other pathways and neuronal activity to 
refine developing retinogeniculate circuits. Together, these findings raise many questions 
regarding the underlying cellular and molecular mechanisms. For example, if complement is 
tagging synapses, how then are complement-tagged synapses eliminated? 
 
A Novel Role for Microglia in Developmental Synaptic Pruning 
Emerging evidence implicates microglia as key players in developmental synaptic 
pruning (Ransohoff & Stevens, 2011; Schafer et al., 2012; Schafer, Lehrman, & Stevens, 2012). 
As discussed earlier, process-bearing phagocytic microglia have been observed in the dLGN 
and several other postnatal brain regions including hippocampus, cerebellum, and olfactory bulb 
(Dalmau et al., 1998; Perry, Hume, & Gordon, 1985), but until recently, the function of microglia 
in normal brain had remained a mystery. Microglia express an array of phagocytic receptors, 
including complement receptor 3 (CR3/CD11b/CD18) that could mediate the engulfment of 
synaptic elements during development. In the brain, microglia are the only resident cells 
expressing CR3 (Bobak et al., 1987; Graeber, 2010; Guillemin & Brew, 2004; Ransohoff & 
Perry, 2009). In the immune system, the activated C3 fragment C3b (iC3b) opsonizes the 
surface of cells/debris and ―tags‖ them for elimination by phagocytic macrophages that express 
C3 receptors (CR3/CD11b) (Carroll, 2004; Gasque, 2004; van Lookeren Campagne, 
Wiesmann, & Brown, 2007). 
Using the mouse retinogeniculate system as a model, microglia were found to engulf 
RGC presynaptic inputs during a peak pruning period in the developing dLGN (Schafer et al., 182 
 
2012). Moreover, genetic or pharmacological disruptions in microglia-mediated engulfment 
during the postnatal period resulted in sustained functional deficits in eye-specific segregation.  
Furthermore, microglia-mediated engulfment of synaptic inputs was dependent upon signaling 
between CR3, expressed specifically by microglia, and complement component C3, which is 
highly expressed in the postnatal dLGN (see figure 96.4) (Schafer et al., 2012). Interestingly, 
microglia-mediated engulfment was found to be regulated by neuronal activity. When 
competition between inputs from the two eyes was enhanced, microglia preferentially engulfed 
inputs from the eye with reduced neuronal activity. Although it is not yet known whether or how 
microglia target specific ―weaker‖ synapses, these data are consistent with previous work 
demonstrating a decreased synaptic territory of the ―weaker‖ inputs and increased territory of 
―stronger‖ inputs within the dLGN (see figure 96.5) (Cook, Prusky, & Ramoa, 1999; Del Rio & 
Feller, 2006; Huberman, Feller, & Chapman, 2008; Penn et al., 1998; Shatz, 1990; Shatz & 
Stryker, 1988; Stellwagen & Shatz, 2002). 
Recent studies also suggest that microglia associate with postsynaptic elements during 
synaptic remodeling in the hippocampus and juvenile visual cortex, raising the question of 
whether microglia-dependent pruning is a global mechanism of synaptic remodeling in the CNS 
(Paolicelli et al., 2011; Tremblay, Lowery, & Majewska, 2010). Paolicelli et al. (2011) 
demonstrated a role for the fractalkine receptor (CX3CR1), expressed on the surface of 
microglia, in hippocampal synapse development and maturation. Cx3cr1
KO mice have a 
transient reduction in the number of microglia in the postnatal brain; thus, fractalkine signaling 
could interact with complement and other signals to regulate microglia-mediated developmental 
pruning by influencing microglia number or, possibly, recruitment to synaptic sites in the 
postnatal brain (Ransohoff & Stevens, 2011). Together these new findings raise several 
fundamental questions related to the underlying mechanisms of microglia- and complement-
mediated pruning including how neural activity, complement, and microglia may interact to 
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Microglia may not be the only cells in the CNS phagocytosing material in the healthy, 
normal brain—astrocytes also show evidence of phagocytic capabilities (Al-Ali & Al-Hussain, 
1996; Bechmann & Nitsch, 1997; Cahoy et al., 2008). Although it is not yet clear whether 
astrocyte refine circuitry like microglia, a specialized class of astrocytes in the ONH myelin 
transition zone (MTZ) has been shown to normally express a common phagocytic marker, the 
galactose-specific lectin Mac-2 (also known as Lgals3 or galectin-3) (Nguyen et al., 2011; Sun 
et al., 2009) (see figure 96.1). In normal, healthy mice, large inclusions of axonal material have 
been observed in these astrocytes, suggesting that MTZ astrocytes may phagocytose axonal 
components as a form of axonal maintenance in the normal animal (Nguyen et al., 2011). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Other Immune Molecules 
Complement is among several immune-related molecules that have been identified as 
mediators of synaptic refinement and plasticity in the visual system (reviewed in Boulanger, 
2009; Shatz, 2009). These include neuronal pentraxins (e.g., NP1/2, NARP) and components of 
 
Figure 96.5. Model for microglia- and complement-dependent synapse 
elimination. Recent work demonstrated that microglia engulf less active inputs. 
The model for complement-dependent synapse elimination suggests that 
complement (C1q or C3) specifically tags these synapses for elimination by 
microglial engulfment via complement receptor 3(CR3)–C3 signaling. 184 
 
the adaptive immune system (e.g., class I major histocompatibility complex [MHC I] family of 
proteins and receptors) (Bjartmar et al., 2006; Corriveau, Huh, & Shatz, 1998; Datwani et al., 
2009; Huh et al., 2000). It is not clear at this point if these pathways interact with glia and/or 
complement or represent parallel pathways for refinement. 
Class I MHC molecules were the first to be identified as mediators of synaptic 
refinement. These molecules were initially shown to be expressed in an activity-dependent 
manner in the LGN. Infusion of tetrodotoxin to block all action potential activity in the LGN 
significantly reduced expression of class I MHC molecules. Furthermore, increasing neuronal 
firing with kainic acid induced seizure resulted in dramatic increases in class I MHC expression 
(Corriveau, Huh, & Shatz, 1998). The activity-dependent regulation of this gene suggested a 
potential role for the class I MHC signaling pathway in synaptic refinement. The role for class I 
MHC in activity-driven structural remodeling and synaptic plasticity was later demonstrated by 
examining three mouse strains deficient in class I MHC signaling: beta 2–microglobulin 
knockout mice, CD3 zeta-deficient mice, and a strain deficient in TAP1 and beta 2–
microglobulin (Goddard, Butts, & Shatz, 2007; Huh et al., 2000). All three mouse mutants 
showed similar defects in synaptic refinement in the retinogeniculate system, assayed by 
neuroanatomical tracing of eye specific territories (see figure 96.4). Mice deficient in class I 
MHC also showed enhanced long-term potentiation (LTP) and absent long-term depression in 
the adult hippocampus (Huh et al., 2000), implicating MHCs in plasticity in other brain regions 
as well. In the hippocampus, class I MHC was shown to modulate plasticity by inhibiting NMDA 
receptor-regulated alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor 
(AMPAR) trafficking (Fourgeaud et al., 2010), but it is not clear if this same mechanism plays a 
role in visual system plasticity. 
Understanding the mechanism by which class I MHC signaling promotes synaptic 
refinement and plasticity are important questions and areas of active investigation; however, 
recent work demonstrated that MHC I affects even earlier stages of development. MHC I is 185 
 
present at synapses in visual cortex during the peak of synaptogenesis and works as a negative 
regulator of excitatory and inhibitory synaptogenesis. In vitro, knocking down MHC I signaling 
increased excitatory and inhibitory synapse density, while beta 2-microglobulin deficient  mice 
showed an increase in synapse density throughout the brain in vivo (Glynn et al., 2011). The 
strength of excitatory and inhibitory synapses was also modulated by MHC I, suggesting that 
this molecule has diverse and important functions throughout development. Interestingly, recent 
work demonstrated a colocalization of C1q and MHC I proteins at RGC synapses in the 
postnatal LGN (Datwani et al., 2009), hinting that these proteins may interact during 
development. Recent work also has revealed enhanced ocular dominance plasticity in mice 
class I MHC signaling supporting a role for this pathway in experience-dependent plasticity, as 
discussed in the following section (Syken et al., 2006). 
Neuronal pentraxins (NP1 and 2) were found play a role in retinogeniculate refinement. 
Neuronal pentraxins are synaptic proteins with homology to pentraxins of the peripheral immune 
system, which are traditionally involved in opsonization and phagocytosis of dead cells in the 
immune system (Nauta et al., 2003). Mice deficient in neuronal pentraxins, NP1 and NP2, as 
well as the receptor, NPR, have transient defects in eye-specific segregation in the dLGN (see 
figure 96.4) (Bjartmar et al., 2006). These defects were not maintained into adulthood, and the 
eye-specific retinogeniculate inputs became segregated by postnatal day 30 (P30). A similar 
age-dependent phenotype results when spontaneous activity in the retina is blocked from P1–
P10 and then allowed to recover. When retinal activity was measured in mice deficient in 
neuronal pentraxins, levels of RGC spiking activity were dramatically increased, which may 
explain the phenotype in eye specific segregation (Bjartmar et al., 2006). Interetingly, PTX3, a 
long pentraxin, which has homology to neuronal pentraxins, can enhance microglial phagocytic 
activity (Jeon et al., 2010). In addition, neuronal pentraxins are significantly homologous to short 
pentraxins such as C-reactive protein, which is a well-described binding partner of C1q. Thus, 186 
 
neuronal pentraxins could potentially serve as synaptic binding partners for C1q during synapse 
development. 
Neuronal pentraxins also have other functions in the developing visual system. Neuronal 
pentraxins are required for normal acetylcholine-mediated retinal wave activity during 
development. NP1 can also interact with another neuronal pentraxin, Narp, to influence 
synaptogenesis and synaptic plasticity. Narp was identified as an activity-dependent immediate 
early gene that can promote synaptogenesis and the clustering of AMPARs in other systems 
(O‘Brien et al., 1999; Tsui et al., 1996). When complexed with NP1, Narp has an enhanced 
synaptogenic effect, mediating both activity-dependent and activity-independent clustering of 
AMPARs (Bjartmar et al., 2006; Xu et al., 2003). These interesting acute phase proteins seem 
to have critical roles in both synaptogenesis and synaptic refinement. 
 
Role of Glia and Immune Molecules in Visual Experience-Dependent Plasticity 
After eye opening, sensory experience helps to shape developing visual circuitry and 
tune visual responses. As the visual cortex matures, it develops exquisite organization, and 
visual receptive fields, along with ocular dominance and orientation selectivity columns, are 
mapped to the cortex (Hensch, 2004; Sur & Rubenstein, 2005). Recent work has demonstrated 
that astrocytes not only develop finely tuned responses to visual stimuli that mimic the mapping 
of neuronal responses but also influence the magnitude and duration of adjacent visually driven 
neuronal responses via glutamate transporters (Schummers, Yu, & Sur, 2008). The effects of 
sensory experience on glia and the role of glial cells in opening and closing the critical periods 
for visual plasticity have yet to be fully explored, although there have been clues that astrocytes, 
oligodendrocytes, and microglia influence cortical plasticity. 
One of the first clues that astrocytes might play an instructive role in ocular dominance 
plasticity came from a study in the late 1980s by Müller and Best. They showed that introducing 
kitten astrocytes into the mature cat visual cortex could reopen the critical period for ocular 187 
 
dominance (Müller & Best, 1989). Dark-rearing kittens, which delays maturation of the visual 
cortex, has also been shown to delay astrocyte maturation in visual cortex, linking neuronal 
activity with astrocyte maturation in this area (Müller, 1990). The neuron–astrocyte signaling 
pathways required for critical period plasticity have yet to be identified, however, and are an 
open area of active research. 
Microglia have also been recently implicated in experience-dependent plasticity. Recent 
in vivo imaging experiments have shown that microglia processes are highly dynamic and often 
associate with dendritic spines during the critical period for ocular dominance (Tremblay, 
Lowery, & Majewska, 2010; Tremblay et al., 2011; Wake et al., 2009). In experiments in which 
retinal activity was reduced via tetrodotoxin or enucleation of both eyes, microglia retracted their 
processes away from spines and showed reduced motility overall (Wake et al., 2009). Microglia 
were also shown to participate in the experience-dependent structural remodeling that occurs 
after dark adapting mice for 1 week and exposing them to light. Dark exposure decreases 
synaptic strength, and microglia processes were often found associated with subsets of spines. 
The presence of phagocytic compartments in microglial processes also increased with dark 
adapting. Upon exposure to light, microglia remained phagocytic, however were less often 
associated with spines (Tremblay, Lowery, & Majewska, 2010). These experience-dependent 
changes in microglial dynamics support a role for microglia in experience-dependent structural 
remodeling. 
Myelinating oligodendrocytes, as well as specific myelin proteins, have also been 
implicated in limiting experience-dependent plasticity in the adult visual cortex. Myelin-related 
proteins such as Nogo, MAG, and OMgp have been extensively studied as potent inhibitors of 
axonal growth and regeneration (Filbin, 2003). Nogo, which is expressed on the surface of 
oligodendrocytes, interacts with the Nogo receptor (NgR) expressed on axons to inhibit axonal 
growth. Interestingly, these proteins also seem to limit cortical plasticity (GrandPré, Li, & 
Strittmatter, 2002). When myelination is disrupted as in the NgR–/– mouse, mice enter the 188 
 
critical period normally; however, experience-dependent plasticity persists into adulthood such 
that even at P60 or beyond, monocular deprivation can trigger an increase in cortical responses 
to the nondeprived eye (see figure 96.4) (McGee et al., 2005). Myelin-derived Nogo, MAG, and 
OMgp, which have a broad distribution throughout the layers of visual cortex in adult versus 
juvenile mice, are thought to consolidate the neural circuitry established during experience-
dependent plasticity. 
A critical role for immune molecules has also been discovered in ocular dominance 
plasticity. In this system, monocular visual deprivation results in the weakening and pruning of 
inputs projecting from regions innervated by the deprived eye and an expansion of inputs from 
the nondeprived eye (see figure 96.4). Class I MHC molecules as well as proteins that interact 
with MHC I, such as paired-immunoglobulin–like receptor B (PirB), have been implicated in 
limiting ocular dominance plasticity. In mice that lack the transmembrane portion of PirB, thus 
preventing PirB signaling, ocular dominance plasticity, particularly the expansion of nondeprived 
inputs, is more robust and can be induced at any age (Syken et al., 2006). Interestingly, tumor 
necrosis factor alpha (TNF-alpha), a cytokine produced by astrocyte cultures and microglia, is 
also required for the strengthening of nondeprived inputs. Mice deficient in TNF-alpha exhibit 
the expected loss of deprived-eye responses (see figure 96.4), but the increase in cortical 
response to stimulation of the open eye is absent (Kaneko et al., 2008). This result supports the 
hypothesis that the weakening and strengthening of inputs in response to monocular deprivation 
are two distinct processes. 
The mechanism by which TNF-alpha is acting in ocular dominance plasticity has not 
been fully elucidated. Beattie and colleagues showed that the proinflammatory cytokine TNF-
alpha enhanced synaptic efficacy by increasing surface expression of AMPARs (Beattie et al., 
2002), which could explain the failure of synaptic strengthening during ocular dominance 
plasticity. In addition, TNF-alpha recently has been implicated in homeostatic synaptic scaling, a 
form of synaptic plasticity that involves uniform adjustments in the strength of all synapses on a 189 
 
cell in response to prolonged changes in the cell‘s synaptic activity such as blockade of synaptic 
function. Stellwagen and Malenka showed that TNF-alpha mediates synaptic scaling in 
response to prolonged activity blockade (Stellwagen & Malenka, 2006). Another possibility is 
that TNF-alpha affects plasticity as a result of its ability to induce MHC I expression (Israel et al., 
1989). In fact, many proinflammatory cytokines including interleukin (IL-) 6, IL-1 beta, IL-2, IL-
18, IL-8, and interferon-alpha and -beta all can inhibit hippocampal LTP, suggesting 
convergence on some common pathway (Boulanger, 2009). A major missing piece of the 
puzzle, however, is the identity of the molecules that scale down activity in the projections from 
the deprived eye. 
Discussion 
This chapter has highlighted the diversity of glial morphology and function in the visual 
system. The normal progression of visual development, originally viewed through a 
―neurocentric‖ lens, is now understood to be dramatically influenced by the diverse types of 
visual system glia. Conversely, ―activation‖ and dysfunction of glial cells can be damaging to the 
CNS and are hallmarks of many CNS diseases. Thus, understanding the role of glia and 
immune molecules during normal development could provide important insight into the 
mechanisms underlying neurodevelopmental disorders and neurodegenerative diseases 
affecting visual system function. 
The recent work reviewed here has provided a strong foundation for understanding the 
many roles that glia play in visual system development and function and has paved the way for 
many future studies. Many important and open questions remain, including the following: What 
are the cues that promote the terminal differentiation of glial precursors into their diverse 
morphological subtypes? What is the significance of ―NG2‖ cells in visual function? Do 
astrocytes and other glial cells directly regulate development of inhibitory synapses? How do 
glia help control experience-dependent remodeling of synaptic circuits? How do microglia sense 
and read out activity-dependent cues to help sculpt developing synaptic circuits? Do immune 190 
 
molecules, such as class I MHC and complement, have other functions in the developing visual 
system? 
Despite recent advances in understanding the molecules and pathways that underlie 
neuron–glia and neural–immune communication during visual development, there is still a need 
for better molecular tools to manipulate subsets of glial cells at the right place and time in vivo. 
Regardless, the exciting new findings highlighted here lay a strong foundation in a new area of 
neuroscience, in which there is much to explore and discover. 
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